[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 17236
1. Francik R, Kryczyk-Kozioł J, Francik S, Gryboś R, Krośniak M: Bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism? Biomed Res Int; 2017;2017:6950516
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?
  • Vanadium is a trace element mainly connected with regulation of insulin metabolism which is particularly important in diabetes.
  • Nevertheless, the effect of vanadium on lipid metabolism is still a problematic issue; therefore, the main purpose of this study was to investigate the effect of 3 organic complexes of vanadium such as sodium (2,2'-bipyridine)oxidobisperoxovanadate(V) octahydrate, bis(2,2'-bipyridine)oxidovanadium(IV) sulfate dehydrate, and bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) sulfate dihydrate in conjunction with high-fat as well as control diet in nondiabetes model on the following lipid parameters: total cholesterol, triglycerides, and high density lipoprotein as well as activity of paraoxonase 1.
  • The most significant effect was observed in case of bis(4,4'-dimethyl-2,2' bipyridine)oxidovanadium(IV) sulfate dehydrate in rats fed with high-fat diet.
  • Based on our research, bis(4,4'-dimethyl-2,2'-bipyridine)oxidovanadium(IV) sulfate dihydrate should be the aim of further research and perhaps it will be an important factor in the regulation of lipid metabolism.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Opin Chem Biol. 2001 Aug;5(4):416-23 [11470605.001]
  • [Cites] Cell Biochem Biophys. 2006;44(1):73-81 [16456236.001]
  • [Cites] Mol Med. 2007 Mar-Apr;13(3-4):203-9 [17592556.001]
  • [Cites] Saudi J Biol Sci. 2016 May;23(3):420-5 [27081369.001]
  • [Cites] J Nutr. 2000 Oct;130(10):2427-33 [11015468.001]
  • [Cites] Curr Med Chem. 2005;12(10):1161-208 [15892631.001]
  • [Cites] BioData Min. 2013 Apr 25;6(1):9 [23618370.001]
  • [Cites] Atherosclerosis. 2002 Feb;160(2):425-32 [11849667.001]
  • [Cites] Arch Biochem Biophys. 2005 Aug 15;440(2):158-64 [16055077.001]
  • [Cites] Diabetes Res Clin Pract. 2005 Nov;70(2):103-9 [16188572.001]
  • [Cites] J Clin Invest. 1996 Apr 1;97(7):1630-9 [8601628.001]
  • [Cites] Arch Med Res. 2015 Jul;46(5):328-38 [26135634.001]
  • [Cites] Metabolism. 2004 Feb;53(2):153-8 [14767865.001]
  • [Cites] Pharmacol Res. 2006 Jul;54(1):30-8 [16524741.001]
  • [Cites] N Am J Med Sci. 2012 Nov;4(11):523-32 [23181222.001]
  • [Cites] Mol Genet Metab. 2012 Jan;105(1):141-8 [22030099.001]
  • [Cites] J Trace Elem Med Biol. 2005;18(3):211-7 [15966569.001]
  • [Cites] Eur J Neurosci. 2015 Mar;41(5):631-40 [25728181.001]
  • [Cites] Diabet Med. 2005 Jan;22(1):2-13 [15606684.001]
  • [Cites] Am J Hum Genet. 1983 Mar;35(2):214-27 [6301268.001]
  • [Cites] Behav Res Methods. 2013 Jun;45(2):536-46 [23055163.001]
  • [Cites] Lipids Health Dis. 2014 Feb 24;13:39 [24558984.001]
  • [Cites] DNA Cell Biol. 2012 Jun;31(6):975-82 [22320866.001]
  • [Cites] Eur J Prev Cardiol. 2016 Jul;23(11):1202-10 [27118362.001]
  • (PMID = 28529953.001).
  • [ISSN] 2314-6141
  • [Journal-full-title] BioMed research international
  • [ISO-abbreviation] Biomed Res Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Nahimana MR, Nyandwi A, Muhimpundu MA, Olu O, Condo JU, Rusanganwa A, Koama JB, Ngoc CT, Gasherebuka JB, Ota MO, Okeibunor JC: A population-based national estimate of the prevalence and risk factors associated with hypertension in Rwanda: implications for prevention and control. BMC Public Health; 2017 Jul 10;18(1):2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Hypertension is a leading cause of cardiovascular diseases and a growing public health problem in many developed and developing countries.
  • A logistic regression model revealed that age (AOR: 8.02, 95% CI: 5.63-11.42, p < 0.001), living in semi-urban area (AOR: 1.30, 95% CI: 1.01-1.67, p = 0.040) alcohol consumption (AOR: 1.24, 95% CI: 1.05-1.44, p = 0.009) and, raised BMI (AOR: 3.93, 95% CI: 2.54-6.08, p < 0.001) were significantly associated with hypertension.
  • The risk of having hypertension was 2 times higher among obese respondents (AOR: 3.93, 95% CI: 2.54-6.08, p-value < 0.001) compared to those with normal BMI (AOR: 1.74, 95% CI: 1.30-2.32, p-value < 0.001).
  • Females (AOR: 0.75, 95% CI: 0.63-0.88, p < 0.001) and students (AOR: 0.45, 95% CI: 0.25-0.80, p = 0.007) were less likely to be hypertensive.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hum Hypertens. 2006 Nov;20(11):898-900 [16971958.001]
  • [Cites] Curr Hypertens Rep. 2013 Jun;15(3):134-6 [23536128.001]
  • [Cites] N Am J Med Sci. 2011 May;3(5):242-6 [22558602.001]
  • [Cites] Diabetes Res Clin Pract. 2013 Apr;100(1):19-28 [23453178.001]
  • [Cites] Br J Gen Pract. 2012 Mar;62(596):e224-6 [22429442.001]
  • [Cites] J Hum Hypertens. 2010 Dec;24(12 ):786-95 [20220771.001]
  • [Cites] Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):750-8 [23149426.001]
  • [Cites] BMC Public Health. 2010 Sep 22;10:569 [20860807.001]
  • [Cites] JAMA. 2013 Sep 4;310(9):959-68 [24002282.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2224-60 [23245609.001]
  • [Cites] Vasc Health Risk Manag. 2013;9:177-85 [23662063.001]
  • [Cites] J Hum Hypertens. 2001 Oct;15(10):727-31 [11607804.001]
  • [Cites] BMC Med. 2015 May 29;13:126 [26021319.001]
  • [Cites] Int J Hypertens. 2016;2016:3292938 [27200184.001]
  • [Cites] Int J Epidemiol. 2014 Feb;43(1):116-28 [24505082.001]
  • [Cites] PLoS One. 2014 Jan 15;9(1):e84238 [24454721.001]
  • [Cites] Int J Hypertens. 2013;2013:409083 [23573413.001]
  • [Cites] J Clin Hypertens (Greenwich). 2015 Jul;17(7):499-502 [25727743.001]
  • [Cites] Global Health. 2014 May 21;10:42 [24886649.001]
  • [Cites] PLoS One. 2013 Jun 11;8(6):e65938 [23776574.001]
  • [Cites] J Fam Issues. 2010 Sep;31(9):1211-1229 [26752799.001]
  • [Cites] BMC Neurol. 2012 Oct 02;12:117 [23031547.001]
  • [Cites] Hypertens Res. 2013 Aug;36(8):711-7 [23486167.001]
  • [Cites] Soc Sci Med. 2007 Nov;65(9):1853-66 [17640788.001]
  • [Cites] Int J Epidemiol. 2004 Dec;33(6):1345-52 [15218014.001]
  • [Cites] PLoS One. 2014 Aug 04;9(8):e104300 [25090232.001]
  • [Cites] Iran J Public Health. 2013 Aug;42(8):925-6 [26056650.001]
  • [Cites] J Hypertens. 2015 May;33(5):948-56 [25668349.001]
  • [Cites] BMC Public Health. 2016 Jul 18;16:590 [27430560.001]
  • [Cites] Hypertension. 2015 Feb;65(2):291-8 [25385758.001]
  • [Cites] J Cardiovasc Dis Res. 2012 Jul;3(3):191-6 [22923935.001]
  • [Cites] Am J Epidemiol. 2000 Aug 1;152(3):272-8 [10933274.001]
  • [Cites] Circulation. 2016 Mar 22;133(12):1199-208 [27002082.001]
  • [Cites] BMJ Open. 2013 Aug 30;3(8):e003423 [23996822.001]
  • [Cites] Circulation. 2001 Nov 27;104(22):2746-53 [11723030.001]
  • [Cites] Int J Cardiol. 2016 Dec 1;224:256-264 [27664572.001]
  • [Cites] Stroke. 2007 Apr;38(4):1304-8 [17322074.001]
  • [Cites] Glob Heart. 2016 Mar;11(1):47-59 [27102022.001]
  • [Cites] Int Arch Med. 2011 Oct 05;4:34 [21974840.001]
  • [Cites] BMC Public Health. 2015 Feb 28;15:203 [25880433.001]
  • [Cites] J Hum Hypertens. 2015 Mar;29(3):204-9 [25078490.001]
  • [Cites] Am J Hypertens. 2015 Jan;28(1):89-97 [24862960.001]
  • [Cites] Lancet Diabetes Endocrinol. 2014 Aug;2(8):634-47 [24842598.001]
  • [Cites] Nutr Rev. 2013 Mar;71(3):168-79 [23452284.001]
  • [Cites] PLoS One. 2016 Feb 16;11(2):e0149437 [26881429.001]
  • [Cites] J Hum Hypertens. 2015 Apr;29(4):247-53 [25273858.001]
  • [Cites] Hypertension. 2013 Jul;62(1):18-26 [23670299.001]
  • (PMID = 28693458.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Epidemiology / Hypertension / Non-communicable diseases / Risk factors / Rwanda
  •  go-up   go-down


3. Punsawad C, Phasuk N, Bunratsami S, Thongtup K, Siripakonuaong N, Nongnaul S: Prevalence of intestinal parasitic infection and associated risk factors among village health volunteers in rural communities of southern Thailand. BMC Public Health; 2017 Jun 09;17(1):564

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Intestinal parasitic infections remain prevalent and constitute a public health problem in certain rural areas of Thailand.
  • The overall prevalence of intestinal helminths was 9.3% (95% confidence interval [CI]: 6.3-13.0).
  • The prevalence of hookworm, Strongyloides stercoralis, and Trichuris trichiura were 8.0% (95% CI: 5.3-11.5), 0.9% (95% CI: 0.2-2.7), and 0.3% (95% CI: 0-1.7), respectively.
  • Blastocystis hominis accounted for the highest percentage of intestinal protozoan infections 4.0% (95% CI: 2.2-6.8), followed by Giardia intestinalis 0.6% (95% CI: 0-2.2).
  • Having dogs at home was associated with soil-transmitted helminth (STH) infection in study participants (Crude prevalence ratio [CPR]: 2.3; 95% CI: 1.0-5.2).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2015 Aug 25;10(8):e0136342 [26305361.001]
  • [Cites] Korean J Parasitol. 2013 Dec;51(6):727-34 [24516280.001]
  • [Cites] Am J Trop Med Hyg. 2011 Apr;84(4):594-8 [21460016.001]
  • [Cites] Parasit Vectors. 2014 May 12;7:221 [24886763.001]
  • [Cites] Sci Rep. 2014 Feb 14;4:4101 [24525479.001]
  • [Cites] Trop Biomed. 2008 Dec;25(3):237-42 [19287363.001]
  • [Cites] Adv Parasitol. 2004;58:197-288 [15603764.001]
  • [Cites] Parasit Vectors. 2014 Jan 21;7:37 [24447578.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Jun 12;8(6):e2854 [24921627.001]
  • [Cites] J Community Health. 2015 Aug;40(4):780-8 [25744815.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 1994 Dec;25(4):745-51 [7667725.001]
  • [Cites] Korean J Parasitol. 2013 Dec;51(6):747-9 [24516284.001]
  • [Cites] Rev Inst Med Trop Sao Paulo. 1972 Nov-Dec;14(6):397-400 [4675644.001]
  • [Cites] Lancet. 2006 May 6;367(9521):1521-32 [16679166.001]
  • [Cites] Int J Parasitol. 2000 Nov;30(12-13):1379-93 [11113263.001]
  • [Cites] BMC Public Health. 2014 Feb 14;14:166 [24528627.001]
  • [Cites] J Clin Microbiol. 1986 Oct;24(4):548-50 [3771743.001]
  • [Cites] Am J Trop Med Hyg. 2015 Aug;93(2):361-70 [26055746.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 2002;33 Suppl 3:113-9 [12971490.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 2002 Sep;33(3):468-73 [12693578.001]
  • [Cites] BMC Public Health. 2013 Feb 18;13:151 [23419037.001]
  • [Cites] J Clin Invest. 2008 Apr;118(4):1311-21 [18382743.001]
  • [Cites] N Engl J Med. 2004 Aug 19;351(8):799-807 [15317893.001]
  • (PMID = 28599633.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Intestinal parasitic infection / Nakhon Si Thammarat Province / Risk factors / Thailand / Village health volunteers
  •  go-up   go-down


Advertisement
4. Yang H, Guo W, Li J, Cao S, Zhang J, Pan J, Wang Z, Wen P, Shi X, Zhang S: Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis. PLoS One; 2017;12(3):e0166360

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, a meta-analysis was performed to evaluate this issue.
  • Reports with odds ratio (OR), risk ratio (RR) and corresponding 95% confidence intervals (CI) were considered.
  • A significant inverse association was shown between leptin and coronary heart disease (CHD), with an overall OR of 1.16 (95% CI: 1.02-1.32), but not for stroke (OR = 1.21, 95% CI 0.98-1.48) under sociodemographic adjustment.
  • Further adjustment for additional cardiovascular risk factors resulted in ORs of 1.16 (95% CI 0.97-1.40) for CHD and 1.10 (95% CI 0.89-1.35) for stroke.
  • The findings remained when analyses were restricted to high-quality studies and indicated OR estimates of 1.07 (95% CI 0.96-1.19) for CHD and 0.98 (95% CI 0.76-1.25) for stroke.
  • In a subgroup meta-analysis, a high leptin level was not independently associated with CHD in both females (OR = 1.03, 95% CI 0.86-1.23) and males (OR = 1.09, 95% CI 0.95-1.26) or with stroke in both females (OR = 1.13, 95% CI 0.87-1.47) and males (OR = 0.80, 95% CI 0.59-1.09).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 1997 Sep;82(9):2904-10 [9284717.001]
  • [Cites] Arq Bras Endocrinol Metabol. 2014 Nov;58(8):817-23 [25465603.001]
  • [Cites] J Endocrinol. 2014 Jan 08;220(2):T47-59 [24403378.001]
  • [Cites] Nature. 1998 Aug 27;394(6696):897-901 [9732873.001]
  • [Cites] Acta Biochim Biophys Sin (Shanghai). 2010 May 15;42(5):325-31 [20458445.001]
  • [Cites] Nat Neurosci. 1998 Oct;1(6):445-50 [10196541.001]
  • [Cites] Indian Heart J. 2005 Jan-Feb;57(1):39-43 [15852893.001]
  • [Cites] Am J Cardiol. 2007 Jul 15;100(2):234-9 [17631076.001]
  • [Cites] J Biol Chem. 2002 Nov 8;277(45):42557-62 [12200416.001]
  • [Cites] Obesity (Silver Spring). 2007 Jul;15(7):1694-701 [17636087.001]
  • [Cites] Heart. 2015 Aug;101(15):1182-9 [26041770.001]
  • [Cites] Cytokine. 2008 Jun;42(3):353-7 [18448353.001]
  • [Cites] Endocrine. 2006 Feb;29(1):81-90 [16622295.001]
  • [Cites] Science. 1998 Sep 11;281(5383):1683-6 [9733517.001]
  • [Cites] Circulation. 2004 May 11;109(18):2181-5 [15117839.001]
  • [Cites] Circulation. 2016 Jan 26;133(4):447-54 [26811276.001]
  • [Cites] Diabetes. 1999 Feb;48(2):426-9 [10334326.001]
  • [Cites] Circulation. 2001 Dec 18;104(25):3052-6 [11748099.001]
  • [Cites] J Am Coll Cardiol. 2009 Jan 13;53(2):167-75 [19130985.001]
  • [Cites] J Intern Med. 1999 Oct;246(4):409-18 [10583712.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] PLoS One. 2015 Jun 02;10(6):e0128987 [26035431.001]
  • [Cites] World J Cardiol. 2014 Jul 26;6(7):539-54 [25068015.001]
  • [Cites] Nature. 2006 Dec 14;444(7121):875-80 [17167476.001]
  • [Cites] Atherosclerosis. 2015 Mar;239(1):67-72 [25574859.001]
  • [Cites] J Intern Med. 2004 Aug;256(2):128-36 [15257725.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):e302-7 [17615382.001]
  • [Cites] Stroke. 2015 Oct;46(10 ):2881-5 [26337973.001]
  • [Cites] Circulation. 2000 Sep 12;102(11):1296-301 [10982546.001]
  • [Cites] Clin Endocrinol (Oxf). 2010 Jan;72(1):32-7 [19473179.001]
  • [Cites] Ann Neurol. 2012 Apr;71(4):478-86 [22522440.001]
  • [Cites] Atherosclerosis. 2012 Dec;225(2):341-7 [23099119.001]
  • [Cites] Lancet. 2014 Mar 15;383(9921):970-83 [24269108.001]
  • [Cites] Metabolism. 2013 Nov;62(11):1513-21 [23866981.001]
  • [Cites] Clin Exp Pharmacol Physiol. 2013 Jun;40(6):347-56 [23517328.001]
  • [Cites] Stroke. 2011 Jul;42(7):1813-20 [21546486.001]
  • [Cites] Platelets. 2010;21(1):11-9 [19954410.001]
  • [Cites] Atherosclerosis. 2014 Mar;233(1):3-10 [24529114.001]
  • [Cites] Lancet. 2011 Feb 12;377(9765):557-67 [21295846.001]
  • [Cites] J Endocrinol. 2013 Jan 02;216(1):T17-36 [23160967.001]
  • (PMID = 28278178.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


5. Rekhtina IG, Mendeleeva LP, Biryukova LS: [Light-chain deposition disease is a hematologic problem]. Ter Arkh; 2017;89(1):38-42
MedlinePlus Health Information. consumer health - Chronic Kidney Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Light-chain deposition disease is a hematologic problem].
  • [Transliterated title] Bolezn' depozitov legkikh tsepeĭ — gematologicheskaia problema.
  • By the initiation of therapy, all the patients were diagnosed as having chronic kidney disease (Stage III (n=2), Stage IV (n=2), and dialysis-related renal failure (n=5)).
  • К началу терапии у всех больных диагностирована хроническая болезнь почек (у 2 III стадии, у 2 IV стадии, у 5 зависимая от диализа почечная недостаточность).

  • Genetic Alliance. consumer health - Light chain deposition disease.
  • MedlinePlus Health Information. consumer health - Blood Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28252625.001).
  • [ISSN] 0040-3660
  • [Journal-full-title] Terapevticheskii arkhiv
  • [ISO-abbreviation] Ter. Arkh.
  • [Language] rus
  • [Publication-type] Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


6. Byrnes J, King N, Hawe P, Peters P, Pickett W, Davison C: Patterns of youth injury: a comparison across the northern territories and other parts of Canada. Int J Circumpolar Health; 2015 Jan;74(1):27864
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • For those living in the northern territories (Yukon, Nunavut, and the Northwest Territories), injury represents an even greater problem, with higher rates of injury for people of all ages in northern areas compared with the rest of Canada; however, no such comparative studies have focussed specifically on non-fatal injury in youth.
  • Among northern youth, female sex (RR=0.87, 95% CI 0.81-0.94), average (RR=0.88, 95% CI 0.80-0.97) or above-average affluence (RR=0.84, 95% CI 0.76-0.91), not being drunk in the past 12 months (RR=0.77, 95% CI 0.69-0.85), not riding an all-terrain vehicle (RR=0.81, 95% CI 0.68-0.97) and not having permanent road access (RR=0.89, 95% CI 0.80-0.98) were protective against injury; sport participation increased risk (RR=1.45, 95% CI 1.33-1.59).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28417796.001).
  • [ISSN] 2242-3982
  • [Journal-full-title] International journal of circumpolar health
  • [ISO-abbreviation] Int J Circumpolar Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Aboriginal populations / Indigenous health / adolescent / alcohol policy / epidemiology / injury / northern health / population health
  •  go-up   go-down


7. Yaeger JP, Moreno MA: The Role of Age and Setting in Adolescents' First Drinking Experience for Predicting College Problem Drinking. J Am Coll Health; 2017 Jun 16;:0

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The Role of Age and Setting in Adolescents' First Drinking Experience for Predicting College Problem Drinking.
  • PURPOSE: The purpose of this study was to determine the reliability of longitudinally reporting age at first drink (AFD), and to test AFD and setting of first drink (SFD) as predictors of collegiate problem drinking.
  • METHODS: AFD, SFD, and problem drinking were measured using the Alcohol Use Disorders Identification Test (AUDIT) during the first year of college.
  • Social SFD was the strongest independent predictor for higher AUDIT scores (b = 4.74, 95% CI; 1.91, 7.57; p = .002).
  • CONCLUSIONS: Findings suggest caution should be used in relying upon using AFD as a sole predictor of problem drinking.
  • SFD may be a complementary measure to identify students at high-risk for collegiate problem drinking.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28622114.001).
  • [ISSN] 1940-3208
  • [Journal-full-title] Journal of American college health : J of ACH
  • [ISO-abbreviation] J Am Coll Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Alcohol / Clinical Medicine / Community Health / Health Education
  •  go-up   go-down


8. Andrews JA, Harrison RF, Brown LJE, MacLean LM, Hwang F, Smith T, Williams EA, Timon C, Adlam T, Khadra H, Astell AJ: Using the NANA toolkit at home to predict older adults' future depression. J Affect Disord; 2017 Apr 15;213:187-190

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We tested multiple values of the selection parameter in order to produce a model with low deviance.
  • The cross-validated area under the ROC curve for this model was 0.88 (CI: 0.69-0.97).
  • LIMITATIONS: While results are based on a small sample, the methodology for the selection of variables appears suitable for the problem at hand, suggesting promise for a wider study and ultimate deployment with older adults at increased risk of depression.
  • CONCLUSIONS: We have identified self-reported scales of sadness and tiredness as sensitive measures which have the potential to predict future depression status in older adults, partially addressing the problem of underdiagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.
  • (PMID = 28259086.001).
  • [ISSN] 1573-2517
  • [Journal-full-title] Journal of affective disorders
  • [ISO-abbreviation] J Affect Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Depression / Lasso / Machine learning / Older adults / Technology / Touchscreen
  •  go-up   go-down


9. Gimzewska M, Jackson AI, Yeoh SE, Clarke M: Totally percutaneous versus surgical cut-down femoral artery access for elective bifurcated abdominal endovascular aneurysm repair. Cochrane Database Syst Rev; 2017 02 21;2:CD010185
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SEARCH METHODS: For this update the Cochrane Vascular Information Specialist (CIS) searched their Specialised Register (last searched October 2016) and CENTRAL (2016, Issue 9).
  • The second study was a larger study with few sources of bias and good methodology.We observed no significant difference in mortality between groups, with only one mortality occurring overall, in the totally percutaneous group (risk ratio (RR) 1.50; 95% confidence interval (CI) 0.06 to 36.18; 181 participants; moderate-quality evidence).
  • In this study we observed only one failure of aneurysm exclusion in the surgical cut-down femoral artery access group (RR 0.17, 95% CI 0.01 to 4.02; 151 participants; moderate-quality evidence).
  • No wound infections occurred in the cut-down femoral artery access group or the percutaneous group across either study (moderate-quality evidence).There was no difference in major complication rate between cut-down femoral artery access and percutaneous groups (RR 0.91, 95% CI 0.20 to 1.68; 181 participants; moderate-quality evidence); or in bleeding complications and haematoma (RR 0.94, 95% CI 0.31 to 2.82; 181 participants; high-quality evidence).Only one study reported long-term complication rates at six months, with no differences between the percutaneous and cut-down femoral artery access group (RR 1.03, 95% CI 0.34 to 3.15; 134 participants; moderate-quality evidence).We detected differences in surgery time, with percutaneous approach being significantly faster than cut-down femoral artery access (mean difference (MD) -31.46 minutes; 95% CI -47.51 minutes to -15.42 minutes; 181 participants; moderate-quality evidence).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [UpdateOf] Cochrane Database Syst Rev. 2014 Feb 27;(2):CD010185 [24578199.001]
  • (PMID = 28221665.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  •  go-up   go-down


10. Haider BA, Sharma R, Bhutta ZA: Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries. Cochrane Database Syst Rev; 2017 02 24;2:CD006980
Hazardous Substances Data Bank. VITAMIN A .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Vitamin A deficiency is a major public health problem in low and middle income countries.
  • SEARCH METHODS: We used the standard search strategy of the Cochrane Neonatal Review Group to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 2), MEDLINE via PubMed (1966 to 13 March 2016), Embase (1980 to 13 March 2016) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to 13 March 2016).
  • Therefore, we analysed data and presented estimates for term infants (when specified) and for all infants.Data for term neonates from three studies did not show a statistically significant effect on the risk of infant mortality at six months in the vitamin A group compared with the control group (typical risk ratio (RR) 0.80; 95% confidence interval (CI) 0.54 to 1.18; I<sup>2</sup> = 63%).
  • Analysis of data for all infants from 11 studies revealed no evidence of a significant reduction in the risk of infant mortality at six months among neonates supplemented with vitamin A compared with control neonates (typical RR 0.98, 95% CI 0.89 to 1.07; I<sup>2</sup> = 47%).
  • We observed similar results for infant mortality at 12 months of age with no significant effect of vitamin A compared with control (typical RR 1.04, 95% CI 0.94 to 1.15; I<sup>2</sup> = 47%).
  • Given this finding and the absence of a clear indication of the biological mechanism through which vitamin A could affect mortality, along with substantial conflicting findings from individual studies conducted in settings with potentially varying levels of maternal vitamin A deficiency and infant mortality, absence of follow-up studies assessing any long-term impact of a bulging fontanelle after supplementation and the finding of a potentially harmful effect among female infants, additional research is warranted before a decision can be reached regarding policy recommendations for this intervention.

  • MedlinePlus Health Information. consumer health - Vitamin A.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [UpdateOf] Cochrane Database Syst Rev. 2011 Oct 05;(10):CD006980 [21975758.001]
  • (PMID = 28234402.001).
  • [ISSN] 1469-493X
  • [Journal-full-title] The Cochrane database of systematic reviews
  • [ISO-abbreviation] Cochrane Database Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Vitamins; 11103-57-4 / Vitamin A
  •  go-up   go-down


11. Haba Y, Williams MV, Ong J, Ostrowski J, Oliver RT: Favourable IGCCCG subgroups of stage II NSGCT patients may require less chemotherapy if TNM staging is included. J Clin Oncol; 2004 Jul 15;22(14_suppl):4532

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate this issue the impact of nodal (stage II) versus extra nodal (stage IV) metastases in each of the IGCCCG sub-groups has been examined in an audit of 447 patients treated in centres where chemotherapy rather than RPLND was primary management for stage 2 non-seminoma.
  • N+, n=156); 85% of stage IV (i.e. M+, n=94).
  • In contrast survival was significantly influenced in intermediate and poor risk cases with 79% of stage II (N+, n=29) patients alive compared to 60% of stage IV (M+, n=92) (x2 4.05p = <0.05).
  • CONCLUSIONS: Extralymphatic spread (stage IV) is prognostically significant within intermediate and poor risk IGCCCG.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28016059.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Luong NV, Kantarjian HM, Faderl SH, Thomas DA, Vu KD: Occurence of venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL), or lymphoblastic leukemia (LL). J Clin Oncol; 2009 May 20;27(15_suppl):7059

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 7059 Background: Venous thromboembolism (VTE) is a significant public health issue.
  • In a univariate model, pts with baseline platelet (plt) count 50-99 x 10<sup>9</sup>/L were 2.2 times (95% CI: 1.05-4.55) more likely to develop VTE than pts who had plt >100 x 10<sup>9</sup>/L.
  • Pts aged 40-59 yrs were 2.3 times (95% CI: 1.15-4.59) more likely to develop VTE than pts aged 15-39 yrs.
  • Women were 1.8 times (95%CI: 1.04-3.4) more likely than men to have a VTE.
  • Pts with a history of VTE were 15.2 times (95% CI: 2.97-77.51) more likely to develop a VTE than pts who had no prior VTE history.
  • Pts with > 3 comorbidities were 2.6 times (95% CI: 1.19-5.48) more likely to develop VTE than pts without comorbidities.
  • Pts who used oral contraception or hormone replacement therapy (OCP/HRT) were 2 times (95% CI: 1.07-3.92) more likely to develop VTE than non-users.
  • Pts with Philadelphia chromosome (Ph)-positive ALL were 3 times (95%CI: 1.41-6.17) more likely to develop VTE than pts with Ph-negative ALL.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27961450.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Haines T, Bowles KA: Cost-effectiveness of using a motion-sensor biofeedback treatment approach for the management of sub-acute or chronic low back pain: economic evaluation alongside a randomised trial. BMC Musculoskelet Disord; 2017 Jan 17;18(1):18

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There is high need to identify effective and economically efficient means for managing this problem.
  • The intervention group had greater use of trial-related medical and therapy resources [$477 per participant (95% CI: $447, $508)], but lower use of non-trial medical and therapy resources [$-53 per participant (95% CI: $-105, $-0)], and a greater improvement in productivity [$-5123 per participant (95% CI: $-10,174, $-72)].
  • There was >99% confidence in this finding of dominance in both the primary and sensitivity analyses.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28095832.001).
  • [ISSN] 1471-2474
  • [Journal-full-title] BMC musculoskeletal disorders
  • [ISO-abbreviation] BMC Musculoskelet Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cost-effectiveness / Economic evaluation / Low back pain / Randomized trial
  •  go-up   go-down


14. Mina F, Attina V, Duroc Y, Veuillet E, Truy E, Thai-Van H: Auditory steady state responses and cochlear implants: Modeling the artifact-response mixture in the perspective of denoising. PLoS One; 2017;12(3):e0174462

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Auditory steady state responses (ASSRs) in cochlear implant (CI) patients are contaminated by the spread of a continuous CI electrical stimulation artifact.
  • The aim of this work was to model the electrophysiological mixture of the CI artifact and the corresponding evoked potentials on scalp electrodes in order to evaluate the performance of denoising algorithms in eliminating the CI artifact in a controlled environment.
  • 32-channel scalp recordings of the CI artifact-response were then generated by solving the electromagnetic forward problem.
  • As an application, the framework's simulated 32-channel datasets were used to compare the performance of 4 commonly used Independent Component Analysis (ICA) algorithms: infomax, extended infomax, jade and fastICA in eliminating the CI artifact.
  • Among the ICA algorithms tested, simulations showed that infomax was the most efficient and reliable in denoising the CI artifact-response mixture.
  • Denoising algorithms can induce undesirable deformation of the signal of interest in real CI patient recordings.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Audiol. 2004 Dec;43 Suppl 1:S39-43 [15732381.001]
  • [Cites] J Assoc Res Otolaryngol. 2010 Jun;11(2):267-82 [20033246.001]
  • [Cites] Ear Hear. 2004 Dec;25(6):611-23 [15604921.001]
  • [Cites] PLoS One. 2012;7(9):e45375 [23028971.001]
  • [Cites] J Assoc Res Otolaryngol. 2006 Sep;7(3):253-66 [16715356.001]
  • [Cites] Neural Comput. 1995 Nov;7(6):1129-59 [7584893.001]
  • [Cites] Neuroimage. 2016 Oct 15;140:89-98 [26481671.001]
  • [Cites] Hear Res. 2012 Feb;284(1-2):6-15 [22234161.001]
  • [Cites] ScientificWorldJournal. 2014 Feb 04;2014:501738 [24688394.001]
  • [Cites] Clin Neurophysiol. 2001 Sep;112(9):1698-711 [11514253.001]
  • [Cites] Comput Intell Neurosci. 2011;2011:156869 [21253357.001]
  • [Cites] Int J Audiol. 2009 Aug;48(8):561-7 [19842810.001]
  • [Cites] Hear Res. 2016 May;335:149-60 [26994660.001]
  • [Cites] J Neural Eng. 2015 Jun;12(3):031001 [25834104.001]
  • [Cites] Psychophysiology. 2011 Nov;48(11):1470-80 [21635266.001]
  • [Cites] Physiol Meas. 2005 Feb;26(1):R15-39 [15742873.001]
  • [Cites] J Neurosci Methods. 2005 Feb 15;141(2):171-98 [15661300.001]
  • [Cites] Anesth Analg. 1968 Nov-Dec;47(6):717-23 [4972743.001]
  • [Cites] Clin Neurophysiol. 2004 Dec;115(12):2811-24 [15546789.001]
  • [Cites] IEEE Trans Biomed Eng. 2009 Dec;56(12):2851-7 [19695980.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2001 Apr 27;58(2):153-62 [11278024.001]
  • [Cites] J Assoc Res Otolaryngol. 2012 Aug;13(4):573-89 [22569837.001]
  • [Cites] Brain Topogr. 2002 Winter;15(2):69-86 [12537303.001]
  • [Cites] Laryngoscope. 1998 Apr;108(4 Pt 1):554-9 [9546269.001]
  • [Cites] Clin Neurophysiol. 2007 Mar;118(3):676-89 [17223382.001]
  • [Cites] Int J Audiol. 2003 Jun;42(4):177-219 [12790346.001]
  • [Cites] J Neurosci Methods. 2012 Jul 30;209(1):212-8 [22743800.001]
  • [Cites] ORL J Otorhinolaryngol Relat Spec. 1992;54(6):285-94 [1475097.001]
  • [Cites] Hear Res. 2013 Aug;302:60-73 [23632279.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2012 Nov;76(11):1627-32 [22910837.001]
  • [Cites] Bioinformatics. 2002;18 Suppl 2:S231-40 [12386007.001]
  • [Cites] IEEE Trans Biomed Eng. 2007 Mar;54(3):380-8 [17355049.001]
  • [Cites] Acta Otolaryngol. 2010;130(1):102-7 [19424919.001]
  • [Cites] Neural Netw. 2000 May-Jun;13(4-5):411-30 [10946390.001]
  • [Cites] Hear Res. 2008 Jan;235(1-2):105-13 [18093768.001]
  • [Cites] Neuroimage. 2016 Jan 1;124(Pt A):168-80 [26302675.001]
  • [Cites] Ear Hear. 2014 Sep-Oct;35(5):533-43 [24681426.001]
  • [Cites] Neural Comput. 1999 Feb 15;11(2):417-41 [9950738.001]
  • [Cites] Cochlear Implants Int. 2015 Jan;16(1):32-8 [24855994.001]
  • [Cites] IEEE Trans Biomed Eng. 2011 Feb;58(2):348-54 [20813628.001]
  • [Cites] Front Psychol. 2012 Jul 09;3:233 [22787453.001]
  • [Cites] J Am Acad Audiol. 2007 Feb;18(2):126-40 [17402299.001]
  • [Cites] Hear Res. 2013 Aug;302:84-95 [23727626.001]
  • [Cites] IEEE Trans Biomed Eng. 2003 Jun;50(6):754-67 [12814242.001]
  • [Cites] IEEE Trans Neural Netw. 1999;10(3):626-34 [18252563.001]
  • [Cites] Clin Neurophysiol. 2006 Aug;117(8):1772-82 [16807102.001]
  • [Cites] Hear Res. 1988 Nov;36(2-3):153-62 [3209488.001]
  • [Cites] Hear Res. 2010 Jan;259(1-2):95-106 [19878712.001]
  • [Cites] PLoS One. 2014 Mar 05;9(3):e90044 [24599314.001]
  • (PMID = 28350887.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Hmone MP, Li M, Agho K, Alam A, Dibley MJ: Factors associated with intention to exclusive breastfeed in central women's hospital, Yangon, Myanmar. Int Breastfeed J; 2017;12:29

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Under-nutrition is a public health problem in Myanmar.
  • RESULTS: After adjusting for potential confounders, working women were less likely to intend to EBF (adjusted odds ratio (AOR) = 0.30, CI 0.17-0.53).
  • Women from rich households (AOR = 2.43, CI 1.08-5.47) and middle income households (AOR = 1.79, CI 1.01-3.16); those who had high (AOR = 10.19, CI 3.43-30.23) and medium (AOR = 5.46, CI 1.79-16.72) breastfeeding knowledge levels, and received information from health professionals (AOR = 2.29, CI 1.29-4.03) and mobile internet (AOR 3.62, CI 2.04-6.41) had a higher intention to EBF.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JMIR Res Protoc. 2017 Jun 28;6(6):e126 [28659252.001]
  • [Cites] Breastfeed Med. 2009 Mar;4(1):25-30 [19196037.001]
  • [Cites] Women Birth. 2010 Dec;23(4):135-45 [20299299.001]
  • [Cites] Pediatrics. 2010 Jul;126(1):e18-25 [20566605.001]
  • [Cites] Lancet. 2013 Aug 3;382(9890):427-51 [23746772.001]
  • [Cites] J Community Health. 2008 Apr;33(2):53-60 [18060485.001]
  • [Cites] Breastfeed Rev. 2000 Mar;8(1):25-33 [10842578.001]
  • [Cites] Birth. 2002 Dec;29(4):278-84 [12484390.001]
  • [Cites] Can J Public Health. 2014 May 09;105(3):e179-85 [25165836.001]
  • [Cites] Int Breastfeed J. 2006 Oct 12;1:18 [17034645.001]
  • [Cites] Appetite. 2016 Jan 1;96:62-9 [26344810.001]
  • [Cites] J Hum Lact. 1999 Sep;15(3):195-201 [10578797.001]
  • [Cites] J Hum Lact. 2010 Aug;26(3):248-57 [20110564.001]
  • [Cites] Birth. 2007 Sep;34(3):212-9 [17718871.001]
  • [Cites] Int Breastfeed J. 2009 Oct 16;4:9 [19835586.001]
  • [Cites] J Obstet Gynecol Neonatal Nurs. 2002 Jan-Feb;31(1):12-32 [11843016.001]
  • [Cites] Acta Paediatr. 2003;92 (3):352-6 [12725552.001]
  • [Cites] J Obstet Gynecol Neonatal Nurs. 2003 Nov-Dec;32(6):734-44 [14649593.001]
  • [Cites] Breastfeed Med. 2012 Dec;7(6):526-34 [22424469.001]
  • [Cites] BMC Public Health. 2012 Nov 26;12:1031 [23181985.001]
  • [Cites] Matern Child Health J. 2004 Jun;8(2):65-70 [15198173.001]
  • [Cites] Breastfeed Rev. 2002 Jul;10(2):13-9 [12227559.001]
  • [Cites] Breastfeed Rev. 2007 Nov;15(3):17-25 [18062138.001]
  • [Cites] BMC Med Inform Decis Mak. 2016 Jun 04;16:60 [27260252.001]
  • [Cites] Demography. 2001 Feb;38(1):115-32 [11227840.001]
  • [Cites] Pediatrics. 2008 Oct;122 Suppl 2:S69-76 [18829834.001]
  • [Cites] Cochrane Database Syst Rev. 2017 Feb 28;2:CD001141 [28244064.001]
  • (PMID = 28694842.001).
  • [ISSN] 1746-4358
  • [Journal-full-title] International breastfeeding journal
  • [ISO-abbreviation] Int Breastfeed J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Associated factors / Breastfeeding knowledge / Exclusive breastfeeding / Intention to breastfeed / Myanmar / Pregnant women / Socio-economic factors / Sources of breastfeeding
  •  go-up   go-down


16. Haufe S, Wiechmann K, Stein L, Kück M, Smith A, Meineke S, Zirkelbach Y, Rodriguez Duarte S, Drupp M, Tegtbur U: Low-dose, non-supervised, health insurance initiated exercise for the treatment and prevention of chronic low back pain in employees. Results from a randomized controlled trial. PLoS One; 2017;12(6):e0178585

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Back pain is a major problem requiring pragmatic interventions, low in costs for health care providers and feasible for individuals to perform.
  • RESULTS: Muscle strength for back extension increased after the 5-month intervention with a significant between-group difference (mean 27.4 Newton [95%CI 2.2; 60.3]) favoring the exercise group (p = 0.035).
  • Low back pain was reduced more in subjects after exercise than control (mean difference -0.74 cm [95%CI -1.17; -0.27], p = 0.002).
  • After stratified analysis only subjects with preexisting chronic low back pain showed a between-group difference (exercise versus controls) after the intervention in their strength for back extension (mean 55.7 Newton [95%CI 2.8; 108.5], p = 0.039), self-perceived pain (mean -1.42 cm [95%CI -2.32; -0.51], p = 0.003) and work ability (mean 2.1 points [95%CI 0.2; 4.0], p = 0.032).
  • Significant between-group differences were not observed in subjects without low back pain: strength for back extension (mean 23.4 Newton [95%CI -11.2; 58.1], p = 0.184), self-perceived pain (mean -0.48 cm [95%CI -0.99; 0.04], p = 0.067) and work ability (mean -0.1 points [95%CI -0.9; 0.9], p = 0.999).
  • An interaction between low back pain subgroups and the study intervention (exercise versus control) was exclusively observed for the work ability index (p = 0.016).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28662094.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD, Breast Cancer Surveillance Consortium: National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium. Radiology; 2017 Apr;283(1):59-69
International Agency for Research on Cancer - Screening Group. diagnostics - Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Results Overall diagnostic performance measures were as follows: cancer detection rate, 34.7 per 1000 (95% confidence interval [CI]: 34.1, 35.2); abnormal interpretation rate, 12.6% (95% CI: 12.5%, 12.7%); positive predictive value (PPV) of a biopsy recommendation (PPV<sub>2</sub>), 27.5% (95% CI: 27.1%, 27.9%); PPV of biopsies performed (PPV<sub>3</sub>), 30.4% (95% CI: 29.9%, 30.9%); false-negative rate, 4.8 per 1000 (95% CI: 4.6, 5.0); sensitivity, 87.8% (95% CI: 87.3%, 88.4%); and specificity, 90.5% (95% CI: 90.4%, 90.6%).
  • Performance metrics varied widely across diagnostic indications, with cancer detection rate (64.5 per 1000) and abnormal interpretation rate (18.7%) highest for diagnostic mammograms obtained to evaluate a breast problem with a lump.

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Mammography.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Screen. 2005;12 (1):50-4 [15814020.001]
  • [Cites] AJR Am J Roentgenol. 2008 May;190(5):1200-8 [18430832.001]
  • [Cites] Radiol Clin North Am. 2000 Jul;38(4):759-72 [10943276.001]
  • [Cites] Br J Radiol. 2012 Dec;85(1020):e1226-32 [22993383.001]
  • [Cites] Ann Intern Med. 2011 Oct 18;155(8):493-502 [22007043.001]
  • [Cites] J Am Coll Radiol. 2013 Dec;10 (12 ):913-7 [24295940.001]
  • [Cites] Radiology. 2005 Jun;235(3):775-90 [15914475.001]
  • [Cites] AJR Am J Roentgenol. 1997 Oct;169(4):1001-8 [9308451.001]
  • [Cites] AJR Am J Roentgenol. 2001 Mar;176(3):729-33 [11222214.001]
  • [Cites] Radiology. 2013 May;267(2):359-67 [23297329.001]
  • [Cites] J Clin Oncol. 2015 Oct 1;33(28):3137-43 [26282663.001]
  • [Cites] Int J Cancer. 2015 Nov 1;137(9):2198-207 [25944711.001]
  • [Cites] Int J Cancer. 2010 Oct 15;127(8):1905-12 [20104518.001]
  • (PMID = 28244803.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA093373; United States / NCI NIH HHS / CA / P01 CA154292; United States / NCI NIH HHS / CA / U54 CA163303; United States / NCI NIH HHS / CA / P30 CA023108; United States / NCI NIH HHS / CA / HHSN261201100031C
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Yu Y, Wei L, Shen Y, Xiao W, Huang J, Xu J: Windmill Flap Nipple Reduction: A New Method of Nipple Plasty. Aesthetic Plast Surg; 2017 Apr 03;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Nipple hypertrophy is a common aesthetic issue for Asian women.
  • Thus, methods to correct this problem are needed.
  • LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28374295.001).
  • [ISSN] 1432-5241
  • [Journal-full-title] Aesthetic plastic surgery
  • [ISO-abbreviation] Aesthetic Plast Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Nipple hypertrophy / Nipple reduction / Surgical management
  •  go-up   go-down


19. Serrano Falcón B, Álvarez Sánchez Á, Diaz-Rubio M, Rey E: Prevalence and factors associated with faecal impaction in the Spanish old population. Age Ageing; 2017 01 12;46(1):119-124
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Background: Faecal impaction (FI) is a common problem in old people living in nursing home.
  • At least 53 people reported FI within the past year (5.3% (CI 95%: 3.9–6.7%)).
  • Conclusion: FI is a prevalent problem in old Spanish population.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28181648.001).
  • [ISSN] 1468-2834
  • [Journal-full-title] Age and ageing
  • [ISO-abbreviation] Age Ageing
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


20. Udovicich C, Perera K, Leahy C: Anaemia in school-aged children in an Australian Indigenous community. Aust J Rural Health; 2016 Dec 14;
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After treatment, the mean rise in haemoglobin was 13% (95% CI 11-15) at the 4-week interval.
  • DISCUSSION: Anaemia in Indigenous Australian school-aged children is a major public health issue.
  • Community wide interventions are required to combat this alarming issue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 National Rural Health Alliance Inc.
  • (PMID = 27973736.001).
  • [ISSN] 1440-1584
  • [Journal-full-title] The Australian journal of rural health
  • [ISO-abbreviation] Aust J Rural Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Keywords] NOTNLM ; Indigenous population / anaemia / children / malnutrition / public health / rural
  •  go-up   go-down


21. Krishnan A, Xu T, Hutfless S, Park A, Stasko T, Vidimos AT, Leshin B, Coldiron BM, Bennett RG, Marks VJ, Brandt R, Makary MA, Albertini JG, and the American College of Mohs Surgery Improving Wisely Study Group: Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution. JAMA Dermatol; 2017 Jun 01;153(6):565-570
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution.
  • Persistent high outlier status was associated with performing Mohs surgery in a solo practice (odds ratio, 2.35; 95% CI, 1.25-4.35).
  • Volume of cases per year, practice experience, and geographic location were not associated with persistent high outlier status.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28453605.001).
  • [ISSN] 2168-6084
  • [Journal-full-title] JAMA dermatology
  • [ISO-abbreviation] JAMA Dermatol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Thomas S, Crooks K, Taylor K, Massey PD, Williams R, Pearce G: Reducing recurrence of bacterial skin infections in Aboriginal children in rural communities: new ways of thinking, new ways of working. Aust J Prim Health; 2017 Jan 10;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Reports from health workers, school staff and community members in rural NSW suggested that bacterial skin infections are a significant health issue for Aboriginal children and their families, affecting quality of life and contributing to poor school attendance.
  • (iv) families have survived but more could thrive; and (v) something can and should be done about the problem.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28068507.001).
  • [ISSN] 1448-7527
  • [Journal-full-title] Australian journal of primary health
  • [ISO-abbreviation] Aust J Prim Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


23. Luiza VL, Tavares NU, Oliveira MA, Arrais PS, Ramos LR, Pizzol TD, Mengue SS, Farias MR, Bertoldi AD: Catastrophic expenditure on medicines in Brazil. Rev Saude Publica; 2016 Dec;50(suppl 2):15s
MedlinePlus Health Information. consumer health - Medicines.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The prevalence and confidence intervals (95%CI) of the outcomes were stratified according to socioeconomic classification and calculated according to the region, the number of residents dependent on income, the presence of children under five years and residents in a situation of dependency by age.
  • Although the problem is important, permeated by aspects of iniquity, Brazilian policies seem to be protecting families from catastrophic expenditure on health and on medicine.
  • OBJETIVO: Descrever a magnitude do gasto catastrófico em medicamentos no Brasil segundo região, tamanho das famílias e composição familiar em termos de moradores em situação de dependência.
  • MÉTODOS: Utilizados dados de inquérito domiciliar nacional, de base populacional, com amostra probabilística, aplicado entre setembro de 2013 e fevereiro de 2014 em domicílios urbanos.
  • O gasto catastrófico em medicamentos foi o principal desfecho de interesse.
  • As prevalências e intervalos de confiança de 95% (IC95%) desses desfechos foram estratificados segundo classificação socioeconômica e calculadas de acordo com a região, o número de moradores dependentes da renda, a presença de crianças menores de cinco anos e de moradores em situação de dependência, por idade.
  • RESULTADOS: Em cerca de um de cada 17 domicílios (5,3%) foi relatado gasto catastrófico em saúde e, em 3,2%, os medicamentos foram reportados como um dos itens responsáveis por esta situação.
  • Presença de três ou mais moradores (3,6%) e morador em situação de dependência jovem (3,6%) foram as situações com maior relato de gasto catastrófico em medicamentos.
  • O Sudeste foi a região com menor prevalência de gasto catastrófico em medicamentos.
  • As prevalências de domicílios com gasto catastrófico em saúde e medicamentos em relação ao total de domicílios apresentaram tendência regressiva para as classes econômicas.
  • Domicílios pluripessoais, presença de moradores em situação de dependência econômica e pertencimento à classe D ou E tiveram a maior proporção de gasto catastrófico em medicamentos.
  • Ainda que o problema se mostre importante, permeado por aspectos de iniquidade, as políticas brasileiras parecem estar protegendo as famílias do gasto catastrófico em saúde e em medicamentos.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cad Saude Publica. 2013 Aug;29(8):1605-16 [24005926.001]
  • [Cites] Rev Panam Salud Publica. 2014 Feb;35(2):128-35 [24781094.001]
  • [Cites] Bull World Health Organ. 2008 Nov;86(11):849-856 [19030690.001]
  • [Cites] Int J Epidemiol. 2008 Aug;37(4):758-65 [18411201.001]
  • [Cites] Rev Saude Publica. 2014 Oct;48(5):797-807 [25372171.001]
  • [Cites] Health Policy. 2011 May;100(2-3):151-8 [20828854.001]
  • [Cites] Inquiry. 1986 Winter;23(4):382-94 [2947859.001]
  • [Cites] J Popul Ageing. 2012 Sep;5(3):151-162 [22924086.001]
  • [Cites] Cad Saude Publica. 2013 Apr;29(4):691-701 [23568299.001]
  • [Cites] Rev Bras Epidemiol. 2015 Dec;18 Suppl 2:192-203 [27008614.001]
  • [Cites] Cad Saude Publica. 2008 Feb;24(2):267-80 [18278273.001]
  • [Cites] Cad Saude Publica. 2011;27 Suppl 2:S254-62 [21789417.001]
  • [Cites] Cad Saude Publica. 2005;21 Suppl:119-28 [16463003.001]
  • [Cites] Salud Publica Mex. 2011;53 Suppl 2:s85-95 [21877097.001]
  • [Cites] Rev Saude Publica. 2014 Aug;48(4):632-41 [25210822.001]
  • [Cites] Lancet. 2003 Jul 12;362(9378):111-7 [12867110.001]
  • [Cites] Health Policy Plan. 2015 Oct;30(8):1044-52 [25255920.001]
  • [Cites] Health Aff (Millwood). 1986 Winter;5(4):138-45 [3102333.001]
  • [Cites] Am J Public Health. 2011 May;101(5):916-21 [20724692.001]
  • [Cites] Cad Saude Publica. 2010 Jun;26(6):1163-74 [20657981.001]
  • [Cites] Health Aff (Millwood). 2007 Jul-Aug;26(4):972-83 [17630440.001]
  • (PMID = 27982383.001).
  • [ISSN] 1518-8787
  • [Journal-full-title] Revista de saude publica
  • [ISO-abbreviation] Rev Saude Publica
  • [Language] eng; por
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / Pharmaceutical Preparations
  •  go-up   go-down


24. Wolchok JD, Thomas L, Bondarenko IN, O'Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C: Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma. J Clin Oncol; 2011 May 20;29(15_suppl):LBA5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Phase III randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) versus DTIC alone as first-line treatment in patients with unresectable stage III or IV melanoma.
  • : LBA5 The full, final text of this abstract will be available in Part II of the 2011 Annual Meeting Proceedings, distributed onsite at the Meeting on June 4, 2011, and as a supplement to the June 20, 2011, issue of Journal of Clinical Oncology.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28024022.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Dell'Abate P, Bertocchi E, Dalla Valle R, Viani L, Del Rio P, Sianesi M: Iatrogenic diaphragmatic hernia following laparoscopic left colectomy for splenic flexure cancer An unusual complication. Ann Ital Chir; 2016 Nov 03;87

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • È stata decisa risoluzione chirurgica del problema ed è stata eseguita una laparoscopia diagnostica che ha evidenziato un difetto di circa 4 cm dell’emidiaframma sinistro senza alcun danno a carico delle anse erniate che sono quindi state delicatamente ridotte in addome.
  • In primo luogo durante la mobilizzazione della flessura splenica abbiamo usato uno strumento ad ultrasuoni che può causare scottatura del diaframma provocando quindi un punto di debolezza che può poi evolvere in un’ernia; considerando che il tumore era a livello della flessura e che questa si presentava molto alta probabilmente durante tali manovre abbiamo causato un piccolo danno al diaframma del quale non ci siamo accorti in corso di intervento.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28232645.001).
  • [ISSN] 2239-253X
  • [Journal-full-title] Annali italiani di chirurgia
  • [ISO-abbreviation] Ann Ital Chir
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


26. Calabrò RS, Russo M, Naro A, De Luca R, Leo A, Tomasello P, Molonia F, Dattola V, Bramanti A, Bramanti P: Robotic gait training in multiple sclerosis rehabilitation: Can virtual reality make the difference? Findings from a randomized controlled trial. J Neurol Sci; 2017 Jun 15;377:25-30

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Effect sizes were very small and non-significant between the groups for Berg Balance Scale (-0.019, CI95% -2.403 to 2.365) and TUG (-0.064, 95%CI -0.408 to 0.536) favoring RAGT+VR.
  • Effects were moderate-to-large and significant for positive attitude (-0.505, 95%CI -3.615 to 2.604) and problem-solving (-0.905, 95%CI -2.113 to 0.302) sub-items of Coping Orientation to Problem Experienced, thus largely favoring RAGT+VR.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28477702.001).
  • [ISSN] 1878-5883
  • [Journal-full-title] Journal of the neurological sciences
  • [ISO-abbreviation] J. Neurol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Lokomat / Multiple sclerosis / Robotic rehabilitation / Virtual reality
  •  go-up   go-down


27. Bundhun PK, Janoo G, Huang F: Adverse drug events observed in patients with type 2 diabetes mellitus treated with 100 mg versus 300 mg canagliflozin: a systematic review and meta-analysis of published randomized controlled trials. BMC Pharmacol Toxicol; 2017 Apr 16;18(1):19
MedlinePlus Health Information. consumer health - Diabetes Type 2.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The current results showed that serious AEs were not significantly higher in patients who were treated by 300 mg canagliflozin, with OR: 1.01, 95% CI: 0.79-1.29; P = 0.93.
  • Also, a similar rate of death was observed in patients who were treated by either 100 or 300 mg canagliflozin with OR: 1.13, 95% CI: 0.43-2.94; P = 0.80.
  • Urinary tract infections, postural dizziness and hypoglycemia were also similarly manifested, with OR: 0.93, 95% CI: 0.70-1.23; P = 0.61, OR: 1.51, 95% CI: 0.42-5.37; P = 0.53 and OR: 0.96, 95% CI: 0.81-1.13; P = 0.60 respectively.
  • However, drug discontinuation due to AEs significantly favored 100 mg canagliflozin only during this unequal follow-up period with OR: 1.35, 95% CI: 1.06-1.72; P = 0.01, but it was not significantly different when trials with similar follow-up periods were analyzed.
  • However, because this result was partly affected by other anti-diabetic medications which were included in the treatment regimen, further studies based on patients who were treated strictly on canagliflozin monotherapy should be recommended to completely solve this issue.

  • Genetic Alliance. consumer health - Diabetes.
  • Genetic Alliance. consumer health - Diabetes, Type 2.
  • Genetic Alliance. consumer health - Diabetes mellitus type 2.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Obes Metab. 2011 Jul;13(7):669-72 [21457428.001]
  • [Cites] Diabetologia. 2013 Dec;56(12):2582-92 [24026211.001]
  • [Cites] Diabetes Obes Metab. 2013 Dec;15(12):1136-45 [23782594.001]
  • [Cites] J Diabetes Investig. 2015 Mar;6(2):210-8 [25802729.001]
  • [Cites] Eur J Clin Pharmacol. 2014 Oct;70(10):1149-58 [25124541.001]
  • [Cites] Diabetes Obes Metab. 2014 May;16(5):467-77 [24528605.001]
  • [Cites] BMC Endocr Disord. 2014 Apr 18;14:37 [24742013.001]
  • [Cites] Eur J Clin Pharmacol. 2015 Nov;71(11):1325-32 [26282731.001]
  • [Cites] Diabetes Obes Metab. 2013 May;15(5):463-73 [23464594.001]
  • [Cites] Diabetes Obes Metab. 2013 Apr;15(4):372-82 [23279307.001]
  • [Cites] Diabetes Ther. 2016 Jun;7(2):269-78 [26984361.001]
  • [Cites] BMJ. 2009 Jul 21;339:b2700 [19622552.001]
  • [Cites] Consult Pharm. 2014;29(5):335-46 [24849690.001]
  • [Cites] Clin Ther. 2015 May 1;37(5):1045-54 [25795432.001]
  • [Cites] Cardiovasc Diabetol. 2016 Jun 18;15:89 [27316668.001]
  • [Cites] Expert Opin Drug Saf. 2014 Nov;13(11):1535-44 [25340618.001]
  • [Cites] Curr Med Res Opin. 2012 Jul;28(7):1173-8 [22632452.001]
  • [Cites] Curr Med Res Opin. 2016 Aug;32(8):1375-85 [27046479.001]
  • [Cites] Postgrad Med. 2016 May;128(4):371-80 [27002421.001]
  • [Cites] Curr Med Res Opin. 2017 Mar;33(3):553-562 [27977934.001]
  • [Cites] Diabetes Care. 2012 Jun;35(6):1232-8 [22492586.001]
  • [Cites] J Intern Med. 2007 Jan;261(1):32-43 [17222166.001]
  • [Cites] Int J Clin Pract. 2013 Dec;67(12):1267-82 [24118688.001]
  • [Cites] Diabetes Care. 2013 Aug;36(8):2154-61 [23412078.001]
  • [Cites] Postgrad Med. 2017 Jan;129(1):159-168 [27894216.001]
  • [Cites] Kidney Int. 2009 Jun;75(12):1272-7 [19357717.001]
  • [Cites] Diabetes Care. 2015 Mar;38(3):403-11 [25468945.001]
  • [Cites] Curr Med Res Opin. 2015;31(9):1693-702 [26121561.001]
  • [Cites] Diabetes Obes Metab. 2015 Mar;17(3):294-303 [25495720.001]
  • (PMID = 28411624.001).
  • [ISSN] 2050-6511
  • [Journal-full-title] BMC pharmacology & toxicology
  • [ISO-abbreviation] BMC Pharmacol Toxicol
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Hemoglobin A, Glycosylated; 0 / Hypoglycemic Agents; 0SAC974Z85 / Canagliflozin
  • [Keywords] NOTNLM ; Adverse drug events (major topic) / Canagliflozin (major topic) / Oral hypoglycemic agents (major topic) / Type 2 diabetes mellitus (major topic)
  •  go-up   go-down


28. Hashemi H, Yekta A, Jafarzadehpur E, Doostdar A, Ostadimoghaddam H, Khabazkhoob M: The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future. Eye (Lond); 2017 Apr 21;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The prevalence of visual impairment and blindness in underserved rural areas: a crucial issue for future.
  • The prevalence of visual impairment and blindness was 6.43% (95% confidence interval (CI): 3.71-9.14) and 1.18% (95% CI: 0.56-1.79), respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28430177.001).
  • [ISSN] 1476-5454
  • [Journal-full-title] Eye (London, England)
  • [ISO-abbreviation] Eye (Lond)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


29. Mohn J, Graue M, Assmus J, Zoffmann V, Thordarson H, Peyrot M, Rokne B: The effect of guided self-determination on self-management in persons with type 1 diabetes mellitus and HbA&lt;sub&gt;1c&lt;/sub&gt; ≥64 mmol/mol: a group-based randomised controlled trial. BMJ Open; 2017 Jul 03;7(6):e013295
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was HbA<sub>1c</sub> and secondary outcomes (all outcomes 9 months post intervention) were self-monitored blood glucose frequency, self-reported diabetes competence, autonomy support by healthcare providers (Health Care Climate Questionnaire), autonomous versus controlled diabetes motivation (Treatment Self-Regulation Questionnaire), diabetes distress (Problem Areas In Diabetes Scale (PAID) and Diabetes Distress Scale (DDS)), self-esteem (Rosenberg Self-Esteem Scale) and psychological well-being (World Health Organization five-item Well-Being Index scale).
  • With 95% CIs GSD-GT did not have effect on HbA<sub>1c</sub> (B -0.18, CI (-0.48, 0.12), p=0.234).
  • GSD-GT improved autonomy-motivated behaviour (B 0.51, CI (0.25, 0.77), p<0.001), diabetes distress (PAID, B -6.96, CI (-11.40, -2.52), p=0.002), total DDS (B -5.15, CI (-9.34, -0.96), p=0.016), DDS emotional burden (B -7.19, CI (-13.20, -1.19), p=0.019) and self-esteem (B 1.43, CI (0.34, 2.52), p=0.011).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
  • (PMID = 28674125.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; General diabetes / HbA1c / diabetes distress / educational method / psychological functioning / self-management
  •  go-up   go-down


30. Janmaat CJ, van Diepen M, Krediet RT, Hemmelder MH, Dekker FW: Effect of glomerular filtration rate at dialysis initiation on survival in patients with advanced chronic kidney disease: what is the effect of lead-time bias? Clin Epidemiol; 2017;9:217-230
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Without lead-time correction, no difference between early and late starters was present based on eGFR (hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.81-1.3).
  • However, after lead-time correction, early initiation showed a survival disadvantage (HR between 1.1 [95% CI 0.82-1.48] and 1.33 [95% CI 1.05-1.68]).
  • Based on mGFR, the potential survival benefit for early starters without lead-time correction (HR 0.8, 95% CI 0.62-1.03) completely disappeared after lead-time correction (HR between 0.94 [95% CI 0.65-1.34] and 1.21 [95% CI 0.95-1.56]).
  • CONCLUSION: Lead-time bias is not only a methodological problem but also has clinical impact when assessing the optimal kidney function to start dialysis.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nephron Clin Pract. 2012;121(1-2):c73-82 [23128440.001]
  • [Cites] Am J Hypertens. 2012 Nov;25(11):1175-81 [22810845.001]
  • [Cites] Am J Clin Nutr. 2000 Feb;71(2):485-90 [10648262.001]
  • [Cites] J Am Soc Nephrol. 2002 Aug;13(8):2125-32 [12138145.001]
  • [Cites] Kidney Int. 2009 Aug;76(3):257-61 [19455195.001]
  • [Cites] Clin J Am Soc Nephrol. 2009 May;4(5):899-906 [19406960.001]
  • [Cites] Adv Perit Dial. 2010;26:16-20 [21348373.001]
  • [Cites] Semin Dial. 2007 Jan-Feb;20(1):86-90 [17244129.001]
  • [Cites] Am J Kidney Dis. 2005 Nov;46(5):887-96 [16253729.001]
  • [Cites] Kidney Int. 2010 Apr;77(8):700-7 [20147886.001]
  • [Cites] Ann Intern Med. 1999 Mar 16;130(6):461-70 [10075613.001]
  • [Cites] J Intern Med. 2011 Mar;269(3):289-98 [20831629.001]
  • [Cites] Stat Methods Med Res. 2007 Jun;16(3):219-42 [17621469.001]
  • [Cites] Nephrol Dial Transplant. 2013 Oct;28(10):2415-20 [23729490.001]
  • [Cites] Nephrol Dial Transplant. 2013 Mar;28(3):698-705 [23300262.001]
  • [Cites] Am J Kidney Dis. 2003 Jun;41(6):1293-302 [12776283.001]
  • [Cites] CMAJ. 2011 Jan 11;183(1):47-53 [21135082.001]
  • [Cites] Stat Methods Med Res. 2007 Jun;16(3):199-218 [17621468.001]
  • [Cites] Am J Kidney Dis. 2014 May;63(5):806-15 [24508475.001]
  • [Cites] Am J Kidney Dis. 1999 Oct;34(4):694-701 [10516351.001]
  • [Cites] Nephrol Dial Transplant. 2010 Aug;25(8):2616-24 [20519231.001]
  • [Cites] Kidney Int. 2009 Jun;75(11):1223-9 [19242502.001]
  • [Cites] Am J Nephrol. 1995;15(4):283-9 [7573184.001]
  • [Cites] Nephrol Dial Transplant. 2009 Oct;24(10):3175-82 [19515803.001]
  • [Cites] Kidney Int Suppl. 1978 Jun;(8):S112-6 [357813.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Oct;5(10):1828-35 [20634325.001]
  • [Cites] Lancet. 1993 Feb 13;341(8842):415-8 [8094182.001]
  • [Cites] Stat Methods Med Res. 1999 Mar;8(1):3-15 [10347857.001]
  • [Cites] Nephrol Dial Transplant. 2011 Jun;26(6):1932-7 [21056944.001]
  • [Cites] J Am Soc Nephrol. 2003 Sep;14(9):2305-12 [12937307.001]
  • [Cites] Kidney Int Suppl. 1985 Dec;17:S57-9 [3937938.001]
  • [Cites] Nephrol Dial Transplant. 2011 Jul;26(7):2082-6 [21551086.001]
  • [Cites] Nephrol Dial Transplant. 2007 Jul;22(7):1926-32 [17400562.001]
  • [Cites] Hemodial Int. 2007 Jul;11(3):349-53 [17576301.001]
  • [Cites] Kidney Int. 2008 Jan;73(2):148-53 [17978812.001]
  • [Cites] Ann Intern Med. 2007 Feb 6;146(3):177-83 [17283348.001]
  • [Cites] Nephrol Dial Transplant. 2001 Jun;16(6):1132-8 [11390711.001]
  • [Cites] BMC Nephrol. 2011 Aug 11;12:38 [21835038.001]
  • [Cites] N Engl J Med. 2010 Aug 12;363(7):609-19 [20581422.001]
  • [Cites] Lancet. 2001 Sep 29;358(9287):1046-50 [11589934.001]
  • [Cites] J Am Soc Nephrol. 2004 Apr;15(4):1061-70 [15034110.001]
  • [Cites] Nephrol Dial Transplant. 2003 Mar;18(3):552-8 [12584278.001]
  • [Cites] J Am Soc Nephrol. 2003 Apr;14(4):1000-5 [12660334.001]
  • [Cites] Arch Intern Med. 2011 Mar 14;171(5):396-403 [21059968.001]
  • [Cites] Nephrol Dial Transplant. 2009 Oct;24(10):3186-92 [19390120.001]
  • (PMID = 28442934.001).
  • [Journal-full-title] Clinical epidemiology
  • [ISO-abbreviation] Clin Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Keywords] NOTNLM ; end-stage renal disease / epidemiology / hazard model / kidney function / lead time / linear interpolation model
  •  go-up   go-down


31. Han X, Ellwein LB, Guo X, Hu Y, Yan W, He M: Progression of Near Vision Loss and Incidence of Near Vision Impairment in an Adult Chinese Population. Ophthalmology; 2017 May;124(5):734-742

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The 6-year cumulative incidence of uncorrected binocular NVI (UCNVI) across the 3 vision impairment definitions was 55.2% (95% confidence interval [CI], 46.1%-64.3%), 51.3% (95% CI, 44.0%-58.7%), and 42.4% (95% CI, 35.5%-49.3%), respectively.
  • With best-corrected binocular NVI (BCNVI), incidence was 6.89% (95% CI, 4.28%-9.50%), 5.17% (95% CI, 2.89%-7.44%), and 2.62% (95% CI, 1.11%-4.12%), respectively.
  • Cost-effective strategies to provide spectacles to this at-risk population remains an issue requiring further study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
  • (PMID = 28336059.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Lei YY, Huang JY, Zhao QR, Jiang N, Xu HM, Wang ZN, Li HQ, Zhang SB, Sun Z: The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature. World J Surg Oncol; 2017 Mar 21;15(1):68
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Our aim was to clarify this issue.
  • HER2 positive rate was 19.07% (95% CI = 9.16, 28.98).
  • There existed statistical significance between HER2 overexpression and patients' prognosis (RR = 1.47, 95% CI = 1.09, 1.98).
  • Male patients (OR = 1.48, 95% CI = 1.34, 1.65), proximal tumors (OR = 1.25, 95% CI = 1.07, 1.47), intestinal-type tumors (OR = 3.37, 95% CI = 2.54, 4.47), advanced stage cancers (OR = 1.35, 95% CI = 1.10, 1.66), lymph node metastasis (OR = 1.26, 95% CI = 1.14, 1.41), well-differentiated cancers (OR = 1.79, 95% CI = 1.15, 2.76), and distant metastasis (OR = 1.91, 95% CI = 1.08, 3.38) were correlated with higher HER2 expression rates.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res Treat. 2004 Aug;36(4):240-5 [20368841.001]
  • [Cites] Clin Cancer Res. 2012 Nov 1;18(21):5992-6000 [22977193.001]
  • [Cites] Science. 1986 Jun 27;232(4758):1644-6 [3012781.001]
  • [Cites] BMC Gastroenterol. 2015 Nov 04;15:157 [26530403.001]
  • [Cites] Iran J Cancer Prev. 2011 Fall;4(4):170-6 [26322194.001]
  • [Cites] Ann Oncol. 2008 Sep;19(9):1523-9 [18441328.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2012 Jan;20(1):13-24 [21617522.001]
  • [Cites] Onco Targets Ther. 2014 Dec 16;8:7-14 [25565860.001]
  • [Cites] Ann Oncol. 2005 Feb;16(2):273-8 [15668283.001]
  • [Cites] Pathol Oncol Res. 2013 Oct;19(4):855-65 [23800891.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(13):5343-8 [25040999.001]
  • [Cites] Gastric Cancer. 2016 Jul;19(3):1026 [26621522.001]
  • [Cites] World J Surg Oncol. 2012 Dec 18;10:274 [23249720.001]
  • [Cites] Ann Surg Oncol. 2011 Oct;18(10):2833-40 [21468783.001]
  • [Cites] J Egypt Natl Canc Inst. 2007 Jun;19(2):147-57 [19034345.001]
  • [Cites] J Gastric Cancer. 2014 Sep;14(3):180-6 [25328763.001]
  • [Cites] Histopathology. 2008 Jun;52(7):797-805 [18422971.001]
  • [Cites] World J Surg. 2009 Oct;33(10):2112-8 [19636613.001]
  • [Cites] Tumour Biol. 2015 Apr;36(4):3001-7 [25514872.001]
  • [Cites] Int J Clin Oncol. 2014 Apr;19(2):303-11 [23660785.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Cancer Biol Ther. 2015;16(8):1148-59 [26061272.001]
  • [Cites] Gastric Cancer. 2015 Oct;18(4):691-7 [25224659.001]
  • [Cites] Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):121-6 [25176587.001]
  • [Cites] Cancer Chemother Pharmacol. 2015 Aug;76(2):375-82 [26099968.001]
  • [Cites] Hum Pathol. 2007 Sep;38(9):1386-93 [17555797.001]
  • [Cites] Clin Cancer Res. 2004 Mar 1;10(5):1706-16 [15014023.001]
  • [Cites] Tumori. 2015 Nov 7;:0 [26549693.001]
  • [Cites] Clin Transl Oncol. 2013 Apr;15(4):307-12 [22911549.001]
  • [Cites] Pathol Oncol Res. 1999;5(2):104-6 [10393360.001]
  • [Cites] Br J Cancer. 2014 Mar 4;110(5):1163-8 [24473399.001]
  • [Cites] BMC Cancer. 2014 Nov 07;14:823 [25380654.001]
  • [Cites] Surg Today. 2013 Dec;43(12):1390-7 [23512532.001]
  • [Cites] Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84 [23274580.001]
  • [Cites] Cancer Chemother Pharmacol. 2015 Dec;76(6):1267-72 [26482716.001]
  • [Cites] Gastric Cancer. 2014 Jan;17(1):34-42 [23430266.001]
  • [Cites] J Cell Physiol. 2004 Sep;200(3):343-50 [15254961.001]
  • [Cites] Cancer Res Treat. 2016 Apr;48(2):553-60 [26323641.001]
  • [Cites] World J Gastroenterol. 2013 Jun 7;19(21):3316-23 [23745034.001]
  • [Cites] J Clin Diagn Res. 2015 Mar;9(3):EC06-10 [25954623.001]
  • [Cites] J Clin Pathol. 2015 May;68(5):374-80 [25731189.001]
  • [Cites] Cancer Cell. 2009 May 5;15(5):429-40 [19411071.001]
  • [Cites] Asian Pac J Cancer Prev. 2015;16(17):7755-8 [26625793.001]
  • [Cites] Indian J Gastroenterol. 2012 Jun;31(3):103-5 [22763895.001]
  • [Cites] ISRN Surg. 2012;2012:804891 [22900205.001]
  • [Cites] J Oncol. 2011;2011:391564 [22131990.001]
  • [Cites] World J Gastroenterol. 2012 May 21;18(19):2402-7 [22654433.001]
  • [Cites] Diagn Pathol. 2013 May 09;8:76 [23656792.001]
  • [Cites] World J Gastroenterol. 2011 Mar 21;17(11):1501-6 [21472111.001]
  • [Cites] World J Gastroenterol. 2013;19(14):2171-8 [23599643.001]
  • [Cites] Gastric Cancer. 2015 Jul;18(3):467-75 [24993498.001]
  • [Cites] Lancet. 2010 Aug 28;376(9742):687-97 [20728210.001]
  • [Cites] Oncol Lett. 2015 Oct;10(4):2107-2117 [26622804.001]
  • [Cites] Ann Oncol. 2012 Oct;23(10):2656-62 [22689179.001]
  • [Cites] Biochim Biophys Acta. 2007 Aug;1773(8):1263-84 [17126425.001]
  • [Cites] Dig Dis Sci. 2006 Aug;51(8):1371-9 [16868827.001]
  • [Cites] Lancet. 2016 Nov 26;388(10060):2654-2664 [27156933.001]
  • [Cites] Eur J Epidemiol. 2010 Sep;25(9):603-5 [20652370.001]
  • (PMID = 28327158.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Gastric cancer / HER2/neu / Meta / Prognosis
  •  go-up   go-down


33. Abanda NN, Djieugoué JY, Lim E, Pefura-Yone EW, Mbacham WF, Vernet G, Penlap VM, Eyangoh SI, Taylor DW, Leke RGF: Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study. BMC Infect Dis; 2017 May 31;17(1):379

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Drug-resistant tuberculosis, especially multidrug-resistant tuberculosis (MDR-TB), is a major public health problem.
  • RESULTS: The Genotype MTBDRplus assay correctly identified Rifampicin (RIF) resistance in 48/49 isolates (sensitivity, 98% [CI, 89%-100%]), Isoniazid (INH) resistance in 55/60 isolates (sensitivity 92% [CI, 82%-96%]), and MDR-TB in 46/49 (sensitivity, 94% [CI, 83%-98%]).
  • The specificity for the detection of RIF-resistant and MDR-TB cases was 100% (CI, 98%-100%), while that of INH resistance was 99% (CI, 97%-100%).
  • The agreement between the two tests for the detection of MDR-TB was very good (Kappa = 0.96 [CI, 0.92-1.00]).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Microbiol. 2016 Apr;54(4):912-8 [26763971.001]
  • [Cites] PLoS One. 2016 Apr 07;11(4):e0152694 [27054344.001]
  • [Cites] PLoS One. 2015 Mar 23;10(3):e0119628 [25799046.001]
  • [Cites] Int J Tuberc Lung Dis. 2000 Sep;4(9):866-70 [10985656.001]
  • [Cites] PLoS One. 2013 Oct 03;8(10):e76533 [24098523.001]
  • [Cites] J Clin Microbiol. 1999 Mar;37(3):748-52 [9986844.001]
  • [Cites] Int J Tuberc Lung Dis. 2014 Feb;18(2):220-6 [24429317.001]
  • [Cites] J Clin Microbiol. 2012 Apr;50(4):1189-94 [22238443.001]
  • [Cites] J Clin Microbiol. 2013 Aug;51(8):2641-5 [23761146.001]
  • [Cites] Int J Tuberc Lung Dis. 2008 Feb;12(2):139-45 [18230245.001]
  • [Cites] PLoS One. 2016 Mar 02;11(3):e0150321 [26934724.001]
  • [Cites] J Clin Microbiol. 2007 Aug;45(8):2635-40 [17537937.001]
  • [Cites] Science. 1994 Jan 14;263(5144):227-30 [8284673.001]
  • [Cites] Int J Tuberc Lung Dis. 2015 Feb;19(2):185-90 [25574917.001]
  • [Cites] J Clin Microbiol. 2013 Aug;51(8):2633-40 [23761144.001]
  • [Cites] Int J Tuberc Lung Dis. 2011 Mar;15(3):344-51 [21333101.001]
  • [Cites] Antimicrob Agents Chemother. 2015 Jan;59(1):414-20 [25367911.001]
  • [Cites] Epidemiology. 1990 Jan;1(1):43-6 [2081237.001]
  • [Cites] J Antimicrob Chemother. 2010 Jun;65(6):1299-301 [20356906.001]
  • [Cites] BMC Microbiol. 2014 May 03;14:113 [24884632.001]
  • [Cites] J Clin Microbiol. 2014 Jun;52(6):2157-62 [24740074.001]
  • [Cites] Eur Respir J. 2008 Nov;32(5):1165-74 [18614561.001]
  • [Cites] Antimicrob Agents Chemother. 2011 May;55(5):2032-41 [21300839.001]
  • [Cites] PLoS One. 2015 Sep 02;10(9):e0135003 [26332235.001]
  • (PMID = 28569148.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cameroon. InhA promoter mutation / Genotype MTBDRplus assay / KatG codon 315 mutation / Multidrug-resistant tuberculosis (MDR-TB) / Pulmonary tuberculosis / rpoB mutations
  •  go-up   go-down


34. Peters NA, Javed AA, He J, Wolfgang CL, Weiss MJ: Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma. J Surg Res; 2017 Apr;210:253-260

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Underutilization of potential curative surgical treatment remains a problem in the management of hepatocellular carcinoma (HCC).
  • Compared with no surgical therapy, African Americans were less likely to undergo liver transplantation (relative risk ratio [RRR] = 0.54; 95% confidence interval [CI], 0.36-0.79) than Caucasian patients and more likely to undergo surgical resection (RRR = 1.67; 95% CI, 1.13-2.48).
  • Patients from the Pacific West were less likely to be transplanted versus patients from the Southeast (RRR = 0.68; 95% CI, 0.50-0.93).
  • Also, patients who were married (RRR = 2.44; 95% CI, 1.96-3.04) or had health insurance (RRR = 4.74; 95% CI, 1.66-13.6) were more likely to receive liver transplantation.
  • Young age (hazard ratio = 1.02; 95% CI, 1.00-1.03; P = 0.025) and positive marital status (hazard ratio = 0.71; 95% CI, 0.55-0.92; P = 0.010) both were independently associated with increased disease-specific survival.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier Inc. All rights reserved.
  • (PMID = 28457336.001).
  • [ISSN] 1095-8673
  • [Journal-full-title] The Journal of surgical research
  • [ISO-abbreviation] J. Surg. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Disparities / Hepatocellular carcinoma / Liver ablation / Liver cancer / Liver resection / Liver transplantation / Surgical therapy
  •  go-up   go-down


35. Sigalla GN, Rasch V, Gammeltoft T, Meyrowitsch DW, Rogathi J, Manongi R, Mushi D: Social support and intimate partner violence during pregnancy among women attending antenatal care in Moshi Municipality, Northern Tanzania. BMC Public Health; 2017 Mar 09;17(1):240

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Intimate Partner Violence (IPV) is a significant public health problem with negative health consequences for women and their pregnancies.
  • Regarding practical social support, having no one to help financially was associated with increased odds of IPV and repeated episodes of abuse during pregnancy, AOR 3.57, (95% CI 1.85 - 6.90) and AOR 3.21, (95% CI 1.69 - 6.11) respectively.
  • For social support in terms of communication, talking to a member of the family of origin at least monthly was associated with decreased odds of IPV and repeated episodes of IPV during pregnancy, AOR 0.46 (95% CI 0.26 - 0.82) and AOR 0.41 (95% CI 0.23 - 0.73) respectively.
  • Perceiving that family of origin will not offer support was associated with a increased odds of IPV and repeated episodes of IPV, AOR 2.29, (95% CI 1.31 - 3.99) and AOR 2.14, (95% CI 1.23 - 3.74) respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Interpers Violence. 2012 Sep;27(14):2743-69 [22491223.001]
  • [Cites] Reprod Health Matters. 2010 Nov;18(36):171-80 [21111361.001]
  • [Cites] PLoS One. 2016 Sep 15;11(9):e0162844 [27631968.001]
  • [Cites] BMC Pregnancy Childbirth. 2011 Nov 29;11:98 [22126899.001]
  • [Cites] J Interpers Violence. 2014 Mar;29(5):866-88 [24227592.001]
  • [Cites] J Interpers Violence. 2013 Jul;28(10):2134-55 [23300198.001]
  • [Cites] Matern Child Health J. 2013 Apr;17(3):441-7 [22569943.001]
  • [Cites] BMC Public Health. 2011 Nov 25;11 Suppl 5:S4 [22168441.001]
  • [Cites] Trop Med Int Health. 2006 Oct;11(10):1576-84 [17002732.001]
  • [Cites] Soc Psychiatry Psychiatr Epidemiol. 2012 Mar;47(3):427-38 [21290096.001]
  • [Cites] J Midwifery Womens Health. 2002 Sep-Oct;47(5):337-46 [12361345.001]
  • [Cites] Trop Med Int Health. 2013 Jun;18(6):696-711 [23414103.001]
  • [Cites] BMC Pregnancy Childbirth. 2013 Jun 24;13:135 [23800160.001]
  • [Cites] Lancet. 2010 Jul 3;376(9734):41-8 [20557928.001]
  • [Cites] J Womens Health Gend Based Med. 2002 Jun;11(5):465-76 [12165164.001]
  • [Cites] Am J Obstet Gynecol. 2009 Aug;201(2):148.e1-7 [19564020.001]
  • [Cites] J Nerv Ment Dis. 2013 Jul;201(7):602-8 [23817159.001]
  • [Cites] Int J Gynaecol Obstet. 2008 May;101(2):141-5 [18289536.001]
  • [Cites] BMC Public Health. 2016 Aug 04;15:715 [27488516.001]
  • [Cites] BMC Womens Health. 2008 Oct 10;8:17 [18847476.001]
  • [Cites] BJOG. 2013 Jul;120(8):940-6 [23464524.001]
  • [Cites] Violence Against Women. 2006 Jun;12 (6):588-604 [16707813.001]
  • [Cites] BJOG. 2007 Oct;114(10):1246-52 [17877676.001]
  • [Cites] Paediatr Perinat Epidemiol. 2014 Jan;28(1):23-31 [24117986.001]
  • [Cites] PLoS One. 2011 Mar 08;6(3):e17591 [21408120.001]
  • [Cites] Am Psychol. 2006 Sep;61(6):595-606 [16953747.001]
  • [Cites] Hum Reprod. 2007 Mar;22(3):869-77 [17110400.001]
  • [Cites] Lancet. 2006 Oct 7;368(9543):1260-9 [17027732.001]
  • [Cites] Eur J Public Health. 2011 Feb;21(1):92-7 [20181682.001]
  • [Cites] J Consult Clin Psychol. 2002 Apr;70(2):311-9 [11952189.001]
  • (PMID = 28274220.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Intimate partner violence / Pregnancy / Social support / Tanzania
  •  go-up   go-down


36. Cunha R, Maruza M, Montarroyos UR, Coimbra I, de B Miranda-Filho D, Albuquerque MF, Lacerda HR, Ximenes R: Survival of people living with HIV who defaulted from tuberculosis treatment in a cohort, Recife, Brazil. BMC Infect Dis; 2017 Feb 10;17(1):137
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Tuberculosis is a serious public health problem worldwide.
  • The incidence of death was 5.6 deaths per 100 persons per year (CI 95% 4.5 to 7.08).
  • Independent factors associated with death: default from TB treatment 3.65 HR (95% CI 2.28 to 5.83); CD4 < 200 cells/mm<sup>3</sup> 2.39 HR (95% CI 1.44 to 3.96); extrapulmonary tuberculosis 1.56 HR (95% CI 0.93 to 2.63); smoking 2.28 HR (95% CI 1.33 to 3.89); alcohol light 0.13 HR (95% CI 0.03 to 0.56).


37. Wang Y, Ding M, Zhang Q, Wang J, Yang X, Zhou F, Li L, Yuan Z, Jin H, Qian Q: Activation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysis. J Cancer; 2017;8(1):74-84

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The quality of studies was assessed by QUADAS-2 and NOS tools.
  • Patients with high expression of immune active factors, intraepithelial tumor-infiltrating CD4+ , CD8+, and Foxp3+ T lymphocytes, MHC I, NKG2D, showed a better overall survival (OS) than those with low expression (HR=0.52, 95% CI=0.41-0.67, P<0.00001).
  • On the contrary, the high expression of immune suppressive factors (CD66b+ neutrophils, Neutrophil-lymphocyte ratio, Intratumoral IL-17+ cells and PD-1+/CD8+ TILs) was significantly associated with poor OS (HR=1.79, 95% CI=1.44-2.22, P<0.00001).
  • A further analysis of therapies targeting tumor microenvironment modulation showed that the median progression free survival (PFS) for BTC patients who received adjuvant immunotherapy was longer than those who received surgery or chemotherapy alone, and the estimated pooled mean difference demonstrated a highly significant improvement (MD =2.33; 95% CI: 0.63-4.02, P=0.007).
  • The total effect of PFS and OS was statistically longer in experimental group, compared to patients in control groups, respectively (PFS: RR=1.25; 95% CI: 1.08-1.46, P=0.004; OS: RR=1.16; 95% CI: 1.07-1.27, P=0.0006).
  • In subgroup meta-analysis of studies on 6-, 12- and 18-month PFS and OS, it showed that adjuvant immunotherapy could improve the 6-month PFS (RR=1.23; 95% CI: 1.05-1.44, P=0.009), and 6-month OS (RR=1.17; 95% CI: 1.06-1.30, P=0.002).
  • <b>Conclusions:</b> So given the above issue, our meta-analysis confirmed that the level of immune mediators could be a predicative factor for prognosis of BTC patients, and immunotherapy regimens by modulating the tumor microenvironment was superior for enhancing median PFS, 6-month PFS and OS.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Onco Targets Ther. 2013 Oct 30;6:1545-52 [24204165.001]
  • [Cites] Hum Vaccin Immunother. 2013 May;9(5):1069-72 [23376808.001]
  • [Cites] Radiother Oncol. 2015 Oct;117(1):165-70 [26235847.001]
  • [Cites] BMC Cancer. 2015 Jul 21;15:530 [26189560.001]
  • [Cites] Anticancer Drugs. 2013 Sep;24(8):871-7 [23799294.001]
  • [Cites] J Hepatobiliary Pancreat Sci. 2012 Mar;19(2):171-8 [21874278.001]
  • [Cites] Cancer Cell. 2016 Mar 14;29(3):285-96 [26977880.001]
  • [Cites] World J Gastrointest Oncol. 2015 Nov 15;7(11):338-46 [26600933.001]
  • [Cites] J Clin Oncol. 2011 May 20;29(15):1949-55 [21483002.001]
  • [Cites] J Clin Oncol. 2011 Feb 20;29(6):610-8 [21245428.001]
  • [Cites] Ann Intern Med. 2011 Oct 18;155(8):529-36 [22007046.001]
  • [Cites] PLoS One. 2012;7(8):e42274 [22879926.001]
  • [Cites] Cancer Immunol Immunother. 2003 Jul;52(7):423-8 [12695859.001]
  • [Cites] Ann Surg Oncol. 2012 Aug;19(8):2506-14 [22411204.001]
  • [Cites] Ann Oncol. 2015 May;26(5):943-9 [25632066.001]
  • [Cites] Cancer Immunol Immunother. 2016 Feb;65(2):141-50 [26728479.001]
  • [Cites] Clin Cancer Res. 2007 Apr 1;13(7):2075-81 [17404089.001]
  • [Cites] Am Soc Clin Oncol Educ Book. 2014;:e165-70 [24857099.001]
  • [Cites] Science. 2006 Sep 29;313(5795):1960-4 [17008531.001]
  • [Cites] Lancet Oncol. 2014 Jul;15(8):819-28 [24852116.001]
  • [Cites] Cancer Res. 2003 Apr 1;63(7):1555-9 [12670904.001]
  • [Cites] Lancet Oncol. 2012 Feb;13(2):181-8 [22192731.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200 [21460876.001]
  • [Cites] World J Gastroenterol. 2015 Feb 21;21(7):2096-101 [25717243.001]
  • [Cites] Br J Cancer. 2015 Nov 3;113(9):1343-9 [26461054.001]
  • [Cites] Am J Surg Pathol. 2012 Jul;36(7):980-6 [22446942.001]
  • [Cites] Angiogenesis. 2003;6(4):283-7 [15166496.001]
  • [Cites] World J Gastroenterol. 2006 Dec 7;12(45):7233-8 [17143936.001]
  • [Cites] Ann Oncol. 1996 Aug;7(6):593-600 [8879373.001]
  • [Cites] Cancer Sci. 2016 Feb;107(2):116-22 [26608587.001]
  • [Cites] Oncologist. 2008 Apr;13(4):415-23 [18448556.001]
  • [Cites] Tumour Biol. 2014 Dec;35(12 ):11741-50 [25417200.001]
  • [Cites] Transl Lung Cancer Res. 2013 Dec;2(6):442-4 [25806266.001]
  • [Cites] J Surg Oncol. 2003 Dec;84(4):224-8 [14756433.001]
  • [Cites] Br J Cancer. 2013 Nov 12;109(10):2665-74 [24136146.001]
  • [Cites] Pancreas. 2004 Jan;28(1):e26-31 [14707745.001]
  • [Cites] Clin Adv Hematol Oncol. 2013 Jan;11(1):28-34 [23416860.001]
  • [Cites] Ann Oncol. 2009 Jan;20(1):146-59 [18667395.001]
  • [Cites] Gastroenterology. 2009 Oct;137(4):1270-9 [19577568.001]
  • [Cites] Eur J Epidemiol. 2010 Sep;25(9):603-5 [20652370.001]
  • (PMID = 28123600.001).
  • [Journal-full-title] Journal of Cancer
  • [ISO-abbreviation] J Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Keywords] NOTNLM ; biliary tract cancer / immune response mediators / immunotherapy / meta-analysis.
  •  go-up   go-down


38. Domnich A, Arata L, Amicizia D, Puig-Barberà J, Gasparini R, Panatto D: Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis. Vaccine; 2017 Jan 23;35(4):513-520

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.
  • BACKGROUND: In the elderly, traditional influenza inactivated vaccines are often only modestly immunogenic, owing to immunosenescence.
  • Given that adjuvantation is a means of enhancing the immune response, the trivalent inactivated vaccine adjuvanted with MF59 (MF59-TIV) was specifically designed to overcome this problem.
  • Considering that, for ethical reasons, the absolute effectiveness of an influenza vaccine in the elderly cannot be demonstrated in placebo-controlled studies, the present study aimed to assess the effectiveness of MF59-TIV in preventing influenza-related outcomes in the elderly.
  • METHODS: We conducted a systematic review of observational studies aimed at evaluating the effectiveness of MF59-TIV against influenza-related outcomes.
  • Hospitalization due to pneumonia/influenza and laboratory-confirmed influenza were reported in more than one study, while other outcomes (influenza-like illness, cardio- and cerebrovascular accidents) were investigated only by one study each.
  • Pooled analysis of four case-control studies showed an adjusted MF59-TIV effectiveness of 51% (95% CI: 39-61%) against hospitalizations for pneumonia/influenza among community-dwelling seniors.
  • Pooled results of the adjusted vaccine effectiveness against laboratory-confirmed influenza were also high (60.1%), although the 95% CI passed through zero (-1.3 to 84.3%).
  • Other single community-based studies showed very high effectiveness of MF59-TIV in preventing hospitalizations for acute coronary [87% (95% CI: 35-97%)] and cerebrovascular [93% (95% CI: 52-99%)] events.
  • MF59-TIV proved highly effective [94% (95% CI: 47-100%] in reducing influenza-like illness among institutionalized elderly.
  • Furthermore, MF59-TIV displayed greater efficacy than non-adjuvanted vaccines in preventing hospitalizations due to pneumonia/influenza [adjusted risk ratio 0.75 (95% CI: 0.57-0.98)] and laboratory-confirmed influenza [adjusted odds ratio 0.37 (0.14-0.96)].
  • CONCLUSIONS: Our results suggest that MF59-TIV is effective in reducing several influenza-related outcomes among the elderly, especially hospitalizations due to influenza-related complications.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.
  • (PMID = 28024956.001).
  • [ISSN] 1873-2518
  • [Journal-full-title] Vaccine
  • [ISO-abbreviation] Vaccine
  • [Language] eng
  • [Publication-type] Review; Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Elderly / Influenza vaccine / Influenza vaccine effectiveness / MF59-adjuvanted vaccine / Meta-analysis
  •  go-up   go-down


39. Chaudhary N, Bundhun PK, Yan H: Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies. Medicine (Baltimore); 2016 Dec;95(50):e5581
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, in order to solve this issue, we aim to compare the adverse clinical outcomes in AF patients receiving DAPT and DAPT + VKA after percutaneous coronary intervention and stenting (PCI-S).
  • At a mean follow-up period of 15 months, the risk of major bleeding was significantly higher in DAPT + VKA group, with OR 0.62 (95% CI 0.50-0.77, P < 0.0001).
  • There was no significant differences in myocardial infarction and major adverse cardiovascular event between DAPT + VKA and DAPT, with OR 1.27 (95% CI 0.92-1.77, P = 0.15) and OR 1.17 (95% CI 0.99-1.39, P = 0.07), respectively.
  • However, the ST, stroke, and all-cause mortality were significantly lower in the DAPT + VKA group, with OR 1.98 (95% CI 1.03-3.81, P = 0.04), 1.59 (95% CI 1.08-2.34, P = 0.02), and 1.41 (95% CI 1.03-1.94, P = 0.03), respectively.

  • MedlinePlus Health Information. consumer health - Atrial Fibrillation.
  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Europace. 2012 Oct;14(10):1385-413 [22923145.001]
  • [Cites] Circ J. 2016;80(2):354-62 [26725763.001]
  • [Cites] J Am Coll Cardiol. 2008 Feb 26;51(8):818-25 [18294566.001]
  • [Cites] N Engl J Med. 2007 Mar 8;356(10):1030-9 [17296823.001]
  • [Cites] Coron Artery Dis. 2007 May;18(3):193-9 [17429293.001]
  • [Cites] Med Clin North Am. 2008 Jan;92(1):17-40, ix [18060995.001]
  • [Cites] Thromb Haemost. 2010 Apr;103(4):833-40 [20135077.001]
  • [Cites] Europace. 2014 Jan;16(1):6-14 [24084680.001]
  • [Cites] Ann Intern Med. 2011 Apr 5;154(7):472-82 [21464349.001]
  • [Cites] J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76 [24685669.001]
  • [Cites] Clin Cardiol. 2014 Jun;37(6):357-64 [24481953.001]
  • [Cites] Chest. 2008 Sep;134(3):559-67 [18641090.001]
  • [Cites] J Am Coll Cardiol. 2015 Aug 11;66(6):616-27 [26248987.001]
  • [Cites] Thromb Haemost. 2010 Jan;103(1):13-28 [20062939.001]
  • [Cites] Br J Haematol. 2005 Jan;128(2):242-7 [15638860.001]
  • [Cites] J Cardiol. 2015 Mar;65(3):197-202 [25266323.001]
  • [Cites] Catheter Cardiovasc Interv. 2016 Jul;88(1):E12-22 [26354765.001]
  • [Cites] Heart Vessels. 2014 Sep;29(5):578-83 [23974943.001]
  • [Cites] BMJ. 2009 Jul 21;339:b2700 [19622552.001]
  • [Cites] Am J Cardiol. 2015 Jul 1;116(1):37-42 [25956624.001]
  • [Cites] Circ J. 2010 Apr;74(4):701-8 [20208381.001]
  • [Cites] Pharmacotherapy. 2007 May;27(5):691-6 [17461704.001]
  • [Cites] Chest. 2011 Feb;139(2):260-70 [21285053.001]
  • [Cites] Lancet. 2006 Feb 4;367(9508):404-11 [16458764.001]
  • [Cites] Eur Heart J. 2006 Aug;27(16):1979-2030 [16885201.001]
  • [Cites] Am J Cardiol. 2008 Dec 15;102(12):1618-23 [19064015.001]
  • [Cites] Eur Heart J. 2007 Mar;28(6):726-32 [17267456.001]
  • [Cites] Am Heart J. 2012 Apr;163(4):720-8 [22520540.001]
  • [Cites] N Engl J Med. 2009 Sep 17;361(12):1139-51 [19717844.001]
  • [Cites] Circulation. 2011 Mar 15;123(10):e269-367 [21382897.001]
  • [Cites] J Am Coll Cardiol. 2013 Sep 10;62(11):981-9 [23747760.001]
  • [Cites] Catheter Cardiovasc Interv. 2006 Jul;68(1):56-61 [16763985.001]
  • [Cites] Kardiol Pol. 2012;70(1):102-3 [22267443.001]
  • [Cites] Eur Heart J. 2010 Oct;31(19):2369-429 [20802247.001]
  • [Cites] Europace. 2014 Mar;16(3):308-19 [24351881.001]
  • [Cites] Can J Cardiol. 2013 Feb;29(2):213-8 [23089528.001]
  • [Cites] Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):144 [25623431.001]
  • [Cites] J Invasive Cardiol. 2006 Apr;18(4):162-4 [16729401.001]
  • [Cites] Med Klin (Munich). 2008 Sep 15;103(9):628-32 [18813885.001]
  • [Cites] Am J Cardiol. 2009 Aug 1;104(3):338-42 [19616664.001]
  • [Cites] Am J Cardiol. 2014 Jul 1;114(1):70-8 [24925801.001]
  • [Cites] J Am Coll Cardiol. 2008 Jan 15;51(2):172-209 [18191745.001]
  • [Cites] N Engl J Med. 2011 Sep 15;365(11):981-92 [21870978.001]
  • [Cites] PLoS One. 2016 Jan 25;11(1):e0147245 [26808678.001]
  • [Cites] Postepy Kardiol Interwencyjnej. 2013;9(3):234-40 [24570724.001]
  • [Cites] Chest. 2011 Jun;139(6):1402-9 [20864616.001]
  • [Cites] Am J Med. 2016 Jun;129(6):592-599.e1 [26797080.001]
  • [Cites] J Thromb Thrombolysis. 2014 Oct;38(3):285-98 [24891133.001]
  • [Cites] Kardiol Pol. 2014;72 (12 ):1253-379 [25524605.001]
  • [Cites] Coron Artery Dis. 2015 Aug;26(5):372-80 [25768244.001]
  • [Cites] JAMA. 2001 May 9;285(18):2370-5 [11343485.001]
  • (PMID = 27977592.001).
  • [ISSN] 1536-5964
  • [Journal-full-title] Medicine
  • [ISO-abbreviation] Medicine (Baltimore)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Meta-Analysis; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Platelet Aggregation Inhibitors; 12001-79-5 / Vitamin K
  •  go-up   go-down


40. Rong H, Cheng X, Garcia JM, Zhang L, Lu L, Fang J, Le M, Hu P, Dong X, Yang J, Wang Y, Luo T, Liu J, Chen JA: Survey of health literacy level and related influencing factors in military college students in Chongqing, China: A cross-sectional analysis. PLoS One; 2017;12(5):e0177776

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Health literacy (HL) has become an important public health issue and is receiving growing attention.
  • Senior (odds ratio [OR] = 1.229, 95% confidence interval [CI] 1.018∼1.484), undergraduate (OR = 1.509, 95% CI 1.151∼1.978), time played games more than 5 hours each week (OR = 0.638, 95% CI 0.486∼0.837), annual household incomes more than 50,000 yuan (OR = 1.231, 95% CI 1.027∼1.476) and father's education level (high school: OR = 2.327, 95% CI 1.186∼4.565; university: OR = 2.450, 95% CI 1.244∼4.825), were independently associated with higher HL level.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatrics. 2009 Nov;124 Suppl 3:S161-2 [19861466.001]
  • [Cites] JAMA. 1995 Dec 6;274(21):1677-82 [7474271.001]
  • [Cites] J Am Geriatr Soc. 2009 Aug;57(8):1475-80 [19515101.001]
  • [Cites] J Gen Intern Med. 2009 Jan;24(1):57-62 [18979142.001]
  • [Cites] Eur J Public Health. 2007 Aug;17(4):353-60 [17130141.001]
  • [Cites] Health Qual Life Outcomes. 2013 Sep 11;11:153 [24020618.001]
  • [Cites] Environ Sci Technol. 2016 May 17;50(10):5346-56 [27071036.001]
  • [Cites] CA Cancer J Clin. 2002 May-Jun;52(3):134-49 [12018928.001]
  • [Cites] Acad Med. 2000 Jan;75(1):12-3 [10667870.001]
  • [Cites] Health Promot Int. 2008 Jun;23(2):152-9 [18223203.001]
  • [Cites] Asia Pac J Public Health. 2015 Mar;27(2):NP2764-72 [23666844.001]
  • [Cites] BMC Fam Pract. 2007 Mar 30;8:16 [17394668.001]
  • [Cites] Health Promot J Austr. 2005 Dec;16(3):168-71 [16375027.001]
  • [Cites] J Health Commun. 2010;15 Suppl 2:9-19 [20845189.001]
  • [Cites] Am J Prev Med. 2005 Apr;28(3):317-22 [15766622.001]
  • [Cites] Am J Obstet Gynecol. 2002 May;186(5):938-43 [12015518.001]
  • [Cites] BMC Public Health. 2012 Jan 25;12:80 [22276600.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Mar;33(3):301-4 [22613383.001]
  • [Cites] BMJ Open. 2014 Oct 13;4(10):e005182 [25311037.001]
  • [Cites] Int J Environ Res Public Health. 2015 Aug 18;12(8):9714-25 [26295246.001]
  • [Cites] J Korean Acad Nurs. 2009 Jun;39(3):386-92 [19571635.001]
  • [Cites] J Health Commun. 2010;15 Suppl 2:5-8 [20845188.001]
  • [Cites] Wei Sheng Yan Jiu. 2014 Jan;43(1):73-7 [24564115.001]
  • [Cites] J Gen Intern Med. 1998 Dec;13(12):791-8 [9844076.001]
  • [Cites] J Health Commun. 2010;15 Suppl 2:42-50 [20845192.001]
  • [Cites] BMC Public Health. 2015 Jul 11;15:637 [26163383.001]
  • [Cites] J Natl Med Assoc. 2008 Nov;100(11):1304-8 [19024227.001]
  • [Cites] J Gen Intern Med. 2006 Aug;21(8):893-5 [16881955.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Aug;32(8):781-5 [22093467.001]
  • [Cites] J Health Commun. 2011;16 Suppl 3:279-94 [21951258.001]
  • (PMID = 28545133.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Gebrihet TA, Mesgna KH, Gebregiorgis YS, Kahsay AB, Weldehaweria NB, Weldu MG: Awareness, treatment, and control of hypertension is low among adults in Aksum town, northern Ethiopia: A sequential quantitative-qualitative study. PLoS One; 2017;12(5):e0176904

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, little is documented in the issue.
  • P-values of < 0.05 were considered statistically significant.
  • RESULTS: The overall prevalence of hypertension was 16.5% (95% CI: 13.4, 20.0).
  • Being unable to read and write [AOR = 4.73, 95% CI:1.11, 20.23], not consuming fruit [AOR = 4.31, 95% CI:1.74, 10.66], being physically inactive [AOR = 20.11, 95% CI:8.75, 6.20], not knowing physical inactivity is a risk factor of hypertension [AOR = 3.57, 95% CI: 1.69, 7.69] and being overweight/obese [AOR = 9.2, 95% CI:4.54, 18.67] were significantly associated with hypertension.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hum Hypertens. 2006 Nov;20(11):898-900 [16971958.001]
  • [Cites] JAMA. 2003 May 14;289(18):2363-9 [12746359.001]
  • [Cites] Integr Blood Press Control. 2013 Jul 31;6:111-7 [23986649.001]
  • [Cites] Hypertension. 2003 Dec;42(6):1206-52 [14656957.001]
  • [Cites] BMC Cardiovasc Disord. 2009 Aug 23;9:39 [19698178.001]
  • [Cites] BMC Cardiovasc Disord. 2012 Nov 28;12 :113 [23186560.001]
  • [Cites] Afr Health Sci. 2009 Sep;9(3):153-60 [20589143.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2224-60 [23245609.001]
  • [Cites] J Hum Hypertens. 2001 Oct;15(10):727-31 [11607804.001]
  • [Cites] Ethiop J Health Sci. 2014 Jan;24(1):21-6 [24591795.001]
  • [Cites] BMC Cardiovasc Disord. 2014 Mar 05;14:33 [24592854.001]
  • [Cites] BMC Res Notes. 2012 Oct 24;5:579 [23095492.001]
  • [Cites] Am J Epidemiol. 1977 Nov;106(5):351-61 [920724.001]
  • [Cites] Hypertension. 2008 Apr;51(4):1080-7 [18259032.001]
  • [Cites] BMC Cardiovasc Disord. 2014 Nov 05;14:155 [25373922.001]
  • [Cites] Arch Intern Med. 2004 Oct 25;164(19):2126-34 [15505126.001]
  • [Cites] BMC Public Health. 2015 Aug 28;15:830 [26315787.001]
  • [Cites] J Hum Hypertens. 2007 Jan;21(1):28-37 [17066088.001]
  • [Cites] PLoS One. 2014 Aug 04;9(8):e104300 [25090232.001]
  • [Cites] J Family Community Med. 2014 Jan;21(1):29-38 [24695988.001]
  • [Cites] BMC Public Health. 2014 Nov 18;14:1177 [25407513.001]
  • [Cites] Int J Gen Med. 2012;5:553-61 [22807644.001]
  • [Cites] Br J Nutr. 2004 Aug;92(2):311-9 [15333163.001]
  • [Cites] Ethiop Med J. 2011 Apr;49(2):139-47 [21796914.001]
  • [Cites] Int J Environ Res Public Health. 2013 Mar 18;10(3):1125-38 [23507738.001]
  • [Cites] J Hum Hypertens. 2000 Oct-Nov;14(10-11):739-47 [11095164.001]
  • [Cites] J Am Coll Cardiol. 2007 Nov 20;50(21):2085-92 [18021879.001]
  • [Cites] Stroke. 2007 Apr;38(4):1304-8 [17322074.001]
  • [Cites] Bull World Health Organ. 2001;79(6):490-500 [11436469.001]
  • [Cites] Hypertens Res. 2008 Jul;31(7):1435-43 [18957815.001]
  • [Cites] PLoS One. 2014 Nov 21;9(11):e112790 [25415321.001]
  • [Cites] East Afr J Public Health. 2009 Dec;6(3):268-73 [20803917.001]
  • [Cites] J Am Board Fam Med. 2008 Jul-Aug;21(4):300-8 [18612056.001]
  • [Cites] Curr Hypertens Rep. 2013 Dec;15(6):659-68 [24052212.001]
  • [Cites] Am J Hypertens. 2012 Feb;25(2):180-9 [21993367.001]
  • [Cites] J Hum Hypertens. 2011 Mar;25(3):164-71 [20445569.001]
  • [Cites] J Clin Hypertens (Greenwich). 2009 Nov;11(11):611-4 [19878368.001]
  • [Cites] BMC Public Health. 2014 Sep 09;14:937 [25201163.001]
  • (PMID = 28489865.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


42. Ayele T, Jarso H, Mamo G: Clinical Outcomes of Tenofovir &lt;i&gt;Versus&lt;/i&gt; Zidovudine-based Regimens Among People Living with HIV/AIDS: a Two Years Retrospective Cohort Study. Open AIDS J; 2017;11:1-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Through 24 months analysis, TDF based regimen had a protective effect against death and opportunistic infections (OIs), (AHR=0.79, 95% CI [0.24, 2.62]) and (AHR=0.78, 95%CI [0.43, 1.4] respectively.
  • Those with body mass-index (BMI) <18.5kg/m2 (AHR=3.21, 95%CI [0.93, 11.97]) had higher hazard of death.
  • Absence of baseline prophylaxis (AHR=8.22, 95% CI [1.7, 39.77]), Cotrimoxazole prophylaxis alone (AHR=6.15, 95% CI [1.47, 26.67]) and BMI<18.5kg/m2 (AHR=2.06, 95% CI [1.14, 3.73]) had higher hazards of OIs.
  • However, since this study was not dealt with toxicity of the regimens, we recommend to conduct high quality design on this issue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Infect Dis. 2008 Apr 22;8:52 [18430196.001]
  • [Cites] AIDS. 2007 Jun 19;21(10):1273-81 [17545703.001]
  • [Cites] AIDS Res Ther. 2008 Oct 28;5:23 [18957083.001]
  • [Cites] Trop Med Int Health. 2010 Nov;15(11):1357-63 [20868414.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Feb 15;(2):CD007276 [22336829.001]
  • [Cites] PLoS One. 2010 May 11;5(5):e10584 [20485670.001]
  • [Cites] Clin Infect Dis. 2012 Mar;54(6):862-75 [22357809.001]
  • [Cites] J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):475-81 [21857354.001]
  • [Cites] J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):535-40 [17057609.001]
  • [Cites] J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16 Suppl 1:S14-22 [9389311.001]
  • [Cites] AIDS. 2012 Jan 28;26(3):365-73 [22095194.001]
  • [Cites] PLoS One. 2013 May 14;8(5):e64459 [23691224.001]
  • [Cites] J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):209-21 [19644384.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Mar;46(3):716-23 [11850253.001]
  • [Cites] AIDS. 2007 Jan 30;21(3):351-9 [17255742.001]
  • [Cites] Ann Pharmacother. 2003 Jun;37(6):849-59 [12773076.001]
  • [Cites] HIV Med. 2006 Oct;7(7):442-50 [16925730.001]
  • [Cites] J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):74-8 [17971715.001]
  • [Cites] J Med Case Rep. 2014 Aug 21;8:281 [25146249.001]
  • [Cites] AIDS. 2010 Jul 31;24(12):1849-55 [20622529.001]
  • [Cites] N Engl J Med. 2006 Jan 19;354(3):251-60 [16421366.001]
  • [Cites] AIDS. 2009 Aug 24;23(13):1727-9 [19571724.001]
  • [Cites] Glob Health Action. 2010 Oct 29;3:null [21042435.001]
  • [Cites] JAMA. 2004 Jul 14;292(2):191-201 [15249568.001]
  • [Cites] Curr Opin HIV AIDS. 2010 Jan;5(1):38-47 [20046146.001]
  • [Cites] Pan Afr Med J. 2015 Jan 22;20:63 [26090021.001]
  • (PMID = 28217219.001).
  • [Journal-full-title] The open AIDS journal
  • [ISO-abbreviation] Open AIDS J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Jimma University Specialize hospital / Tenofovir regimen / Treatment outcomes / Zidovudine regimen
  •  go-up   go-down


43. Liu Y, Brossard M, Roqueiro D, Margaritte-Jeannin P, Sarnowski C, Bouzigon E, Demenais F: SigMod: an exact and efficient method to identify a strongly interconnected disease-associated module in a gene network. Bioinformatics; 2017 May 15;33(10):1536-1544

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To date, most network-assisted methods aim at finding genes connected in a background network, whatever the density or strength of their connections.
  • Our method is formulated as a binary quadratic optimization problem, which can be solved exactly through graph min-cut algorithms.
  • Compared to existing methods, SigMod has several desirable properties: (i) edge weights quantifying confidence of connections between genes are taken into account, (ii) the selection path can be computed rapidly, (iii) the identified gene module is strongly interconnected, hence includes genes of high functional relevance, and (iv) the method is robust against noise from either the GWAS results or the network resource.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28069594.001).
  • [ISSN] 1367-4811
  • [Journal-full-title] Bioinformatics (Oxford, England)
  • [ISO-abbreviation] Bioinformatics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


44. Chan PY, Joseph MA, Des Jarlais DC, Uusküla A: Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia. Int J STD AIDS; 2017 Jan 01;:956462417714635
HIV InSite. treatment guidelines - Adherence to HIV Antiretroviral Therapy .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Participants with problem drinking reported significant suboptimal adherence to ART (adjusted odds ratio [AOR] 0.42, 95% CI 0.19-0.97).
  • Daily injection drug use was also associated with suboptimal adherence (AOR 0.34, 95% CI 0.13-0.91).
  • Problem drinking has not been commonly reported as a factor of suboptimal ART adherence among PWID; further research would be useful to identify the pathways that might be involved.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28618981.001).
  • [ISSN] 1758-1052
  • [Journal-full-title] International journal of STD & AIDS
  • [ISO-abbreviation] Int J STD AIDS
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; AIDS / ART / Europe / HIV / treatment
  •  go-up   go-down


45. Cheng HG, Phillips MR, Zhang Y, Wang Z: Relationship of drinking motives with alcohol consumption and alcohol-related problems identified in a representative community-based study from Ningxia, China. Addict Behav; 2017 Jun 13;74:156-161

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FINDINGS: The enhancement motive is significantly associated with the level of alcohol consumption (β=0.52, 95% CI=0.27, 0.78).
  • The conformity motive is associated with higher levels of alcohol dependence (β=0.74, 95% CI=0.50, 0.98) and adverse consequences of drinking (β=0.43, 95% CI=0.04, 0.81).
  • This study highlights the need to consider local context when adapting prevention or intervention strategies developed in western countries to address the problem of the harmful use of alcohol in China.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28648993.001).
  • [ISSN] 1873-6327
  • [Journal-full-title] Addictive behaviors
  • [ISO-abbreviation] Addict Behav
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Alcohol Use Disorder Identification Test / Alcohol epidemiology / China / Drinking Motives Questionnaire / Drinking motive / Population survey
  •  go-up   go-down


46. Ahankari A, Bapat S, Myles P, Fogarty A, Tata L: Factors associated with preterm delivery and low birth weight: a study from rural Maharashtra, India. F1000Res; 2017;6:72

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multivariable logistic regression analysis provided odds ratios (OR) with 95% confidence intervals (CI) for preterm delivery and LBW according to each maternal risk factor.
  • The odds of preterm delivery were three times higher (OR=3.23, 95% CI 1.36 to 7.65) and the odds of LBW were double (OR=2.03, 95% CI 1.14 to 3.60) among women <22 years of age compared with older women.
  • Future studies should explore other related risk factors and the reasons for poor birth outcomes in younger mothers in this population, to inform the design of appropriate public health policies that address this issue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Obstet Gynaecol. 2008 Aug;28(6):604-7 [19003655.001]
  • [Cites] Indian Pediatr. 1994 Oct;31(10):1221-5 [7875782.001]
  • [Cites] Int J Epidemiol. 2001 Dec;30(6):1233-41 [11821313.001]
  • [Cites] Indian Pediatr. 2012 Jan;49(1):25-8 [21719926.001]
  • [Cites] Int J Epidemiol. 1992 Apr;21(2):263-72 [1428479.001]
  • [Cites] PLoS Med. 2007 Oct 16;4(10):e296 [17941714.001]
  • [Cites] Lancet. 2009 May 30;373(9678):1883-9 [19278721.001]
  • [Cites] Indian J Public Health. 2008 Apr-Jun;52(2):65-71 [19125537.001]
  • [Cites] PLoS One. 2012;7(7):e40040 [22792210.001]
  • [Cites] Indian Pediatr. 2000 Aug;37(8):872-6 [10951635.001]
  • [Cites] Natl Vital Stat Rep. 1999 Jul 30;47(23):1-23 [10461445.001]
  • [Cites] Indian Pediatr. 2001 Mar;38(3):271-5 [11255304.001]
  • [Cites] Indian J Pediatr. 2010 Jan;77(1):87-9 [19936646.001]
  • [Cites] Indian J Med Res. 2009 Nov;130(5):600-8 [20090114.001]
  • (PMID = 28529697.001).
  • [Journal-full-title] F1000Research
  • [ISO-abbreviation] F1000Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; India / Maharashtra / birth weight / gravidity / maternal age
  •  go-up   go-down


47. Oh J, Kim SH, Park KN, Oh SH, Kim YM, Kim HJ, Youn CS: High-sensitivity C-reactive protein/albumin ratio as a predictor of in-hospital mortality in older adults admitted to the emergency department. Clin Exp Emerg Med; 2017 Mar;4(1):19-24
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We performed a retrospective analysis of patients admitted to the ED with any medical problem between May 2013 and October 2013 who were older than 65 years.
  • Multivariate logistic analysis showed that the hs-CRP/albumin ratio was associated with all-cause in-hospital mortality after adjusting for other confounding factors (odds ratio, 1.011; 95% confidence interval [CI], 1.003 to 1.020).
  • The prognostic value of the hs-CRP/albumin ratio for predicting mortality (area under the curve, 0.728; 95% CI, 0.696 to 0.758) was greater than that of hs-CRP alone (area under the curve, 0.706; 95% CI, 0.674 to 0.738; P<0.001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2016 Jun 03;11(6):e0156790 [27258004.001]
  • [Cites] EuroIntervention. 2016 Jun 20;12 (3):345-51 [26158553.001]
  • [Cites] N Engl J Med. 2004 Apr 1;350(14):1387-97 [15070788.001]
  • [Cites] J Am Geriatr Soc. 2001 Oct;49(10):1379-86 [11890500.001]
  • [Cites] Postgrad Med. 2011 Jan;123(1):114-9 [21293091.001]
  • [Cites] Ann Emerg Med. 2002 Mar;39(3):238-47 [11867975.001]
  • [Cites] J Am Geriatr Soc. 2005 Jul;53(7):1222-6 [16108943.001]
  • [Cites] Ann Emerg Med. 2010 Sep;56(3):261-9 [20619500.001]
  • [Cites] Stroke. 2014 Mar;45(3):707-16 [24523037.001]
  • [Cites] Acad Emerg Med. 1998 Dec;5(12):1157-62 [9864128.001]
  • [Cites] PLoS One. 2013;8(3):e59321 [23555017.001]
  • [Cites] PLoS One. 2015 Sep 14;10 (9):e0138150 [26367532.001]
  • [Cites] Lancet. 2010 Jan 9;375(9709):132-40 [20031199.001]
  • [Cites] Scand J Trauma Resusc Emerg Med. 2010 Feb 11;18:8 [20146829.001]
  • [Cites] Intensive Care Med. 1996 Jul;22(7):707-10 [8844239.001]
  • [Cites] J Pain Symptom Manage. 2012 Mar;43(3):631-7 [21925833.001]
  • [Cites] PLoS One. 2015 Jul 09;10(7):e0132109 [26158725.001]
  • [Cites] BMC Nephrol. 2011 Jun 29;12:30 [21714897.001]
  • [Cites] Ann Emerg Med. 2008 Jun;51(6):769-74 [18069088.001]
  • [Cites] Natl Health Stat Report. 2010 Aug 6;(26):1-31 [20726217.001]
  • (PMID = 28435898.001).
  • [Journal-full-title] Clinical and experimental emergency medicine
  • [ISO-abbreviation] Clin Exp Emerg Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Aged / Albumins / C-reactive protein / Mortality
  •  go-up   go-down


48. Mpyet C, Muhammad N, Adamu MD, Muazu H, Umar MM, Goyol M, Yahaya HB, Onyebuchi U, Ogoshi C, Hussaini T, Isiyaku S, William A, Flueckiger RM, Chu BK, Willis R, Pavluck AL, Olobio N, Phelan S, Macleod C, Solomon AW, Global Trachoma Mapping Project: Prevalence of Trachoma in Kano State, Nigeria: Results of 44 Local Government Area-Level Surveys. Ophthalmic Epidemiol; 2017 Jun;24(3):195-203
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: State-wide crude prevalence of TF in persons aged 1-9 years was 3.4% (95% CI 3.3-3.5%), and of trichiasis in those aged ≥15 years was 2.3% (95% CI 2.1-2.4%).
  • State-wide prevalence of trichiasis in adult women was significantly higher than in adult men (2.6% vs 1.8%; OR = 1.5, 95% CI 1.3-1.7; p = 0.001).
  • CONCLUSION: Trichiasis is a public health problem in most LGAs in Kano.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28276755.001).
  • [ISSN] 1744-5086
  • [Journal-full-title] Ophthalmic epidemiology
  • [ISO-abbreviation] Ophthalmic Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Global Trachoma Mapping Project / Kano State / Nigeria / prevalence / trachoma / trichiasis
  •  go-up   go-down


49. Kuzman M, Posavec M: Medical use, nonmedical use of prescription medication and risk behaviour among Croatian adolescents. Psychiatr Danub; 2016 Dec;28(Suppl-2):223-233
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: In multivariate analysis for all three survey years the strongest predictor for prescription medication use was use of sedatives/tranquilizers without prescription (OR 6.14; CI 4.08-9.23; OR 8.16; CI4.65-14.32; OR 9.77; CI5.92-15.13).
  • Frequent drinking and excessive drinking or drunkenness also predicted prescription medication use, (OR 1.85; CI1.10-3.10; OR 2.01: CI 1.20-3.39).
  • Among other problem behaviours lower school performance (OR 2.92; CI 1.41-6.05; OR 2.56; CI 1.12-5.87), missed school days OR 1.59; OR1.01-2.51; OR1.72; CI 1.03-2.87), aggressive behaviour (OR 1.532; CI 1.01-2.28; OR1.65; CI 1.04-2.62), depressive symptoms (OR 2.19; CI 1.24-3.85) and poorer financial situation were connected with prescription medication use.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28035127.001).
  • [ISSN] 0353-5053
  • [Journal-full-title] Psychiatria Danubina
  • [ISO-abbreviation] Psychiatr Danub
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Croatia
  •  go-up   go-down


50. Uusküla A, Raag M, Marsh K, Talu A, Vorobjov S, Des Jarlais D: HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLoS One; 2017;12(2):e0170956

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
  • HIV prevalence was 18% (95%CI 8-28%) (41% (95%CI 19-63%) among female and 7% (95%CI 2-12%) among male new injectors).
  • In multivariable analysis, gender (male: OR 0.12, 95% CI 0.03-0.45), main drug injected (fentanyl: OR 6.7, 95% CI 1.3-35.7) and syringe sharing (distributive: OR 0.11, 95% CI 0.02-0.55; and receptive: OR 3.7, 95% CI 1.0-13.5) were associated with the HIV seropositivity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J STD AIDS. 2007 Jun;18(6):389-91 [17609027.001]
  • [Cites] Drug Alcohol Depend. 2016 Jan 1;158:102-9 [26651427.001]
  • [Cites] Drug Alcohol Depend. 2007 Jul 10;89(2-3):145-52 [17276623.001]
  • [Cites] AIDS Behav. 2015 Jan;19(1):199-210 [24920342.001]
  • [Cites] BMC Infect Dis. 2011 Apr 06;11:86 [21466704.001]
  • [Cites] BMJ. 1992 Mar 28;304(6830):809-13 [1392708.001]
  • [Cites] Drug Alcohol Depend. 2007 Nov;91 Suppl 1:S4-17 [17582705.001]
  • [Cites] J Urban Health. 2004 Jun;81(2):249-59 [15136658.001]
  • [Cites] BMC Public Health. 2011 Jun 30;11:517 [21718469.001]
  • [Cites] AIDS. 2006 Oct 24;20(16):2120-3 [17053361.001]
  • [Cites] Am J Epidemiol. 2008 Nov 15;168(10):1099-109 [18849303.001]
  • [Cites] Eur Addict Res. 2009;15(3):163-70 [19506377.001]
  • [Cites] J Urban Health. 2010 Mar;87(2):304-17 [20131018.001]
  • [Cites] Antivir Ther. 2013;18 Suppl 2:19-25 [23784671.001]
  • [Cites] HIV Med. 2008 Aug;9(7):503-7 [18484977.001]
  • [Cites] BMC Public Health. 2006 Mar 02;6:54 [16512922.001]
  • [Cites] BMJ Open. 2012 Oct 18;2(5):null [23087014.001]
  • [Cites] AIDS Care. 2015;27(1):105-11 [25054646.001]
  • [Cites] J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Apr 15;11(5):499-509 [8605596.001]
  • [Cites] Arch Intern Med. 2001 May 28;161(10):1281-8 [11371255.001]
  • [Cites] J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):67-72 [9928732.001]
  • [Cites] Am J Drug Alcohol Abuse. 2002;28(3):453-75 [12211360.001]
  • [Cites] Harm Reduct J. 2009 Feb 20;6:3 [19232088.001]
  • [Cites] Am J Public Health. 1996 May;86(5):655-61 [8629715.001]
  • [Cites] Am J Public Health. 2014 May;104(5):816-21 [24625174.001]
  • [Cites] J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):86-93 [12514419.001]
  • [Cites] J Public Health (Oxf). 2008 Jun;30(2):119-25 [18308743.001]
  • [Cites] Int J Drug Policy. 2015 Feb;26 Suppl 1:S16-21 [25277726.001]
  • [Cites] Afr J Drug Alcohol Stud. 2011;10(1):1-9 [23024611.001]
  • [Cites] Drug Alcohol Depend. 2012 Jul 1;124(1-2):95-107 [22257753.001]
  • [Cites] Int J Drug Policy. 2009 Jul;20(4):317-23 [18790623.001]
  • [Cites] Am J Epidemiol. 1993 Dec 1;138(11):923-36 [8256780.001]
  • [Cites] Lancet. 2008 Nov 15;372(9651):1733-45 [18817968.001]
  • [Cites] Drug Alcohol Depend. 2009 Sep 1;104(1-2):167-74 [19559543.001]
  • [Cites] Int J STD AIDS. 2010 Jul;21(7):489-96 [20852199.001]
  • (PMID = 28152026.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


51. Reimer A, Schmitt A, Ehrmann D, Kulzer B, Hermanns N: Reduction of diabetes-related distress predicts improved depressive symptoms: A secondary analysis of the DIAMOS study. PLoS One; 2017;12(7):e0181218

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Diabetes-related distress was assessed using the Problem Areas In Diabetes (PAID) scale; depressive symptoms were assessed using the Center for Epidemiologic Studies Depression (CES-D) scale.
  • Reliable change indices were established as criteria of meaningful reductions in diabetes distress and depressive symptoms.
  • RESULTS: A reliable reduction of diabetes-related distress (15.43 points in the PAID) was significantly associated with fourfold increased odds for reliable improvement of depressive symptoms (OR = 4.25, 95% CI: 2.05-8.79; P<0.001).
  • Higher age had a positive (Odds Ratio = 2.04, 95% CI: 1.21-3.43; P<0.01) and type 2 diabetes had a negative effect on the meaningful reduction of depressive symptoms (Odds Ratio = 0.12, 95% CI: 0.04-0.35; P<0.001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28700718.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


52. Hartmann M, Cash SB, Yeh CH, Landwehr SC, McAlister AR: Children's purchase behavior in the snack market: Can branding or lower prices motivate healthier choices? Appetite; 2017 Jun 15;117:247-254

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Children's dietary-related diseases and their associated costs have expanded dramatically in many countries, making children's food choice a policy issue of increasing relevance.
  • RESULTS: Children's purchase decisions are primarily determined by product type (Importance Value (IV) 56.6%), while brand (IV 22.8%) and price (IV 20.6%) prove to be of less relevance.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28625855.001).
  • [ISSN] 1095-8304
  • [Journal-full-title] Appetite
  • [ISO-abbreviation] Appetite
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aggregated and mixed logit models / Branding / Children as consumers / Discrete choice experiment / Marketing / children's food preference
  •  go-up   go-down


53. Chaveepojnkamjorn W, Pichainarong N, Thotong R, Sativipawee P, Pitikultang S: Relationship between Breast Cancer and Oral Contraceptive Use among Thai Premenopausal Women: a Case-Control Study. Asian Pac J Cancer Prev; 2017 05 01;18(5):1429-1433

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Background: Breast cancer (BC) is an important issue both in medicine and public health as it is the leading malignancy with high incidence and mortality among women worldwide.
  • Multiple unconditional logistic regression analysis, controlling for possible confounding factors, revealed that TPW with OC use increased the risk of BC by a factor of over 3 times (ORadj=3.39, 95%CI =1.99-5.75).
  • In addition, the greater the duration of OC, the greater the risk (ORadj 6-10 yrs=3.91, 95%CI = 1.99-7.64, ORadj >10 yrs=4.23, 95%CI = 2.05-8.71).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Creative Commons Attribution License
  • (PMID = 28612598.001).
  • [ISSN] 2476-762X
  • [Journal-full-title] Asian Pacific journal of cancer prevention : APJCP
  • [ISO-abbreviation] Asian Pac. J. Cancer Prev.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Thailand
  • [Keywords] NOTNLM ; Breast cancer (major topic) / oral contraceptive use (major topic) / Thai premenopausal women (major topic)
  •  go-up   go-down


54. Owili PO, Muga MA, Pan WC, Kuo HW: Indoor secondhand tobacco smoke and risk of under-five mortality in 23 sub-Saharan Africa countries: A population based study and meta-analysis. PLoS One; 2017;12(5):e0177271
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The association between tobacco smoke exposure and the risk of under-five mortality attenuated in eight countries (Burkina Faso, Benin, Congo, Gabon, Guinea, Liberia, Togo, and Zambia) after adjustment, while the hazard ratios (HR) of daily exposure to tobacco smoke in Kenya (HR = 1.40; 95% CI, 1.16-1.70) and Namibia (HR = 1.40; 1.07-1.83) grew.
  • The children in rural areas in SSA were 1.08 (95% CI, 1.04-1.13) times more likely to die than their urban peers.
  • In general, the exposure to household tobacco smoke was associated with an increased risk of under-five mortality in SSA (HR = 1.09; 95% CI, 1.06-1.13).
  • Policymakers in low- and middle-income countries, where tobacco control as a child health issue is relatively neglected, should integrate tobacco control measures with other child health promotion policies.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Public Health. 2008 Oct;98(10):1824-6 [18309124.001]
  • [Cites] Stat Med. 2002 Jun 15;21(11):1539-58 [12111919.001]
  • [Cites] Hum Exp Toxicol. 1999 Apr;18(4):202-5 [10333302.001]
  • [Cites] Acta Obstet Gynecol Scand. 2010;89(4):531-9 [20230310.001]
  • [Cites] Lancet. 2011 Jan 8;377(9760):139-46 [21112082.001]
  • [Cites] Am J Prev Med. 2007 Jun;32(6):542-3 [17533072.001]
  • [Cites] Thorax. 1997 Oct;52(10):905-14 [9404380.001]
  • [Cites] BMC Public Health. 2014 Jun 10;14:580 [24913038.001]
  • [Cites] Thorax. 1997 Nov;52(11):1003-9 [9487351.001]
  • [Cites] Thorax. 2005 Oct;60(10):794-5 [16192361.001]
  • (PMID = 28542166.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Shavadia J, Welsh R, Gershlick A, Zheng Y, Huber K, Halvorsen S, Steg PG, Van de Werf F, Armstrong PW: Relationship Between Arterial Access and Outcomes in ST-Elevation Myocardial Infarction With a Pharmacoinvasive Versus Primary Percutaneous Coronary Intervention Strategy: Insights From the STrategic Reperfusion Early After Myocardial Infarction (STREAM) Study. J Am Heart Assoc; 2016 Jun 13;5(6)
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The effectiveness of radial access (RA) in ST-elevation myocardial infarction (STEMI) has been predominantly established in primary percutaneous coronary intervention (pPCI) with limited exploration of this issue in the early postfibrinolytic patient.
  • On multivariable analysis, this benefit on the primary composite outcome favoring RA persisted (adjusted odds ratio [OR], 0.59; 95% CI, 0.44-0.78; <i>P</i><0.001) and was evident in both pPCI (adjusted OR, 0.63; 95% CI, 0.43-0.92) and PI cohorts (adjusted OR, 0.57 95% CI, 0.37-0.86; <i>P</i> interaction=0.730).

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
  • [Cites] JACC Cardiovasc Interv. 2013 Aug;6(8):814-23 [23968700.001]
  • [Cites] Catheter Cardiovasc Interv. 2007 Nov 1;70(5):670-5 [17563094.001]
  • [Cites] Am J Epidemiol. 2006 Feb 1;163(3):262-70 [16371515.001]
  • [Cites] N Engl J Med. 1985 Apr 4;312(14 ):932-6 [4038784.001]
  • [Cites] Circulation. 2008 Sep 23;118(13):1335-46 [18779444.001]
  • [Cites] JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):20-9 [25616814.001]
  • [Cites] Circ Cardiovasc Interv. 2015 Jun;8(6):e002049 [26056249.001]
  • [Cites] EuroIntervention. 2013 Mar;8(11):1242-51 [23354100.001]
  • [Cites] J Am Coll Cardiol. 2014 Mar 18;63(10):964-72 [24211309.001]
  • [Cites] JACC Cardiovasc Interv. 2015 Dec 21;8(14 ):1868-76 [26718516.001]
  • [Cites] Eur Heart J. 2012 Oct;33(20):2569-619 [22922416.001]
  • [Cites] J Am Coll Cardiol. 2012 Dec 18;60(24):2481-9 [22858390.001]
  • [Cites] Am Heart J. 2009 Jan;157(1):132-40 [19081409.001]
  • [Cites] Heart. 2012 Apr;98 (7):552-7 [22337951.001]
  • [Cites] J Am Coll Cardiol. 2012 Dec 18;60(24):2500-3 [23237562.001]
  • [Cites] Am Heart J. 2010 Jul;160(1):30-35.e1 [20598969.001]
  • [Cites] Lancet. 2015 Jun 20;385(9986):2465-76 [25791214.001]
  • [Cites] Am J Cardiol. 2014 Sep 15;114(6):811-9 [25108302.001]
  • [Cites] N Engl J Med. 2013 Apr 11;368(15):1379-87 [23473396.001]
  • [Cites] J Invasive Cardiol. 2012 Aug;24(8):412-6 [22865313.001]
  • [Cites] N Engl J Med. 1993 Sep 2;329(10 ):673-82 [8204123.001]
  • [Cites] J Am Coll Cardiol. 2012 Dec 18;60(24):2490-9 [23103036.001]
  • [Cites] Catheter Cardiovasc Interv. 2014 Feb;83(2):228-36 [24123781.001]
  • (PMID = 28525886.001).
  • [ISSN] 2047-9980
  • [Journal-full-title] Journal of the American Heart Association
  • [ISO-abbreviation] J Am Heart Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; ST‐segment elevation myocardial infarction / arterial access / pharmacoinvasive strategy / primary percutaneous coronary intervention
  •  go-up   go-down


56. Mohamed AA, Yosef AH, James C, Al-Hussaini TK, Bedaiwy MA, Amer SAKS: Ovarian reserve after salpingectomy: a systematic review and meta-analysis. Acta Obstet Gynecol Scand; 2017 Jul;96(7):795-803

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Although there has been a growing concern over the possible damaging effect of salpingectomy on ovarian reserve, this issue remains uncertain.
  • Data were extracted and entered into RevMan software for calculation of the weighted mean difference (WMD) and 95% CI.
  • RESULTS: Pooled results of group 1 studies showed no statistically significant change in serum AMH concentration after salpingectomy (WMD, -0.10 ng/mL; 95% CI -0.19 to 0.00, I<sup>2</sup> = 0%).
  • Similarly, meta-analysis of group 2 showed no statistically significant difference in serum AMH concentration between salpingectomy group and controls (WMD, -0.11 ng/mL; 95% CI -0.37 to 0.14, I<sup>2</sup> = 77%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Nordic Federation of Societies of Obstetrics and Gynecology.
  • (PMID = 28471535.001).
  • [ISSN] 1600-0412
  • [Journal-full-title] Acta obstetricia et gynecologica Scandinavica
  • [ISO-abbreviation] Acta Obstet Gynecol Scand
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Anti-Müllerian hormone / laparoscopy / ovarian function / ovarian reserve / salpingectomy
  •  go-up   go-down


57. Wang W, Zhou L, Sun L: Ondansetron for neuraxial morphine-induced pruritus: A meta-analysis of randomized controlled trials. J Clin Pharm Ther; 2017 Aug;42(4):383-393
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ondansetron has been used to deal with the problem of neuraxial morphine-induced pruritus (NMIP).
  • We calculated risk ratios (RR) with 95% confidence intervals (CI) for dichotomous data.
  • RESULTS AND DISCUSSION: Our traditional meta-analysis showed that prophylactic ondansetron could significantly reduce the incidence of NMIP in non-obstetric patients (three trials, RR=0.63, 95% CI 0.45-0.89, P=.008) with modest heterogeneity (I<sup>2</sup> =47%) while it did not show the preventive efficacy of NMIP in obstetric patients (seven trials, RR=0.84, 95% CI 0.69-1.03, P=.10) with obvious heterogeneity (I<sup>2</sup>  =82% ).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Ltd.
  • (PMID = 28464238.001).
  • [ISSN] 1365-2710
  • [Journal-full-title] Journal of clinical pharmacy and therapeutics
  • [ISO-abbreviation] J Clin Pharm Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; clinical pharmacy / meta-analysis / morphine / ondansetron / pruritus
  •  go-up   go-down


58. Pek EA, Remfry A, Pendrith C, Fan-Lun C, Bhatia RS, Soong C: High Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults. J Hosp Med; 2017 May;12(5):310-316

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A clear understanding of the extent of the problem and its contributors is required to implement effective interventions.
  • Admission to a surgical or specialty service was associated with significantly increased odds of potentially inappropriate prescription compared to the general internal medicine service (odds ratio [OR], 6.61; 95% confidence interval [CI], 2.70-16.17).
  • Prescription by an attending physician or fellow was associated with significantly fewer prescriptions compared to first-year trainees (OR, 0.28; 95% CI, 0.08-0.93).
  • Nighttime prescriptions did not reach significance in initial bivariate analyses but were associated with increased odds of potentially inappropriate prescription in our regression model (OR, 4.48; 95% CI, 2.21-9.06).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28459898.001).
  • [ISSN] 1553-5606
  • [Journal-full-title] Journal of hospital medicine
  • [ISO-abbreviation] J Hosp Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Richardson JS, Guzauskas GF, Fann JR, Temkin NR, Bush NE, Bell KR, Gahm GA, Smolenski DJ, Brockway JA, Hansen RN: Economic evaluation of telephone-based concussion management for combat-related mild traumatic brain injury. J Telemed Telecare; 2017 Jan 01;:1357633X17696586

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The CONTACT study tested an individualized telephone support intervention employing problem solving therapy (PST) for mTBI in soldiers recently returned from deployment.
  • Results The PST intervention resulted in an annual per-enrolee cost of $1027 (95% CI: $836 to $1248), while EO costs were $32 (95% CI: $25 to $39), resulting in a net incremental cost of $996 per enrolee (95% CI: $806 to $1,217).
  • The ICERs were $68,658/QALY based on EQ-5D (95% CI: -$463,535 to $596,661) and $49,284/QALY based on SF-6D (95% CI: $26,971 to $159,309).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28372513.001).
  • [ISSN] 1758-1109
  • [Journal-full-title] Journal of telemedicine and telecare
  • [ISO-abbreviation] J Telemed Telecare
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cost effectiveness / cost minimization / telehealth
  •  go-up   go-down


60. Mujoo S, Ali Z, Jehangir M, Iqbal A, Qayoom N, Lone AQ: A Comparative Evaluation of Ramosetron with Ondansetron for the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Urological Procedures. Anesth Essays Res; 2017 Jan-Mar;11(1):78-83

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Postoperative nausea and vomiting (PONV) is a common problem causing distress to patients in the postoperative period.
  • Patients were randomly distributed to receive either injection ramosetron 0.3 mg intravenously (IV) or injection ondansetron 6 mg IV just before extubation.
  • CONCLUSION: A single dose of IV ramosetron (0.3 mg) is more effective when compared with a single dose IV ondansetron (6 mg) in the prevention of PONV.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Anesth. 1994 Sep-Oct;6(5):370-7 [7986508.001]
  • [Cites] Anaesthesia. 2010 May;65(5):500-4 [20337618.001]
  • [Cites] Ann Acad Med Singapore. 2005 Mar;34(2):196-205 [15827668.001]
  • [Cites] Can J Anaesth. 1991 Apr;38(3):298-302 [1828016.001]
  • [Cites] Jpn J Clin Oncol. 2009 Feb;39(2):111-5 [19060294.001]
  • [Cites] Anaesthesia. 1997 May;52(5):443-9 [9165963.001]
  • [Cites] J Korean Med Sci. 2007 Oct;22(5):878-82 [17982239.001]
  • [Cites] Anesth Analg. 1999 Aug;89(2):476-9 [10439770.001]
  • [Cites] Anesth Analg. 2006 Jun;102(6):1884-98 [16717343.001]
  • [Cites] Spine (Phila Pa 1976). 2008 Aug 1;33(17):E602-6 [18670328.001]
  • [Cites] Anesthesiology. 2012 Sep;117(3):475-86 [22846680.001]
  • [Cites] Arch Ophthalmol. 2005 Jan;123(1):25-8 [15642807.001]
  • [Cites] Can J Anaesth. 1999 Oct;46(10):991-3 [10522590.001]
  • [Cites] Clin Ther. 2002 May;24(5):766-72 [12075944.001]
  • [Cites] Anesthesiology. 1999 Sep;91(3):693-700 [10485781.001]
  • [Cites] Br J Anaesth. 2012 Nov;109(5):742-53 [23035051.001]
  • [Cites] Nurs Stand. 2001 Jun 20-26;15(40):47-52; quiz 53-5 [12206076.001]
  • [Cites] Br J Anaesth. 2000 Nov;85(5):675-7 [11094578.001]
  • [Cites] Br J Anaesth. 2009 Oct;103(4):549-53 [19700442.001]
  • [Cites] Jpn J Clin Oncol. 2005 Dec;35(12):695-9 [16319109.001]
  • [Cites] Anesth Analg. 2000 Feb;90(2):472-5 [10648342.001]
  • [Cites] Anesthesiology. 1999 Jul;91(1):109-18 [10422935.001]
  • (PMID = 28298761.001).
  • [ISSN] 0259-1162
  • [Journal-full-title] Anesthesia, essays and researches
  • [ISO-abbreviation] Anesth Essays Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Ondansetron / postoperative nausea and vomiting / ramosetron
  •  go-up   go-down


61. Nieberler M, Häußler P, Kesting MR, Kolk A, Stimmer H, Nentwig K, Weirich G, Wolff KD: Intraoperative cell isolation for a cytological assessment of bone resection margins in patients with head and neck cancer. Br J Oral Maxillofac Surg; 2017 Jun;55(5):510-516

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present an advanced cytological approach to assess complex margins that may solve the problem.
  • Intraoperative cell isolation plus (ICICAB) allowed the microscopic assessment of up to 1cm<sup>3</sup> of bony tissue to detect disseminated carcinoma cells within the cancellous bone with a sensitivity of 92.3% (95% CI 74.9% to 99.1%), and a specificity of 100% (95% CI 95.1% to 100%), and positive and negative predictive values of 100% (95% CI 85.8% to 100%) and 97.4% (95%CI 90.8% to 99.7%), respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28292525.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  • [Keywords] NOTNLM ; bone margins / frozen sections / mouth neoplasms / resection status / squamous cell carcinoma / surgical margins
  •  go-up   go-down


62. Villalobos A, Allen-Leigh B, Salazar-Alberto J, De Castro F, Barrientos-Gutiérrez T, Leyva-López A, Rojas-Martínez R: Quality of reproductive healthcare for adolescents: A nationally representative survey of providers in Mexico. PLoS One; 2017;12(3):e0173342

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A sexual and reproductive quality-of-healthcare index was defined and multinomial logistic regression was utilized in 2015.
  • RESULTS: At the national level 13.9% (95%CI: 6.9-26.0) of healthcare units provide low quality, 68.6% (95%CI: 58.4-77.3) medium quality and 17.5% (95%CI: 11.9-25.0) high quality reproductive healthcare services to adolescents.
  • In Mexico and other middle- to low-income countries where quality-of-care has been shown to be a problem, incorporating adolescent-friendly, gender-equity and rights-based perspectives could contribute to improvement.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Glob Public Health. 2014;9(6):639-46 [24922347.001]
  • [Cites] Health Aff (Millwood). 2007 May-Jun;26(3):w310-23 [17389636.001]
  • [Cites] Perspect Sex Reprod Health. 2003 May-Jun;35(3):144-7 [12866788.001]
  • [Cites] Med Care. 2001 Aug;39(8 Suppl 2):II46-54 [11583121.001]
  • [Cites] Lancet. 2007 Apr 7;369(9568):1220-31 [17416266.001]
  • [Cites] Lancet. 2011 Jun 18;377(9783):2093-102 [21652063.001]
  • [Cites] Lancet. 2007 May 5;369(9572):1565-73 [17482988.001]
  • [Cites] Eur J Contracept Reprod Health Care. 2012 Aug;17(4):254-9 [22681177.001]
  • [Cites] Glob Health Action. 2013 May 15;6:20444 [23680267.001]
  • [Cites] Glob Public Health. 2014;9(6):599-606 [25010845.001]
  • [Cites] Curationis. 2005 Feb;28(1):52-8 [15850153.001]
  • [Cites] BJOG. 2014 Mar;121 Suppl 1:40-8 [24641534.001]
  • [Cites] Perspect Sex Reprod Health. 2007 Dec;39(4):206-15 [18093037.001]
  • [Cites] Ethiop J Health Sci. 2013 Nov;23(3):245-54 [24307824.001]
  • [Cites] Contraception. 2014 Sep;90(3):211-25 [24916724.001]
  • [Cites] Glob Health Action. 2012;5:null [22855646.001]
  • [Cites] Salud Publica Mex. 2013;55 Suppl 2:S235-40 [24626700.001]
  • [Cites] Stud Fam Plann. 1990 Mar-Apr;21(2):61-91 [2191476.001]
  • [Cites] Stud Fam Plann. 1989 Jan-Feb;20(1):1-16 [2652381.001]
  • [Cites] Glob Public Health. 2016 Jan 8;:1-14 [26745032.001]
  • [Cites] Int J Gynaecol Obstet. 2016 Jul;134(1):22-8 [27177515.001]
  • [Cites] J Adolesc Health. 2005 Aug;37(2):155-62 [16026725.001]
  • [Cites] Salud Publica Mex. 2013;55 Suppl 2:S83-90 [24626718.001]
  • [Cites] BMC Pregnancy Childbirth. 2014 Jan 18;14:31 [24438644.001]
  • [Cites] Reprod Health. 2016 Feb 06;13:10 [26852400.001]
  • [Cites] Lancet. 2003 Oct 11;362(9391):1225-30 [14568747.001]
  • (PMID = 28273129.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Hylton E, Wirtz AL, Zelaya CE, Latkin C, Peryshkina A, Mogilnyi V, Dzhigun P, Kostetskaya I, Galai N, Beyrer C: Sexual Identity, Stigma, and Depression: the Role of the "Anti-gay Propaganda Law" in Mental Health among Men Who Have Sex with Men in Moscow, Russia. J Urban Health; 2017 Jun;94(3):319-329

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Depression is a major public health problem in the Russian Federation and is particularly of concern for men who have sex with men (MSM).
  • Bisexual identity had a protective association against probable depression (reference: homosexual identity AOR 0.71; 95%CI 0.52-0.97; p < 0.01).
  • Those who experienced recent stigma (last 12 months) were more likely to report probable depression (reference: no stigma; AOR 1.75; 95%CI 1.20-2.56; p < 0.01).
  • Among participants with stigma, probable depression increased 1.67-fold after the passage of the anti-gay laws AOR 1.67; 95%CI 1.04-2.68; p < 0.01).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AIDS. 2005 May;19 Suppl 2:S67-72 [15930843.001]
  • [Cites] AIDS Behav. 2017 Jan;21(1):261-273 [26896120.001]
  • [Cites] AIDS Behav. 2015 Aug;19(8):1460-9 [25969182.001]
  • [Cites] AIDS Care. 2016;28 Suppl 1:140-7 [27002772.001]
  • [Cites] Am J Orthopsychiatry. 2009 Oct;79(4):500-10 [20099941.001]
  • [Cites] J R Soc Med. 2014 May;107(5):176-177 [24833651.001]
  • [Cites] PLoS One. 2016 Jun 01;11(6):e0155519 [27248818.001]
  • [Cites] Can J Commun Ment Health. 2003 Fall;22(2):15-30 [15868835.001]
  • [Cites] BMC Psychiatry. 2008 Aug 18;8:70 [18706118.001]
  • [Cites] Am J Public Health. 2003 Jun;93(6):939-42 [12773359.001]
  • [Cites] Br J Psychiatry. 2006 Apr;188:359-65 [16582063.001]
  • [Cites] Psychol Health Med. 2009 Dec;14(6):705-15 [20183543.001]
  • [Cites] AIDS. 2015 Dec;29 Suppl 3:S251-9 [26562814.001]
  • [Cites] AIDS Behav. 2016 Mar;20(3):523-36 [25893659.001]
  • [Cites] AIDS Behav. 2016 Feb;20(2):304-16 [26386592.001]
  • [Cites] Addiction. 1993 Jun;88(6):791-804 [8329970.001]
  • [Cites] PLoS One. 2013;8(3):e58099 [23516434.001]
  • [Cites] Sex Transm Infect. 2016 Mar;92(2):161-7 [26297721.001]
  • [Cites] Lancet. 2013 Nov 9;382(9904):1575-86 [23993280.001]
  • [Cites] Soc Sci Med. 2012 Apr;74(8):1261-8 [22401646.001]
  • [Cites] Public Health Rep. 2007;122 Suppl 1:39-47 [17354526.001]
  • [Cites] Arch Sex Behav. 2016 Aug;45(6):1483-91 [26679303.001]
  • [Cites] Drug Alcohol Depend. 2013 Nov;132 Suppl 1:S17-24 [23906993.001]
  • [Cites] PLoS Med. 2013 Nov;10(11):e1001547 [24223526.001]
  • [Cites] Lancet. 2012 Jul 28;380(9839):378-87 [22819653.001]
  • [Cites] AIDS Care. 2014;26(3):387-95 [23875610.001]
  • (PMID = 28243868.001).
  • [ISSN] 1468-2869
  • [Journal-full-title] Journal of urban health : bulletin of the New York Academy of Medicine
  • [ISO-abbreviation] J Urban Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Bisexuality / Criminal law / Depression / Homosexuality / Men who have sex with men / Russian Federation / Stigma
  •  go-up   go-down


64. Cagnazzo F, Gambacciani C, Morganti R, Perrini P: Aneurysm rebleeding after placement of external ventricular drainage: a systematic review and meta-analysis. Acta Neurochir (Wien); 2017 Apr;159(4):695-704

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The association between external ventricular drainage (EVD) and aneurysm rerupture is still a controversial issue.
  • Rebleeding occurred in 18.8% (95% CI = 16.4-20.6%) of patients requiring EVD and in 6.4% (95% CI = 5.8-7.1%) of patients who did not require EVD (OR = 3.92, p < 0.0001).
  • High Fisher grades (III-IV) were present in 75% of patients with rerupture and in 60% of patients without aneurysmal rerupture (p < 0.0001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28243810.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; Aneurysm rebleeding / Aneurysm rupture / External ventricular drainage / Intracranial aneurysms / Subarachnoid hemorrhage
  •  go-up   go-down


65. Sigalla GN, Mushi D, Meyrowitsch DW, Manongi R, Rogathi JJ, Gammeltoft T, Rasch V: Intimate partner violence during pregnancy and its association with preterm birth and low birth weight in Tanzania: A prospective cohort study. PLoS One; 2017;12(2):e0172540

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Intimate partner violence (IPV) is a public health problem that affects millions of women worldwide.
  • Women exposed to physical IPV were three times more likely to experience PTB (AOR = 2.9; CI 95%: 1.3-6.5) and LBW (AOR = 3.2; CI 95%: 1.3-7.7).
  • Women with previous adverse pregnancy outcomes and exposure to physical IPV had a further increased risk of PTB (AOR = 4.5; CI 95%: 1.5-13.7) and LBW (AOR = 4.8; CI 95%: 1.6-14.8) compared to those without previous history of adverse outcome.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28235031.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Malagù M, Trevisan F, Scalone A, Marcantoni L, Sammarco G, Bertini M: Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study). Am J Cardiol; 2017 Apr 01;119(7):1036-1040
MedlinePlus Health Information. consumer health - Pacemakers and Implantable Defibrillators.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is a single-center observational study which reflects our systematic approach to the problem.
  • On a multivariate analysis, heparin and coronary artery disease were independent predictors of pocket hematoma (relative risk [RR] 3.48, 95% confidence interval [CI] 1.55 to 7.83 and RR 2.43, 95% CI 1.25 to 4.76, respectively), whereas the no-bridge protocol was associated with a reduction of pocket hematoma (RR 0.33, 95% CI 0.14 to 0.76).

  • MedlinePlus Health Information. consumer health - Blood Thinners.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28153344.001).
  • [ISSN] 1879-1913
  • [Journal-full-title] The American journal of cardiology
  • [ISO-abbreviation] Am. J. Cardiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Platelet Aggregation Inhibitors
  •  go-up   go-down


67. Carpenter WR, Abbott DH, Provenzale DT, Weinberger M, Reeve BB, Jackson GL: Examining potential cancer care disparities in an equal access system: Quality of colorectal cancer care (CRC) in the Veterans Affairs (VA) health care system. J Clin Oncol; 2012 Dec;30(34_suppl):229

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : 229 Background: Racial disparities in cancer treatment and outcomes are a substantial problem nationally.
  • Compared to blacks, whites were more likely to undergo surveillance colonoscopy 6 to 18 months following surgery (OR=1.32, 95% CI 1.01-1.73, p=0.04) and marginally more likely to be referred to medical oncology (OR=1.46, 95% CI 1.00-2.13, p=0.05).
  • Patients who were 75 years or older at diagnosis (p<0.01) or with cardiovascular-related comorbidities (OR=0.65, 95% CI 0.50-0.89, p=0.01) were less likely to be referred to a medical oncologist than their younger, healthier counterparts.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28146949.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Shah SM, Ali R, Loney T, Aziz F, ElBarazi I, Al Dhaheri S, Farooqi MH, Blair I: Prevalence of Diabetes among Migrant Women and Duration of Residence in the United Arab Emirates: A Cross Sectional Study. PLoS One; 2017;12(1):e0169949

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the study participants, based on HbA1C levels, 18.6% (95% CI: 13.9-24.4) had prediabetes and 10.7% (95% CI: 7.2-15.6) had T2DM.
  • Significant correlates of overall T2DM (measured and known diabetes) included length of UAE residence for more than 10 years (Adjusted Odds Ratio [AOR] 2.74, 95% CI: 1.21-6.20), age ≥40 years (AOR = 3.48, 95% CI: 1.53-7.87) and South Asian nationality (AOR 2.10, 95% CI: 0.94-4.70).
  • CONCLUSION: Diabetes is a significant public health problem among migrant women in the UAE, particularly for South Asians.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 2012 Sep;97(9):E1579-639 [22730516.001]
  • [Cites] Biomed Res Int. 2015;2015:506269 [26380277.001]
  • [Cites] BMC Public Health. 2013 May 10;13:458 [23663279.001]
  • [Cites] Am J Public Health. 2013 May;103(5):e45-52 [23488481.001]
  • [Cites] BMC Public Health. 2012 May 25;12:380 [22630043.001]
  • [Cites] BMC Public Health. 2015 Feb 28;15:204 [25885030.001]
  • [Cites] Am J Public Health. 2004 Nov;94(11):1977-84 [15514240.001]
  • [Cites] Circulation. 2012 Jul 10;126(2):182-8 [22753304.001]
  • [Cites] J Immigr Minor Health. 2013 Oct;15(5):953-60 [22968231.001]
  • [Cites] BMC Public Health. 2011 Jun 07;11:441 [21649889.001]
  • [Cites] J Immigr Minor Health. 2012 Oct;14(5):774-85 [22180198.001]
  • [Cites] Diabetes Res Clin Pract. 2010 Jan;87(1):4-14 [19896746.001]
  • [Cites] World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 [11234459.001]
  • [Cites] CMAJ. 2010 May 18;182(8):781-9 [20403889.001]
  • [Cites] Diabetes Care. 2014 Aug;37(8):2081-3 [25061137.001]
  • [Cites] PLoS One. 2012;7(8):e40948 [22905094.001]
  • [Cites] J Glob Health. 2014 Jun;4(1):010404 [24976963.001]
  • [Cites] J Immigr Minor Health. 2014 Feb;16(1):24-34 [23595263.001]
  • [Cites] Diabetes Care. 2008 Aug;31(8):1621-8 [18458142.001]
  • [Cites] Glob Health Action. 2013 Feb 05;6:20100 [23394856.001]
  • [Cites] Am J Public Health. 2012 May;102(5):909-14 [21940918.001]
  • [Cites] J Epidemiol. 2012;22(5):440-7 [22813647.001]
  • [Cites] PLoS One. 2014 Feb 18;9(2):e88495 [24558396.001]
  • [Cites] J Immigr Minor Health. 2015 Apr;17 (2):467-73 [24788362.001]
  • [Cites] Diabetes Care. 2015 Jan;38 Suppl:S8-S16 [25537714.001]
  • [Cites] BMC Cardiovasc Disord. 2015 May 07;15:30 [25948543.001]
  • [Cites] World J Diabetes. 2016 Feb 10;7(3):34-44 [26862371.001]
  • [Cites] Can J Cardiol. 2012 Jan-Feb;28(1):20-6 [21827964.001]
  • [Cites] Med Sci Sports Exerc. 2003 Aug;35(8):1381-95 [12900694.001]
  • [Cites] J Diabetes Complications. 2013 Sep-Oct;27(5):429-35 [23743139.001]
  • [Cites] Diabetes Care. 2011 Feb;34(2):353-7 [21216863.001]
  • [Cites] Diabetes Res Clin Pract. 2006 Mar;71(3):306-12 [16236379.001]
  • [Cites] Ann N Y Acad Sci. 2013 Apr;1281:51-63 [23317344.001]
  • (PMID = 28099445.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


69. Huang J, Tang J, Tang L, Chang HJ, Ma Y, Yan Q, Yu Y: Aggression and related stressful life events among Chinese adolescents living in rural areas: A cross-sectional study. J Affect Disord; 2017 Mar 15;211:20-26

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Aggression is a serious problem for both individuals and society.
  • Regression analyses indicated that the odds of aggression were negatively influenced by chronic long-term stressors related to interpersonal problems (OR=2.03, 95% CI [1.75-2.36]), health adaptation difficulties (OR=1.21, 95% CI [1.09-1.34]), and other troubles (OR=1.93, 95% CI [1.74-2.14]), even after adjustment for parental neglect, emotional management, social support, and other relevant factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28086145.001).
  • [ISSN] 1573-2517
  • [Journal-full-title] Journal of affective disorders
  • [ISO-abbreviation] J Affect Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Adolescents / Aggression / Mental health / Rural communities / Stressful life events
  •  go-up   go-down


70. Soubeiga JK, Millogo T, Bicaba BW, Doulougou B, Kouanda S: Prevalence and factors associated with hypertension in Burkina Faso: a countrywide cross-sectional study. BMC Public Health; 2017 Jan 11;17(1):64

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: High blood pressure (HBP) is an increasing public health issue for developing countries.
  • The overall prevalence of hypertension in Burkina Faso was 18% (95% CI: 16.19%-19.96%).
  • In urban areas the prevalence was 24.81% (95% CI 20.21%-30.07%) and 15.37% (95% CI 13.67%-17.24%) in rural areas.
  • Increased Body Mass Index (BMI) and older age were consistently associated with higher odds of HBP in both residential areas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28077112.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Burkina Faso / Hypertension / NCDs / Prevalence / Risk Factors
  •  go-up   go-down


71. Nielsen RV, Fomsgaard JS, Siegel H, Martusevicius R, Nikolajsen L, Dahl JB, Mathiesen O: Intraoperative ketamine reduces immediate postoperative opioid consumption after spinal fusion surgery in chronic pain patients with opioid dependency: a randomized, blinded trial. Pain; 2017 Mar;158(3):463-470
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Perioperative handling of surgical patients with opioid dependency represents an important clinical problem.
  • Postoperatively, patients received their usual opioids, paracetamol and IV patient-controlled analgesia with morphine.
  • Patient-controlled analgesia IV morphine consumption 0 to 24 hours postoperatively was significantly reduced in the ketamine group compared with the placebo group: 79 (47) vs 121 (53) mg IV, mean difference 42 mg (95% confidence interval -59 to -25), P < 0.001.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28067693.001).
  • [ISSN] 1872-6623
  • [Journal-full-title] Pain
  • [ISO-abbreviation] Pain
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


72. Ejaz M, Ahmed E, Mubarak M, Hatcher J, Jaffar T: Persistent albuminuria as a surrogate marker of chronic kidney damage among newly diagnosed hypertensives: Prevalence and risk factors in an urban population in Karachi, Pakistan. Clin Exp Hypertens; 2017;39(1):65-73
Hazardous Substances Data Bank. CHOLESTEROL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Hypertension is a major public health problem worldwide and a key factor for chronic kidney disease (CKD).
  • RESULTS: The prevalence of PA signifying CKD was 9.3% with 95% confidence interval (CI) of 7.8-10.8% by UAC and 8.1% by ACR method (95% CI: 6.6-8.4%).
  • Factors independently associated were male gender (odds ratio [OR], 1.92 (95% CI: 1.24-2.97)) and age less than 55 years with positive family history of kidney disease (OR, 15.51; 95% CI: 7.35-32.97).

  • MedlinePlus Health Information. consumer health - Chronic Kidney Disease.
  • MedlinePlus Health Information. consumer health - High Blood Pressure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28060538.001).
  • [ISSN] 1525-6006
  • [Journal-full-title] Clinical and experimental hypertension (New York, N.Y. : 1993)
  • [ISO-abbreviation] Clin. Exp. Hypertens.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers; 97C5T2UQ7J / Cholesterol; AYI8EX34EU / Creatinine
  • [Keywords] NOTNLM ; Albuminuria / Pakistan / chronic kidney disease / hypertension / risk factors
  •  go-up   go-down


73. Lim YJ, Rosita J, Chieng JY, Hazizi AS: The Prevalence and Symptoms Characteristic of Functional Constipation Using Rome III Diagnostic Criteria among Tertiary Education Students. PLoS One; 2016;11(12):e0167243
MedlinePlus Health Information. consumer health - Constipation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using univariable analysis, FC was significantly associated with sex (odds ratio: 1.48, 95% CI: 1.06-2.06) and age group (odds ratio: 1.34, 95% CI: 1.01-1.79) with P value < 0.05 significance level.
  • In multivariate logistic regression analysis, only sex was found significantly associated with FC (adjusted odds ratio: 1.53, 95% CI: 1.08-2.17, P < 0.05).
  • CONCLUSIONS: Based on the prevalence rate, constipation is a common problem among tertiary education students (16.2%), with significantly more prevalence among the female respondents.

  • Genetic Alliance. consumer health - Constipation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2003 Oct 2;349(14):1360-8 [14523145.001]
  • [Cites] BMC Gastroenterol. 2008 Feb 12;8:5 [18269746.001]
  • [Cites] PLoS One. 2015 Apr 01;10(4):e0122222 [25830229.001]
  • [Cites] Aliment Pharmacol Ther. 2008 Oct 1;28(7):917-30 [18644012.001]
  • [Cites] PLoS One. 2012;7(10):e42910 [23071488.001]
  • [Cites] PLoS One. 2013 Aug 20;8(8):e72608 [23977327.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2009;23(6):875-87 [19942165.001]
  • [Cites] Am J Med. 2011 Aug;124(8):714-23 [21663887.001]
  • [Cites] PLoS One. 2015 Jul 24;10(7):e0133521 [26208169.001]
  • [Cites] PLoS One. 2016 Mar 31;11(3):e0152801 [27031865.001]
  • [Cites] Int Urogynecol J Pelvic Floor Dysfunct. 2000;11(2):71-8 [10805262.001]
  • [Cites] Am J Gastroenterol. 2004 Apr;99(4):750-9 [15089911.001]
  • [Cites] Gut. 2001 Jul;49(1):66-72 [11413112.001]
  • [Cites] Eur J Nutr. 2002 Dec;41(6):244-8 [12474067.001]
  • [Cites] J Gastroenterol Hepatol. 2013 Jul;28(7):1141-7 [23432408.001]
  • [Cites] Am J Gastroenterol. 2011 Sep;106(9):1582-91; quiz 1581, 1592 [21606976.001]
  • [Cites] PLoS One. 2013;8(1):e54183 [23349820.001]
  • [Cites] Dig Dis Sci. 1987 Aug;32(8):841-5 [3608732.001]
  • [Cites] Am J Gastroenterol. 2003 Aug;98(8):1790-6 [12907334.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2016 Sep;13(9):501-2 [27407043.001]
  • [Cites] Acta Biomed. 2006 Dec;77(3):157-62 [17312986.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Aug 1;18(3):319-26 [12895216.001]
  • [Cites] Appetite. 2011 Jun;56(3):778-83 [21435366.001]
  • [Cites] Aliment Pharmacol Ther. 2006 Jul 15;24(2):429-38 [16842471.001]
  • [Cites] J Gastroenterol Hepatol. 2003 Dec;18(12):1412-6 [14675271.001]
  • [Cites] Dis Colon Rectum. 1989 Jan;32(1):1-8 [2910654.001]
  • [Cites] World J Gastroenterol. 2012 Nov 28;18(44):6475-80; discussion p. 6479 [23197894.001]
  • [Cites] Lancet. 2004 Jan 10;363(9403):157-63 [14726171.001]
  • [Cites] Cad Saude Publica. 2010 Jul;26(7):1391-402 [20694365.001]
  • [Cites] Rev Esc Enferm USP. 2015 Jun;49(3):443-52 [26107705.001]
  • [Cites] Korean J Intern Med. 2003 Sep;18(3):181-6 [14619388.001]
  • [Cites] PLoS One. 2013;8(3):e58379 [23516468.001]
  • [Cites] Gastroenterology. 2013 Jan;144(1):218-38 [23261065.001]
  • [Cites] J Neurogastroenterol Motil. 2013 Apr;19(2):149-60 [23667746.001]
  • [Cites] Dis Colon Rectum. 1991 Feb;34(2):111-4 [1993406.001]
  • [Cites] Gastroenterology. 2006 Apr;130(5):1480-91 [16678561.001]
  • [Cites] Aliment Pharmacol Ther. 2011 Jan;33(2):251-60 [21091523.001]
  • [Cites] Aliment Pharmacol Ther. 2010 May;31(9):938-49 [20180788.001]
  • [Cites] Dig Dis Sci. 1989 Aug;34(8):1153-62 [2787735.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Mar 15;19(6):704-6 [15023175.001]
  • [Cites] Am J Gastroenterol. 1999 May;94(5):1283-91 [10235208.001]
  • [Cites] Scand J Gastroenterol. 1997 Sep;32(9):920-4 [9299672.001]
  • (PMID = 27997551.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] United States
  •  go-up   go-down


74. Wang JY, Zhai J: [Systematic evaluation of the influence of endometrial stimulation on pregnancy outcome in the patients with artificial insemination]. Zhonghua Yi Xue Za Zhi; 2016 Dec 06;96(45):3680-3685

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • <b>Objective:</b> The association between endometrial stimulation and the intrauterine insemination outcome remains to be a controversial issue, for there being all kinds of conflicting data in the existing literatures.
  • Compared with the control group, the clinical pregnancy rate of experiment group was higher (<i>RR</i>=0.88, 95% <i>CI:</i> 0.82-0.95, <i>P</i>=0.001), while the differences between their abortion rate (<i>RR</i>=0.72, 95% <i>CI:</i> 0.37-1.4, <i>P</i>=0.33) and multiple pregnancies rate (<i>RR</i>=0.78, 95% <i>CI:</i> 0.3-2.01, <i>P</i>=0.60) were insignificant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27978907.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] Journal Article; English Abstract
  • [Publication-country] China
  •  go-up   go-down


75. Burnes D, Henderson CR, Sheppard C, Zhao R, Pillemer K, Lachs MS: Prevalence of Financial Fraud and Scams Among Older Adults in the United States: A Systematic Review and Meta-Analysis. Am J Public Health; 2017 Aug;107(8):1295

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The financial exploitation of older adults was recently recognized by the Centers for Disease Control and Prevention as a serious public health problem.
  • Overall pooled elder financial fraud-scam prevalence (up to 5-year period) across studies was 5.6% (95% confidence interval [CI] = 4.0%, 7.8%), with a 1-year period prevalence of 5.4% (95% CI = 3.2%, 7.6%).
  • Studies using a series of questions describing specific fraud-scam events to measure victimization found a significantly higher prevalence (7.1%; 95% CI = 4.8%, 9.4%) than studies using a single, general-question self-report assessment approach (3.6%; 95% CI = 1.8%, 5.4%).
  • AUTHOR'S CONCLUSIONS: Elder financial fraud and scams is a common problem, affecting approximately 1 of every 18 cognitively intact, community-dwelling older adults each year; it requires further attention from researchers, clinicians, and policymakers.
  • Without effective primary prevention strategies, the absolute scope of this problem will escalate with the growing population of older adults.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28700284.001).
  • [ISSN] 1541-0048
  • [Journal-full-title] American journal of public health
  • [ISO-abbreviation] Am J Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Waldo SW, O'Donnell CI, Prouse A, Plomondon ME, Rao SV, Maddox TM, Ho PM, Armstrong EJ: Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program. Catheter Cardiovasc Interv; 2017 Jun 28;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKROUND: In-stent restenosis (ISR) remains a common clinical problem associated with significant morbidity.
  • Among a propensity-matched cohort of 6,231, the rates of TVR (subdistribution HR: 0.623, 95% CI: 0.511-0.760) and mortality (HR: 0.730, 95% CI: 0.641-0.830) were significantly lower among patients treated with a DES compared with other treatments.
  • After adjustment for known risk factors, treatment with DES continued to be associated with a reduction in mortality rate (Adjusted HR: 0.802, 95% CI: 0.704-0.913).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Wiley Periodicals, Inc.
  • (PMID = 28657149.001).
  • [ISSN] 1522-726X
  • [Journal-full-title] Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • [ISO-abbreviation] Catheter Cardiovasc Interv
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; drug-eluting stents / in-stent restenosis / percutaneous coronary intervention
  •  go-up   go-down


77. Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S: Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG; 2017 May 24;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inositol was associated with significantly improved ovulation rate (RR 2.3; 95% CI 1.1-4.7; I<sup>2</sup> = 75%) and increased frequency of menstrual cycles (RR 6.8; 95% CI 2.8-16.6; I<sup>2</sup> = 0%) compared with placebo.
  • One study reported on clinical pregnancy rate with inositol compared with placebo (RR 3.3; 95% CI 0.4-27.1), and one study compared with metformin (RR 1.5; 95% CI 0.7-3.1).
  • A further, well-designed multicentre trial to address this issue to provide robust evidence of benefit is warranted.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Royal College of Obstetricians and Gynaecologists.
  • (PMID = 28544572.001).
  • [ISSN] 1471-0528
  • [Journal-full-title] BJOG : an international journal of obstetrics and gynaecology
  • [ISO-abbreviation] BJOG
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Inositol / meta analysis / ovulation induction / polycystic ovary syndrome
  •  go-up   go-down


78. Johansson L, Hailer NP, Rahme H: High incidence of periprosthetic joint infection with propionibacterium acnes after the use of a stemless shoulder prosthesis with metaphyseal screw fixation - a retrospective cohort study of 241 patients propionibacter infections after eclipse TSA. BMC Musculoskelet Disord; 2017 May 19;18(1):203
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Unadjusted infection-free survival after 4 years was 88.8% (CI 82.5-95.7) for Eclipse® patients and 95.7% (CI 87.7-100.0) for controls (p = 0.002).
  • After adjustment for age, gender, diagnosis, and type of shoulder prosthesis (total or hemi), the risk ratio for revision due to infection was 4.3 (CI 0.5-39.1) for patients with the Eclipse® prosthesis.
  • The local ethics board (Regionala Etikprövningsnämnden Stockholm) approved the study (Approval number 2015/1590-31, date of issue 2015-10-14).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2017 Mar;475(3):722-732 [26847453.001]
  • [Cites] J Clin Microbiol. 2011 Jul;49(7):2490-5 [21543562.001]
  • [Cites] Biomaterials. 2003 Aug;24(19):3221-7 [12763449.001]
  • [Cites] Plast Reconstr Surg. 2014 Apr;133(4):471e-80e [24675200.001]
  • [Cites] J Biomed Mater Res A. 2007 Jun 1;81(3):705-9 [17187384.001]
  • [Cites] J Shoulder Elbow Surg. 2009 Nov-Dec;18(6):897-902 [19362854.001]
  • [Cites] J Shoulder Elbow Surg. 2013 Apr;22(4):505-11 [22981447.001]
  • [Cites] J Shoulder Elbow Surg. 2015 Jun;24(6):844-7 [25547858.001]
  • [Cites] J Shoulder Elbow Surg. 2015 Aug;24(8):1206-11 [25700640.001]
  • [Cites] Lancet. 1987 Apr 11;1(8537):860 [2882258.001]
  • [Cites] J Bone Joint Surg Am. 2014 Sep 3;96(17):1447-50 [25187583.001]
  • [Cites] Acta Orthop. 2014 Apr;85(2):159-64 [24650025.001]
  • [Cites] Antimicrob Agents Chemother. 2013 Jul;57(7):3424-6 [23629711.001]
  • [Cites] Diagn Microbiol Infect Dis. 2013 Feb;75(2):195-9 [23246074.001]
  • [Cites] J Arthroplasty. 2008 Oct;23(7):984-91 [18534466.001]
  • [Cites] Antimicrob Agents Chemother. 1977 Jan;11(1):171-3 [836012.001]
  • [Cites] Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Sep-Oct;6(5):475-95 [24867883.001]
  • [Cites] J Shoulder Elbow Surg. 2016 May;25(5):846-52 [26704361.001]
  • [Cites] Int Orthop. 2007 Feb;31(1):27-31 [16586132.001]
  • [Cites] J Shoulder Elbow Surg. 2015 Jun;24(6):838-43 [25979553.001]
  • [Cites] J Shoulder Elbow Surg. 2012 Nov;21(11):1534-41 [22516570.001]
  • [Cites] Interdiscip Perspect Infect Dis. 2013;2013:542796 [24023542.001]
  • [Cites] J Bone Joint Surg Br. 1997 Jul;79(4):590-5 [9250744.001]
  • [Cites] J Biomed Mater Res B Appl Biomater. 2009 Oct;91(1):470-80 [19637369.001]
  • [Cites] J Bone Joint Surg Am. 2015 Jun 17;97(12):957-63 [26085528.001]
  • [Cites] N Engl J Med. 2009 Aug 20;361(8):787-94 [19692690.001]
  • [ErratumIn] BMC Musculoskelet Disord. 2017 Jun 8;18(1):249 [28595609.001]
  • (PMID = 28526023.001).
  • [ISSN] 1471-2474
  • [Journal-full-title] BMC musculoskeletal disorders
  • [ISO-abbreviation] BMC Musculoskelet Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Biofilm formation / Orthopedic implant / Periprosthetic infection / Propionibacterium acnes / Shoulder arthroplasty / TSA / TSR
  •  go-up   go-down


79. Kushner T, Lam R, Gray DL, Kaplan DE, Serper M: Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B. J Clin Gastroenterol; 2017 May 10;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • GOALS: To examine patient, provider, and health system barriers to clinical follow-up among US veterans with chronic hepatitis B virus (HBV).
  • Patients had an average of 4.4 primary care visits within 2 years of the index hepatitis B surface antigen positive result, 38% had psychiatry visits, 21% had a psychiatric hospitalization; 26% saw gastroenterology/hepatology specialists.
  • Within 1 year of the index hepatitis B surface antigen positive result, 75% had alanine aminotransferase testing, 14% had HBV entered into the problem list, and 8% had serologic confirmation.
  • In multivariable analyses, cirrhosis [odds ratio (OR)=3.42; 95% confidence interval (CI), 1.84-6.36] was associated with higher odds of appropriate laboratory testing, alcohol misuse (OR=0.45; 95% CI, 0.29-0.80) was associated lower odds.
  • Cirrhosis (OR=2.03; 95% CI, 1.11-3.72) and ≥2 primary care visits per year (OR=1.06; 95% CI, 1.01-1.11) were associated with higher odds of completing gastroenterology/hepatology consultation, whereas ≥1 psychiatric hospitalization in 2 years was associated with lower odds (OR=0.53; 95% CI, 0.34-0.82).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28492425.001).
  • [ISSN] 1539-2031
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Belete T, Medfu G, Yemiyamrew E: Prevalence of HIV Associated Neurocognitive Deficit among HIV Positive People in Ethiopia: A Cross Sectional Study at Ayder Referral Hospital. Ethiop J Health Sci; 2017 Jan;27(1):67-76

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: HIV associated neurocognitive deficit impairs motor activity, neuropsychiatric functioning, daily activity and work activity usually due to the immune suppression effect of the virus.
  • The magnitude of Neuro cognitive deficit was 33.3% (95% CI; 27.7% - 40.6%).
  • Late clinical stage of the illness (AOR= 4.2 (95% CI; 1.19, 14.44)) and impairment in the activity of daily living were significantly associated with neurocognitive deficit (AOR= 7.19 (95% CI; 1.73, 21.83).
  • Hence, this should be a strong alarm for early detection of the problem and consistent review of the treatment regimen.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Behav Med. 2009 Oct;32(5):389-405 [19291386.001]
  • [Cites] Neuropsychol Rev. 2009 Jun;19(2):152-68 [19462243.001]
  • [Cites] AIDS. 2003 Jul 4;17(10):1539-45 [12824792.001]
  • [Cites] AIDS Care. 2016;28 Suppl 1:56-9 [26888472.001]
  • [Cites] AIDS. 2005 Sep 2;19(13):1367-74 [16103767.001]
  • [Cites] J Neurol Sci. 2009 Oct 15;285(1-2):149-53 [19631349.001]
  • [Cites] Curr Infect Dis Rep. 2015 Jun;17(6):485 [25916996.001]
  • [Cites] AIDS Res Treat. 2012;2012:581531 [23050130.001]
  • [Cites] Psychosom Med. 1994 Jan-Feb;56(1):8-17 [8197319.001]
  • [Cites] PLoS One. 2011 Jan 25;6(1):e16049 [21283565.001]
  • [Cites] Neuropsychol Rev. 2009 Jun;19(2):232-49 [19455425.001]
  • [Cites] Int J Infect Dis. 2013 Oct;17(10):e820-31 [23953699.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(5):2731-7 [23803023.001]
  • [Cites] J Neurovirol. 2002 Dec;8 Suppl 2:115-21 [12491162.001]
  • [Cites] BMC Neurol. 2013 Jul 15;13:86 [23855622.001]
  • [Cites] J Neurovirol. 2002 Apr;8(2):136-42 [11935465.001]
  • [Cites] Nat Rev Neurol. 2016 Apr;12(4):234-48 [26965674.001]
  • [Cites] AIDS Behav. 2010 Dec;14(6):1213-26 [20232242.001]
  • [Cites] Neurology. 2010 Dec 7;75(23):2087-96 [21135382.001]
  • [Cites] Int J Mol Sci. 2016 Mar 24;17 (4):434 [27023519.001]
  • [Cites] Biomed Res Int. 2015;2015:641913 [25815329.001]
  • [Cites] PLoS One. 2014 Jun 10;9(6):e98962 [24915530.001]
  • [Cites] PLoS One. 2013 Apr 16;8(4):e61826 [23613945.001]
  • [Cites] J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):48-55 [25331222.001]
  • [Cites] J Int AIDS Soc. 2010 Apr 20;13:15 [20406460.001]
  • [Cites] Top Antivir Med. 2014 May;22(2):594-601 [24901885.001]
  • [Cites] J Neurovirol. 2013 Dec;19(6):550-6 [24277437.001]
  • (PMID = 28458492.001).
  • [ISSN] 2413-7170
  • [Journal-full-title] Ethiopian journal of health sciences
  • [ISO-abbreviation] Ethiop J Health Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ethiopia
  • [Keywords] NOTNLM ; Cognitive Impairment / Ethiopia / HIV Associated Dementia / HIV associated Neurocognitive Deficit / International HIV Dementia Scale / Neuro cognitive deficit
  •  go-up   go-down


81. Asrie F: Prevalence of anemia and its associated factors among pregnant women receiving antenatal care at Aymiba Health Center, northwest Ethiopia. J Blood Med; 2017;8:35-40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Anemia is a global public health problem in both developing and developed countries; ~1.62 billion people suffer from anemia, and pregnant women are the most susceptible to it.
  • RESULTS: The mean with ±2 standard deviation of hemoglobin value was 12±1.3 (95% confidence interval [CI] =11.9-12.5), and the prevalence of anemia from a total of 206 study subjects was 52 (25.2%).
  • Anemia was significantly associated with rural residence and intestinal parasitic infections (adjusted odds ratio [AOR] =9.17, 95% CI =2.15-40, <i>p</i><0.001) and (AOR =55.091, 95% CI =6.88-441.19, <i>p</i><0.001), respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):182-6 [16219519.001]
  • [Cites] Lancet. 2011 Dec 17;378(9809):2123-35 [21813172.001]
  • [Cites] Am J Clin Nutr. 1979 Feb;32(2):368-417 [369352.001]
  • [Cites] BMC Blood Disord. 2009 Sep 07;9:7 [19735547.001]
  • [Cites] Ethiop Med J. 1993 Oct;31(4):251-8 [8287859.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2005 Oct;99(10):739-43 [16024057.001]
  • [Cites] Food Nutr Bull. 2006 Dec;27(4):311-5 [17209473.001]
  • [Cites] Acta Obstet Gynecol Scand. 2001 Jan;80(1):18-26 [11167183.001]
  • [Cites] MedGenMed. 2007 Jul 11;9(3):11 [18092018.001]
  • [Cites] Rev Panam Salud Publica. 1998 May;3(5):285-92 [9643071.001]
  • [Cites] Food Nutr Bull. 2008 Jun;29(2):132-9 [18693477.001]
  • [Cites] Public Health Nutr. 2010 Oct;13(10):1511-8 [20576191.001]
  • [Cites] Trans R Soc Trop Med Hyg. 1991 Nov-Dec;85(6):829-32 [1801367.001]
  • [Cites] Ethiop J Health Sci. 2013 Jul;23 (2):165-73 [23950633.001]
  • [Cites] Arch Latinoam Nutr. 2002 Mar;52(1):5-11 [12214547.001]
  • [Cites] Med Princ Pract. 2009;18(5):368-72 [19648759.001]
  • [Cites] J Obstet Gynaecol. 2006 Oct;26(7):617-9 [17071424.001]
  • [Cites] Anemia. 2012;2012:608658 [22693662.001]
  • (PMID = 28442940.001).
  • [Journal-full-title] Journal of blood medicine
  • [ISO-abbreviation] J Blood Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] New Zealand
  • [Keywords] NOTNLM ; Aymiba / Ethiopia / antenatal care / hemoglobin / pregnancy
  •  go-up   go-down


82. Huang CC, Ho CH, Chen YC, Lin HJ, Hsu CC, Wang JJ, Su SB, Guo HR: Hyperbaric oxygen therapy is associated with lower short- and long-term mortality in patients with carbon monoxide poisoning. Chest; 2017 Apr 17;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This retrospective nationwide population-based cohort study from Taiwan was conducted to clarify this issue.
  • RESULTS: Patients who received HBOT had a lower mortality rate compared to patients who did not (adjusted hazard ratio [AHR]: 0.74; 95% confidence interval [CI]: 0.67-0.81) after adjusting for age, sex, underlying comorbidities, monthly income, and concomitant conditions, especially in patients younger than 20 years (AHR: 0.45; 95% CI: 0.26-0.80) and those with acute respiratory failure (AHR: 0.43; 95% CI: 0.35-0.53).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier Inc.
  • (PMID = 28427969.001).
  • [ISSN] 1931-3543
  • [Journal-full-title] Chest
  • [ISO-abbreviation] Chest
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; carbon monoxide poisoning / hyperbaric oxygen therapy / mortality
  •  go-up   go-down


83. Ibrahim NK, Al-Bloushy RI, Sait SH, Al-Azhary HW, Bar NH, Mirdad GA: Irritable bowel syndrome among nurses working in King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Libyan J Med; 2016 Jan;11(1):30866

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nurses are a vital part of the medical team and their well-being is an important issue.
  • Rome III Criteria, IBS Severity Scoring System (IBS-SSS), Hospital Anxiety and Depression Scale (HADS), and Pittsburgh Sleep Quality Index (PSQI) were included.
  • After controlling for confounding factors in regression analysis, the predictors of IBS were food hypersensitivity (aOR=4.52; 95% CI: 1.80-11.33), morbid anxiety (aOR=4.34; 95% CI: 1.49-12.67), and positive family history of IBS (aOR=3.38; 95% CI: 1.12-13.23).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28349846.001).
  • [ISSN] 1819-6357
  • [Journal-full-title] The Libyan journal of medicine
  • [ISO-abbreviation] Libyan J Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; anxiety / depression / irritable bowel syndrome / nurses / predictors / prevalence / severity / sleep quality
  •  go-up   go-down


84. Malińska M: [Effectiveness of physical activity intervention at workplace]. Med Pr; 2017 Mar 24;68(2):277-301

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although this issue is by no means limited to the workplace, it is precisely the work environment that can provide the basis for keeping and reinforcing more health-conscious attitudes and lifestyles, including programs promoting a physical activity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.
  • (PMID = 28345686.001).
  • [ISSN] 0465-5893
  • [Journal-full-title] Medycyna pracy
  • [ISO-abbreviation] Med Pr
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Keywords] NOTNLM ; ability to work / corporate wellness programs / intervention / musculoskeletal disorders / physical activity / worksite activity programs
  •  go-up   go-down


85. Leader A, Zelikson-Saporta R, Pereg D, Spectre G, Rozovski U, Raanani P, Hermoni D, Lishner M: The Effect of Combined Aspirin and Clopidogrel Treatment on Cancer Incidence. Am J Med; 2017 Jul;130(7):826-832

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • No large-scale cohort study has been performed to address this issue in a heterogeneous real-world scenario.
  • Compared with nonusers, there was a lower risk of cancer in subjects exposed to aspirin with (hazard ratio [HR] 0.46; 95% confidence interval [CI], 0.44-0.49) or without clopidogrel (HR 0.54; 95% CI, 0.52-0.56), on long-term follow-up.
  • Combined treatment was associated with a lower cancer risk than the aspirin-only group (HR 0.92; 95% CI, 0.86-0.97).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28213047.001).
  • [ISSN] 1555-7162
  • [Journal-full-title] The American journal of medicine
  • [ISO-abbreviation] Am. J. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Antiplatelet / Aspirin / Cancer / Clopidogrel
  •  go-up   go-down


86. Mitani Y, Oki Y, Fujimoto Y, Yamaguchi T, Iwata K, Watanabe Y, Takahashi K, Yamada K, Ishikawa A: Relationship between functional independence measure and geriatric nutritional risk index in pneumonia patients in long-term nursing care facilities. Geriatr Gerontol Int; 2017 Feb 11;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relationship between functional independence measure and geriatric nutritional risk index in pneumonia patients in long-term nursing care facilities.
  • AIM: The prevention of pneumonia is an urgent issue among Japanese older adults.
  • However, little has been reported on the relationship between a Functional Independence Measure (FIM) and the Geriatric Nutrition Risk Index (GNRI) for the prevention of pneumonia in patients in long-term care facilities in Japan.
  • (iii) no pneumonia/high GNRI; and (iv) no pneumonia/low GNRI.
  • Receiver operating characteristic analysis showed cut-off values and the area under the curve.
  • Logistic regression showed that FIM (P < 0.001; OR -1.035, 95% CI -1.019-1.051) and GNRI (P = 0.017; OR -1.038, 95% CI -1.007-1.070) were predictors of pneumonia.
  • The cut-off values for FIM and GNRI were 26.6 (P < 0.001, the area under the curve 0.70) and 80.5 (P < 0.001, the area under the curve 0.65), respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 Japan Geriatrics Society.
  • (PMID = 28188968.001).
  • [ISSN] 1447-0594
  • [Journal-full-title] Geriatrics & gerontology international
  • [ISO-abbreviation] Geriatr Gerontol Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Functional Independence Measure / Geriatric Nutritional Risk Index / long-term nursing hospital / pneumonia / predictor tool
  •  go-up   go-down


87. Naotunna NP, Dayarathna M, Maheshi H, Amarasinghe GS, Kithmini VS, Rathnayaka M, Premachandra L, Premarathna N, Rajasinghe PC, Wijewardana G, Agampodi TC, Agampodi SB: Nutritional status among primary school children in rural Sri Lanka; a public health challenge for a country with high child health standards. BMC Public Health; 2017 Jan 10;17(1):57

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Similarly, survey design adjusted prevalence of underweight and stunting were, 25.93% (95% CI 24.07-27.89%) and 43.92%(95% CI 40.55-47.56%).
  • Adjusted mean estimates for hemoglobin was 12.20 (95% CI 12.16-12.24) g/dL.
  • CONCLUSION: This study confirms that malnutrition is still a major problem in North Central Province, Sri Lanka.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28068960.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; BMI / Height for age / Nutritional Status / Obesity / Primary school children / Sri Lanka / Thinness / Weight for age
  •  go-up   go-down


88. Nagai Y, Sunami E, Yamamoto Y, Hata K, Okada S, Murono K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Hoon DS, Watanabe T: LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer. Oncotarget; 2017 Feb 14;8(7):11906-11916

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Colorectal cancer (CRC) is a serious public health problem and non-invasive biomarkers improving diagnosis or therapy are strongly required.
  • LINE-1 hypomethylation level in plasma cfDNA in 114 CRC patients was retrospectively examined by absolute quantitative analysis of methylated alleles real-time PCR, and was expressed using LINE-1 hypomethylation index (LHI) [unmethylated copy number/ (methylated copy number + unmethylated copy number)].
  • Greater LHI values indicated enhanced hypomethylation.
  • Furthermore, early stage I/II (n = 57) as well as advanced stage III/IV (n =57) CRC patients had significantly higher cfDNA LHI than healthy donors (n=53) [stage I/II: median 0.369 (95% confidence interval, 0.360-0.380) vs. 0.332 (0.325-0.339), P < 0.0001; stage III/IV: 0.372 (0.365-0.388) vs. 0.332 (0.325-0.339), P < 0.0001].
  • The receiver operating characteristic analysis showed that cfDNA LHI had the detection capacity of CRC with area under the curve(AUC) of 0.79 and 0.83 in stage I/II and stage III/IV CRC patients, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2014 Apr 3;370(14 ):1287-97 [24645800.001]
  • [Cites] Nat Rev Genet. 2012 Oct;13(10):679-92 [22945394.001]
  • [Cites] Science. 2016 Feb 12;351(6274):aac7247 [26912865.001]
  • [Cites] Surg Today. 2014 Oct;44(10):1807-16 [24150097.001]
  • [Cites] Int J Cancer. 2008 Jun 15;122(12):2767-73 [18366060.001]
  • [Cites] Nat Rev Cancer. 2011 Jun;11(6):426-37 [21562580.001]
  • [Cites] Oncogene. 2004 May 13;23(22):4014-22 [15064737.001]
  • [Cites] J Invest Dermatol. 2012 Jun;132(6):1689-97 [22402438.001]
  • [Cites] Int J Epidemiol. 2011 Jun;40(3):712-8 [21330344.001]
  • [Cites] Clin Chem. 2015 Jan;61(1):112-23 [25388429.001]
  • [Cites] PLoS One. 2012;7(9):e45357 [23049789.001]
  • [Cites] Bioorg Med Chem Lett. 2007 Apr 1;17(7):1912-5 [17276678.001]
  • [Cites] Mol Cancer Res. 2007 May;5(5):461-71 [17510312.001]
  • [Cites] Nat Rev Clin Oncol. 2013 Mar;10(3):130-42 [23381005.001]
  • [Cites] Am J Health Behav. 2014 May;38(3):351-61 [24636031.001]
  • [Cites] Aliment Pharmacol Ther. 2016 Apr;43(7):755-64 [26858128.001]
  • [Cites] Epigenetics. 2011 Jul;6(7):828-37 [21636973.001]
  • [Cites] Gastric Cancer. 2013 Oct;16(4):480-7 [23179365.001]
  • [Cites] Breast Cancer Res Treat. 2012 Aug;134(3):1103-14 [22476853.001]
  • [Cites] J Natl Cancer Inst. 2008 Dec 3;100(23):1734-8 [19033568.001]
  • [Cites] Lancet. 2014 Apr 26;383(9927):1490-502 [24225001.001]
  • [Cites] Ann Surg Oncol. 2012 Oct;19(11):3441-8 [22618722.001]
  • [Cites] Mol Cancer. 2010 May 27;9:125 [20507599.001]
  • [Cites] Nat Rev Clin Oncol. 2013 Aug;10(8):472-84 [23836314.001]
  • [Cites] Oncotarget. 2016 Aug 23;7(34):55098-55109 [27391152.001]
  • [Cites] Nat Rev Genet. 2009 Oct;10(10):691-703 [19763152.001]
  • [Cites] Ann N Y Acad Sci. 2008 Aug;1137:190-6 [18837946.001]
  • [Cites] Cancer Lett. 2008 May 18;263(2):170-81 [18395974.001]
  • [Cites] Clin Cancer Res. 2006 Dec 1;12(23):6985-8 [17145818.001]
  • [Cites] Cancer Res. 2008 Apr 1;68(7):2112-21 [18381416.001]
  • [Cites] Clin Gastroenterol Hepatol. 2013 Jul;11(7):832-8.e1-2 [23376002.001]
  • [Cites] Epidemiology. 2005 Jan;16(1):73-81 [15613948.001]
  • [Cites] Gut. 2014 Feb;63(2):317-25 [23408352.001]
  • [Cites] Br J Cancer. 2013 Dec 10;109(12):3073-83 [24220694.001]
  • [Cites] Ann Surg Oncol. 2015 Apr;22(4):1280-7 [25319577.001]
  • [Cites] Int J Cancer. 2012 Sep 15;131(6):1323-31 [22120154.001]
  • [Cites] PLoS One. 2011 Apr 14;6(4):e18884 [21533144.001]
  • [Cites] BMC Cancer. 2012 Dec 05;12:574 [23216958.001]
  • [Cites] Cochrane Database Syst Rev. 2015 Dec 10;(12):CD011134 [26661580.001]
  • [Cites] Gastroenterology. 2012 Jun;142(7):1460-7.e2 [22446606.001]
  • [Cites] Clin Chem Lab Med. 2010 Nov;48(11):1665-8 [20704532.001]
  • [Cites] CA Cancer J Clin. 2016 Mar-Apr;66(2):96-114 [26797525.001]
  • (PMID = 28060757.001).
  • [ISSN] 1949-2553
  • [Journal-full-title] Oncotarget
  • [ISO-abbreviation] Oncotarget
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA171767
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; LINE-1 / cell-free DNA / colorectal cancer / hypomethylation / plasma
  •  go-up   go-down


89. Rodriguez-Cid J, Motola-Kuba D, Alvarado-Luna G, Sanchez-Lara K, Green D: Association of metabolic syndrome with high mortality in patients with cancer. J Clin Oncol; 2011 May 20;29(15_suppl):e21068

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : e21068 Background: Metabolic syndrome is a worldwide public health problem.
  • A review of files was made to determine clinicopathologic variables at diagnosis that included: height, weight, body mass index, blood pressure, waist circumference and laboratory values (triglyceride, and fasting glucose).
  • Multivariate analysis showed significant higher risk of death in patients with: Metabolic syndrome (HR 1.7; 95% CI 0.49-0.93, p=0.03); BMI >25 (HR 3.7; 95% CI 0.58- 0.89, p=0.026); and Low HDL levels (HR 2.5; 95% CI 0.78-0.98, p=0.01).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28022205.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Brazeau AS, Nakhla M, Wright M, Panagiotopoulos C, Pacaud D, Henderson M, Rahme E, Da Costa D, Dasgupta K: Stigma and Its Impact on Glucose Control Among Youth With Diabetes: Protocol for a Canada-Wide Study. JMIR Res Protoc; 2016 Dec 15;5(4):e242
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The survey includes the Barriers to Diabetes Adherence in adolescent scale (intraclass correlation [ICC]=0.967, 95% CI 0.931-0.984), the Self-Efficacy for Diabetes Self-Management measure (ICC=0.952, 95% CI 0.899-0.977), the World Health Organization-5 Well-Being Index (ICC=0.860, 95% CI 0.705-0.933), 12 closed-ended questions, and an additional 5 open-ended questions to explore challenges and solutions developed by the team of experts, including a patient representative.
  • The results of this study will allow for an appreciation of the magnitude of the problem and the need for developing and implementing solutions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Psychol. 2000 May;55(5):469-80 [10842426.001]
  • [Cites] J Public Health (Oxf). 2005 Sep;27(3):281-91 [15870099.001]
  • [Cites] J Clin Pharm Ther. 2008 Oct;33(5):537-44 [18834369.001]
  • [Cites] Diabetes Care. 2013 Oct;36(10):3002-8 [23656982.001]
  • [Cites] Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3 [24070926.001]
  • [Cites] Diabetes Care. 2003 Apr;26(4):1052-7 [12663572.001]
  • [Cites] Diabetes Res Clin Pract. 2011 Oct;94(1):77-83 [21737172.001]
  • [Cites] Diabetes Care. 1997 May;20(5):760-6 [9135939.001]
  • [Cites] Am J Mens Health. 2015 Sep 18;:null [26385988.001]
  • [Cites] Psychother Psychosom. 2015;84(3):167-76 [25831962.001]
  • [Cites] Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S64-9 [12324988.001]
  • [Cites] J Clin Endocrinol Metab. 2013 May;98(5):1845-59 [23589524.001]
  • [Cites] PLoS One. 2014 Dec 23;9(12):e114620 [25536068.001]
  • [Cites] Clin Chim Acta. 2009 Aug;406(1-2):124-8 [19540216.001]
  • [Cites] Diabet Med. 2015 Oct;32(10):1304-10 [25865313.001]
  • [Cites] J Adv Nurs. 2010 Jan;66(1):128-38 [20423440.001]
  • [Cites] BMC Health Serv Res. 2014 Feb 26;14:89 [24568690.001]
  • [Cites] Diabet Med. 2010 Jan;27(1):79-84 [20121893.001]
  • [Cites] Diabetes Care. 2016 Dec;39(12 ):2141-2148 [27515964.001]
  • [Cites] J Dev Behav Pediatr. 2006 Apr;27(2):98-105 [16682872.001]
  • [Cites] BMJ Open. 2014 Jul 23;4(7):e005625 [25056982.001]
  • [Cites] Acta Paediatr. 2014 Feb;103(2):194-200 [24117768.001]
  • [Cites] Iran J Nurs Midwifery Res. 2013 Jan;18(1):65-70 [23983731.001]
  • [Cites] J Health Psychol. 2015 Sep;20(9):1196-206 [24271691.001]
  • [Cites] Scand J Caring Sci. 2007 Dec;21(4):419-25 [18036004.001]
  • [Cites] Patient. 2013;6(1):1-10 [23322536.001]
  • [Cites] Diabetes Care. 2003 Mar;26(3):631-7 [12610013.001]
  • [Cites] J Pediatr Psychol. 1997 Aug;22(4):541-61 [9302851.001]
  • (PMID = 27979791.001).
  • [Journal-full-title] JMIR research protocols
  • [ISO-abbreviation] JMIR Res Protoc
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT02796248
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Keywords] NOTNLM ; perception / stigma / type 1 diabetes / well-being / youth
  •  go-up   go-down


91. Smits FT, Brouwer HJ, Schene AH, van Weert HC, Ter Riet G: Is frequent attendance of longer duration related to less transient episodes of care? A retrospective analysis of transient and chronic episodes of care. BMJ Open; 2016 Dec 13;6(12):e012563
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reasons for encounter (RFEs) linked to patients' problem lists were defined as chronic ECs (CECs), other episodes as TECs.
  • Compared with non-FAs, the adjusted additional number of TECs was 3.4 (95% CI 3.2 to 3.7, 1yFAs), 6.6 (95% CI 6.1 to 7.0, 2yFAs) and 9.4 (95% CI 8.8 to 10.1, 3yFAs).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
  • [Cites] Fam Pract. 2015 Dec;32(6):624-30 [26450918.001]
  • [Cites] J Psychosom Res. 2014 Dec;77(6):492-503 [25217448.001]
  • [Cites] Fam Pract. 2012 Jun;29(3):283-98 [22308182.001]
  • [Cites] BMC Fam Pract. 2008 Apr 15;9:21 [18412954.001]
  • [Cites] Fam Pract. 2006 Oct;23(5):529-36 [16868006.001]
  • [Cites] BMC Public Health. 2009 Jan 24;9:36 [19166622.001]
  • [Cites] Br J Gen Pract. 2009 Feb;59(559):e44-50 [19192367.001]
  • [Cites] J Psychosom Res. 1999 Aug;47(2):115-30 [10579496.001]
  • [Cites] BMJ Open. 2015 Oct 06;5(10):e008975 [26443661.001]
  • [Cites] Fam Pract. 2007 Dec;24(6):562-9 [17906310.001]
  • [Cites] J Fam Pract. 1996 Feb;42(2):161-7 [8606306.001]
  • [Cites] BMC Fam Pract. 2013 Sep 17;14:138 [24044374.001]
  • [Cites] Public Health. 2005 Feb;119(2):118-37 [15694959.001]
  • [Cites] BMC Fam Pract. 2016 Mar 10;17 :29 [26965443.001]
  • (PMID = 27965250.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; PRIMARY CARE
  •  go-up   go-down


92. Terkawi AS, Abolkhair A, Didier B, Alzhahrani T, Alsohaibani M, Terkawi YS, Almoqbali Y, Tolba YY, Pangililan E, Foula F, Tsang S: Development and validation of Arabic version of the douleur neuropathique 4 questionnaire. Saudi J Anaesth; 2017 May;11(Suppl 1):S31-S39
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cronbach's α was 0.67 (95% confidence interval [CI]: 0.59-0.75), and interclass correlation coefficients was 0.81 (95% CI: 0.76-0.87).
  • Results showed our Arabic DN4 to have good diagnostic accuracy, with area under the curve of 0.88 (95% CI: 0.82-0.94).
  • As with the original version, a score of ≥4 was found to be the best cut-off for the diagnosis of NP, with a sensitivity of 88.31%, specificity of 74.47%, a positive predictive value of 85%, and a negative predictive value of 80%.
  • Most patients found the DN4 questionnaire to be clear and easy to understand, and thought the questionnaire items covered all their problem areas regarding their pain.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pain. 2005 Mar;114(1-2):29-36 [15733628.001]
  • [Cites] Stat Med. 1986 Nov-Dec;5(6):585-91 [3823667.001]
  • [Cites] Pain Pract. 2015 Sep;15(7):627-32 [24796220.001]
  • [Cites] Health Qual Life Outcomes. 2007 Dec 04;5:66 [18053212.001]
  • [Cites] Eur J Pain. 2010 Jan;14(1):58-63 [19282208.001]
  • [Cites] Clin J Pain. 2003 Sep-Oct;19(5):306-14 [12966256.001]
  • [Cites] Ann Acad Med Singapore. 1994 Mar;23(2):129-38 [8080219.001]
  • [Cites] Pain. 2001 May;92(1-2):147-57 [11323136.001]
  • [Cites] Pain Pract. 2013 Mar;13(3):198-205 [22726274.001]
  • [Cites] Eur J Neurol. 2010 Aug;17(8):1010-8 [20298428.001]
  • [Cites] J Pain. 2010 May;11(5):484-90 [20015708.001]
  • [Cites] Pain Pract. 2011 Mar-Apr;11(2):139-47 [20602717.001]
  • [Cites] Biometrics. 1977 Mar;33(1):159-74 [843571.001]
  • [Cites] Lancet. 2016 Oct 8;388(10053):1603-1658 [27733283.001]
  • [Cites] Pain. 2007 Feb;127(3):199-203 [17182186.001]
  • [Cites] Neurology. 2008 Apr 29;70(18):1630-5 [18003941.001]
  • [Cites] Ann Rheum Dis. 2017 Feb 16;:null [28209629.001]
  • (PMID = 28616002.001).
  • [ISSN] 1658-354X
  • [Journal-full-title] Saudi journal of anaesthesia
  • [ISO-abbreviation] Saudi J Anaesth
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Keywords] NOTNLM ; Anesthesia / Arabic / douleur neuropathique 4 / neuropathic pain / reliability / validity
  •  go-up   go-down


93. Zhao Z, Wickersham N, Kangelaris KN, May AK, Bernard GR, Matthay MA, Calfee CS, Koyama T, Ware LB: External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome. Intensive Care Med; 2017 Aug;43(8):1123-1131

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Performance was better in the clinical trials with an AUC of 0.74 (95% CI 0.70-0.79) in FACTT, compared to 0.72 (95% CI 0.67-0.77) in VALID, a more heterogeneous observational cohort.
  • The AUC was 0.73 (95% CI 0.70-0.76) when FACTT and VALID were combined.
  • Although the model performance as measured by AUC was lower than in the original model derivation cohort, the biomarker/clinical model still performed well and may be useful for risk assessment for clinical trial enrollment, an issue of increasing importance as ARDS mortality declines, and better methods are needed for selection of the most severely ill patients for inclusion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28593401.001).
  • [ISSN] 1432-1238
  • [Journal-full-title] Intensive care medicine
  • [ISO-abbreviation] Intensive Care Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; ARDS / Biomarker / Hospital mortality / Prediction / Validation
  •  go-up   go-down


94. Roman J, Dissaux G, Gouillou M, Gobel Y, Potard G, Leclere JC, Conan-Charlet V, Gujral D, Abgral R, Guibourg B, Pradier O, Schick U: Prolonged Overall Treatment Time and Lack of Skin Rash Negatively Impact Overall Survival in Locally Advanced Head and Neck Cancer Patients Treated with Radiotherapy and Concomitant Cetuximab. Target Oncol; 2017 Jun 03;
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Most patients presented with oropharyngeal tumors (52.2%) and stage IV disease (77.2%).
  • After a median follow-up of 17.5 months (1.3-107.6) for all patients, median overall survival was 17.9 months (95% CI: 12.7-23.2), and loco-regional control (LRC) was 9.2 months (95% CI: 3.9-14.4).
  • CONCLUSIONS: Skin and mucosal toxicity remains an issue in patients with LASCC of the head and neck treated with concomitant cetuximab and RT.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28580506.001).
  • [ISSN] 1776-260X
  • [Journal-full-title] Targeted oncology
  • [ISO-abbreviation] Target Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] France
  •  go-up   go-down


95. Davis SM, Daily S, Kristjansson AL, Kelley GA, Zullig K, Baus A, Davidov D, Fisher M: Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis. Harm Reduct J; 2017 May 17;14(1):25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis.
  • BACKGROUND: Previous research on the effectiveness of needle exchange programs (NEP) in preventing hepatitis C virus (HCV) in people who inject drugs (PWID) has shown mixed findings.
  • Study quality was assessed using the Newcastle Ottawa (NOS) scale.
  • Results were considered statistically significant if the 95% confidence interval (CI) did not cross 1.
  • Heterogeneity was estimated using Q and I <sup>2</sup> with alpha values for Q ≤ 0.10 considered statistically significant.
  • Studies had an average NOS score of 7 out of 9 (77.8%) stars.
  • Results were mixed with the odds ratio model indicating no consistent association (OR, 0.51, 95% CI, 0.05-5.15), and the hazard ratio model indicating a harmful effect (HR, 2.05, 95% CI, 1.39-3.03).
  • There is a need for well-designed research studies employing standardized criteria and measurements to clarify this issue.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2011 Aug 13;378(9791):571-83 [21802134.001]
  • [Cites] Addiction. 2012 Jun;107(6):1057-65 [22168373.001]
  • [Cites] Clin Infect Dis. 2013 Aug;57 Suppl 2:S32-8 [23884063.001]
  • [Cites] CMAJ. 2001 Oct 2;165(7):889-95 [11599327.001]
  • [Cites] Am J Public Health. 2013 Jan;103(1):e44-52 [23153148.001]
  • [Cites] Am Med J. 2015 Jul 9;6(1):9-13 [26692957.001]
  • [Cites] Int J Drug Policy. 2001 Apr 1;12(1):45-57 [11275503.001]
  • [Cites] BMJ. 2011 Jul 22;343:d4002 [21784880.001]
  • [Cites] Int J STD AIDS. 2014 Jul;25(8):596-606 [24352120.001]
  • [Cites] J Urban Health. 2013 Jun;90(3):516-28 [22766605.001]
  • [Cites] Clin Lab Sci. 2003 Spring;16(2):99-106 [12757189.001]
  • [Cites] BMC Med Res Methodol. 2008 Sep 14;8:62 [18789163.001]
  • [Cites] Psychol Methods. 2009 Jun;14(2):165-76 [19485627.001]
  • [Cites] Harm Reduct J. 2015 Oct 16;12:22 [26472126.001]
  • [Cites] AIDS Behav. 2013 Nov;17(9):2878-92 [23975473.001]
  • [Cites] Semin Liver Dis. 2011 Nov;31(4):340-6 [22189974.001]
  • [Cites] Dig Liver Dis. 2011 Jan;43(1):66-72 [20739252.001]
  • [Cites] Control Clin Trials. 1986 Sep;7(3):177-88 [3802833.001]
  • [Cites] Addict Res Theory. 2016;24(1):62-68 [27499724.001]
  • [Cites] Am J Public Health. 1995 Nov;85(11):1531-7 [7485666.001]
  • [Cites] Hepatology. 2013 Jun;57(6):2164-70 [23280550.001]
  • [Cites] Can J Public Health. 2010 Jan-Feb;101(1):50-5 [20364539.001]
  • [Cites] BMC Med Res Methodol. 2012 Apr 18;12:51 [22512835.001]
  • [Cites] J Infect Dis. 2011 Jul 1;204(1):74-83 [21628661.001]
  • [Cites] Clin Infect Dis. 2012 Jul;55 Suppl 1:S10-5 [22715208.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2017 Feb;14 (2):122-132 [27924080.001]
  • [Cites] Ann Intern Med. 2012 Feb 21;156(4):271-8 [22351712.001]
  • [Cites] Int J Drug Policy. 2014 Jan;25(1):34-52 [23973009.001]
  • [Cites] Med J Aust. 1997 Jul 7;167(1):17-20 [9236754.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2016 Dec 02;65(47):1336-1342 [27906906.001]
  • [Cites] J Clin Epidemiol. 2009 Aug;62(8):838-844.e3 [19128939.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Clin Infect Dis. 2014 Nov 15;59(10):1411-9 [25114031.001]
  • [Cites] Addiction. 2017 Feb;112(2):236-247 [27566970.001]
  • [Cites] Epidemiology. 2004 Sep;15(5):543-9 [15308953.001]
  • [Cites] Int J Epidemiol. 2014 Feb;43(1):235-48 [24374889.001]
  • [Cites] Prev Med. 2009 Aug;49(1):68-73 [19410600.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):28-35 [24080775.001]
  • [Cites] Drug Alcohol Depend. 2011 Nov 1;118(2-3):100-10 [21515001.001]
  • [Cites] N Engl J Med. 2015 Jul 30;373(5):397-9 [26106947.001]
  • [Cites] Indian J Med Res. 2008 Nov;128(5):640-6 [19179686.001]
  • [Cites] Int J STD AIDS. 2007 Jan;18(1):23-7 [17326858.001]
  • [Cites] J Urban Health. 2000 Mar;77(1):103-12 [10741846.001]
  • [Cites] Clin Infect Dis. 2014 Sep 15;59(6):755-64 [24917659.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 May 8;64(17):453-8 [25950251.001]
  • [Cites] Top Antivir Med. 2013 Feb-Mar;21(1):15-9 [23596274.001]
  • [Cites] J Postgrad Med. 2016 Apr-Jun;62(2):124-5 [26767973.001]
  • [Cites] Addiction. 2011 Nov;106(11):1978-88 [21615585.001]
  • [Cites] J Am Pharm Assoc (2003). 2010 Mar-Apr 1;50(2):148-57 [20199955.001]
  • [Cites] AIDS. 1999 Apr 16;13(6):F45-51 [10397556.001]
  • [Cites] Syst Rev. 2014 Sep 02;3:95 [25178433.001]
  • [Cites] Am J Epidemiol. 2002 Apr 1;155(7):645-53 [11914192.001]
  • [Cites] J Viral Hepat. 2012 Jan;19(1):55-64 [22187945.001]
  • [Cites] Drug Alcohol Depend. 2014 Dec 1;145:48-68 [25456324.001]
  • [Cites] PLoS Med. 2009 Jul 21;6(7):e1000097 [19621072.001]
  • (PMID = 28514954.001).
  • [ISSN] 1477-7517
  • [Journal-full-title] Harm reduction journal
  • [ISO-abbreviation] Harm Reduct J
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / U54 GM104942
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Hepatitis C / Heroin / Injection drug use / Meta-analysis / Needle exchange program / Opioids / Pain / Pain killers / Systematic review
  •  go-up   go-down


96. Katz C, Randall JR, Sareen J, Chateau D, Walld R, Leslie WD, Wang J, Bolton JM: Predicting suicide with the SAD PERSONS scale. Depress Anxiety; 2017 May 04;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Suicide is a major public health issue, and a priority requirement is accurately identifying high-risk individuals.
  • When predicting suicide at 12 months, medium- and high-risk scores on SPS had a sensitivity of 49% and a specificity of 60%; the positive and negative predictive values were 0.9 and 99%, respectively.
  • Half of the suicides at both 6- and 12-month intervals were classified as low risk by SPS at index visit.
  • The area under the curve at 12 months for the Modified SPS was 0.59 (95% confidence interval [CI] range 0.51-0.67).
  • High-risk scores (compared to low risk) were significantly associated with death by suicide over the 5-year study period using the SPS (hazard ratio 2.49; 95% CI 1.34-4.61) and modified version (hazard ratio 2.29; 95% CI 1.24-2.29).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Wiley Periodicals, Inc.
  • (PMID = 28471534.001).
  • [ISSN] 1520-6394
  • [Journal-full-title] Depression and anxiety
  • [ISO-abbreviation] Depress Anxiety
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; emergency psychiatry / epidemiology / suicide risk assessment
  •  go-up   go-down


97. Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, Vollmer S: The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol; 2017 Jun;5(6):423-430
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • FINDINGS: We estimate the global cost of diabetes for 2015 was US$1·31 trillion (95% CI 1·28-1·36) or 1·8% (95% CI 1·8-1·9) of global gross domestic product (GDP).
  • Notably, indirect costs accounted for 34·7% (95% CI 34·7-35·0) of the total burden, although substantial variations existed both in the share and the composition of indirect costs across countries.
  • Although limited data were available for low-income and middle-income countries, our findings suggest that large diabetes-associated costs are not only a problem in high-income settings but also affect poorer world regions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28456416.001).
  • [ISSN] 2213-8595
  • [Journal-full-title] The lancet. Diabetes & endocrinology
  • [ISO-abbreviation] Lancet Diabetes Endocrinol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


98. Woyach JA, Ruppert AS, Guinn D, Lehman A, Blachly JS, Lozanski A, Heerema NA, Zhao W, Coleman J, Jones D, Abruzzo L, Gordon A, Mantel R, Smith LL, McWhorter S, Davis M, Doong TJ, Ny F, Lucas M, Chase W, Jones JA, Flynn JM, Maddocks K, Rogers K, Jaglowski S, Andritsos LA, Awan FT, Blum KA, Grever MR, Lozanski G, Johnson AJ, Byrd JC: BTK&lt;sup&gt;C481S&lt;/sup&gt;-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia. J Clin Oncol; 2017 May 01;35(13):1437-1443
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Results With a median follow-up time of 3.4 years, the estimated cumulative incidence of progression at 4 years is 19% (95% CI, 14% to 24%).
  • Among patients who experienced relapse, acquired mutations of BTK or PLCG2 were found in 85% (95% CI, 71% to 94%), and these mutations were detected an estimated median of 9.3 months (95% CI, 7.6 to 11.7 months) before relapse.
  • Conclusion Relapse of chronic lymphocytic leukemia after ibrutinib is an issue of increasing clinical significance.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2014 Feb 20;123(8):1207-13 [24311722.001]
  • [Cites] Blood. 2015 Aug 13;126(7):842-50 [26116658.001]
  • [Cites] N Engl J Med. 2013 Jul 4;369(1):32-42 [23782158.001]
  • [Cites] Cancer. 2015 Oct 15;121(20):3612-21 [26193999.001]
  • [Cites] N Engl J Med. 2014 Jun 12;370(24):2352-4 [24869597.001]
  • [Cites] N Engl J Med. 2015 Dec 17;373(25):2425-37 [26639149.001]
  • [Cites] Leukemia. 2015 Apr;29(4):895-900 [25189416.001]
  • [Cites] JAMA Oncol. 2015 Apr;1(1):80-7 [26182309.001]
  • [Cites] Blood. 2014 May 22;123(21):3286-95 [24659631.001]
  • [Cites] N Engl J Med. 2014 Jul 17;371(3):213-23 [24881631.001]
  • [Cites] Blood. 2015 Jul 2;126(1):61-8 [25972157.001]
  • [Cites] Blood. 2011 Jun 9;117(23):6287-96 [21422473.001]
  • [Cites] N Engl J Med. 2014 Jun 12;370(24):2286-94 [24869598.001]
  • (PMID = 28418267.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA197870; United States / NCI NIH HHS / CA / P50 CA140158; United States / NCI NIH HHS / CA / K23 CA178183; United States / NCI NIH HHS / CA / R01 CA177292; United States / NCI NIH HHS / CA / R01 CA183444; United States / NCI NIH HHS / CA / P01 CA095426; United States / NCI NIH HHS / CA / P30 CA014236; United States / NCI NIH HHS / CA / R35 CA197734
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Alexander CMO: The origin of inner Solar System water. Philos Trans A Math Phys Eng Sci; 2017 May 28;375(2094)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of the potential volatile sources for the terrestrial planets, the CI and CM carbonaceous chondrites are closest to the planets' bulk H and N isotopic compositions.
  • For the Earth, the addition of approximately 2-4 wt% of CI/CM material to a volatile-depleted proto-Earth can explain the abundances of many of the most volatile elements, although some solar-like material is also required.
  • To test these models, at present the H isotopes of water are the most promising indicators of formation location because they should have become increasingly D-rich with distance from the Sun.
  • The estimated initial H isotopic compositions of water accreted by the CI, CM, CR and Tagish Lake carbonaceous chondrites were much more D-poor than measured outer Solar System objects.
  • 3-7 AU in the Grand Tack model) and possibly close to where they are found today.This article is part of the themed issue 'The origin, history and role of water in the evolution of the inner Solar System'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Author(s).
  • [Cites] Science. 2012 Aug 10;337(6095):721-3 [22798405.001]
  • [Cites] Astron Astrophys. 2014 Dec 1;572:null [25684776.001]
  • [Cites] Nature. 2014 Jan 23;505(7484):525-7 [24451541.001]
  • [Cites] Nature. 2010 Apr 29;464(7293):1320-1 [20428164.001]
  • [Cites] Science. 2011 Jun 24;332(6037):1528-32 [21700868.001]
  • [Cites] Science. 1979 Jul 6;205(4401):49-52 [17778898.001]
  • [Cites] Science. 2012 Nov 30;338(6111):1196-9 [23197530.001]
  • [Cites] Science. 1982 May 7;216(4546):630-3 [17783310.001]
  • [Cites] Sci Adv. 2015 Apr 17;1(3):e1500109 [26601169.001]
  • [Cites] Science. 2014 Sep 26;345(6204):1590-3 [25258075.001]
  • [Cites] Science. 2014 Oct 31;346(6209):623-6 [25359971.001]
  • [Cites] Science. 2011 Aug 26;333(6046):1116-9 [21868668.001]
  • [Cites] Nature. 1997 Sep 18;389(6648):265-8 [9305838.001]
  • [Cites] Science. 2004 Sep 17;305(5691):1763-6 [15375265.001]
  • [Cites] Science. 2011 Jun 24;332(6037):1533-6 [21700869.001]
  • [Cites] Nature. 2011 Oct 05;478(7368):218-20 [21976024.001]
  • [Cites] Nature. 2011 May 26;473(7348):489-92 [21614076.001]
  • [Cites] Nature. 2005 May 19;435(7040):317-20 [15902251.001]
  • [Cites] Science. 2013 Jan 18;339(6117):292-6 [23196909.001]
  • [Cites] Nature. 2011 Jun 05;475(7355):206-9 [21642961.001]
  • [Cites] Nature. 1987 Apr 2;326(6112):477-9 [11540894.001]
  • [Cites] Science. 2013 Jun 14;340(6138):1317-20 [23661641.001]
  • [Cites] Science. 2007 Jul 13;317(5835):231-3 [17569827.001]
  • [Cites] Science. 2015 Jan 23;347(6220):1261952 [25501976.001]
  • [Cites] Geochim Cosmochim Acta. 1994 Dec;58(24):5579-87 [11539151.001]
  • [Cites] Nature. 2010 Apr 29;464(7293):1322-3 [20428165.001]
  • [Cites] Nature. 2014 Jan 30;505(7485):629-34 [24476886.001]
  • [Cites] Science. 1998 Feb 6;279(5352):842-4 [9452379.001]
  • (PMID = 28416723.001).
  • [ISSN] 1364-503X
  • [Journal-full-title] Philosophical transactions. Series A, Mathematical, physical, and engineering sciences
  • [ISO-abbreviation] Philos Trans A Math Phys Eng Sci
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Grand Tack / asteroids / chondrites / terrestrial planets / volatiles / water
  •  go-up   go-down


100. Langlais BT, Panczyk M, Sutter J, Fukushima H, Wu Z, Iwami T, Spaite D, Bobrow B: Barriers to patient positioning for telephone cardiopulmonary resuscitation in out-of-hospital cardiac arrest. Resuscitation; 2017 Jun;115:163-168

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common problem is getting patients to a hard, flat surface.
  • Telecommunicators were less likely to start TCPR instructions in the barrier group than in the non-barrier group (OR: 0.63, 95% CI: 0.45-0.88; p=0.007).
  • Telecommunicator-directed bystander chest compressions were more than twice as likely to start in the non-barrier group (OR: 2.2, 95% CI: 1.6-3.2; p<0.001).
  • Rescuers were 3.7 times more likely to overcome a barrier and start compressions (OR: 3.7, 95% CI: 2.0-6.8; p<0.001) when multiple bystanders were present.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28385638.001).
  • [ISSN] 1873-1570
  • [Journal-full-title] Resuscitation
  • [ISO-abbreviation] Resuscitation
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down






Advertisement